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Translational examination of the orbitofrontal cortex and striatum in 
obsessive compulsive disorder 
Sean Christopher Piantadosi, PhD 
University of Pittsburgh, 2019 
For decades a causal role for orbitofrontal cortex (OFC) and striatal dysfunction in 
obsessive compulsive disorder (OCD) has been hypothesized. Structural as well as functional MRI 
studies have implicated these regions and their interconnections in OCD pathogenesis, though their 
precise roles in encoding obsessive or compulsive symptoms are still an area of active 
investigation. Several lingering questions therefore remain. First, what are the molecular 
adaptations in the OFC and striatum that give rise to these structural and functional deficits in 
OCD? Second, how do activity patterns in these regions give rise to compulsive behavior, and how 
do treatments that reduce compulsive behavior affect these activity patterns? Using a translational 
approach, we have investigated each of these questions for the first time. 
In Chapter 1, we have performed the first post-mortem analysis of OCD tissue looking at 
gene expression in the OFC and striatum. Targeting our analysis only to genes implicated in 
previous clinical and preclinical studies, we found that many genes critical for excitatory synapse 
function were reduced in the OFC of individuals with OCD. Several transcripts were also reduced 
across OFC and striatal brain regions, including DLGAP3 (also known as SAPAP3), which has 
been previously linked to OCD via preclinical studies showing that Sapap3-knockout mice display 
a compulsive behavioral phenotype and cortico-striatal alterations. In Chapter 2, we examine the 
functional consequences of reduced cortico-striatal Sapap3 expression on activity patterns of large 
groups of neurons in the OFC and central striatum using Sapap3-knockout (KO) mice and in vivo 
 v 
calcium imaging. Finally, in Chapter 3 we examine the role of genetically distinct striatal cell types 
in producing compulsive behavior. These data directly test several long-standing hypotheses 
regarding OCD pathogenesis and shed new light on how compulsive behavior may be generated 
in the brain.  
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“An exciting challenge for neuroscience is to convert this emerging genetic 
information into useful biology: information about molecular pathways, identification 
of relevant cell types and circuits (which can be investigated with new technologies 
such as optogenetics) and an understanding of pathogenesis that can be exploited to 
develop treatments.” 
I distinctly remember reading the above quote by Dr. Steven E. Hyman (2013) as I was 
beginning graduate school and was motivated by the idea that we are at a critical juncture between 
the psychiatric clinic and the laboratory. Technological advances, both in terms of our ability to 
clinically recognize features of disease, and newfound genetic and optical tools for precise control 
of specific cells and circuits in model systems, have gotten us closer to realizing the dream of 
translational psychiatry (Licinio 2011). In this thesis, I will test whether there are changes in 
expression of glutamatergic genes in post-mortem brain tissue of patients who suffered from the 
devastating psychiatric illness, obsessive compulsive disorder. Taking a translational approach, I 
will then utilize a mouse lacking a gene critical for normal glutamatergic neurotransmission and 
investigate how this affects neural activity associated with compulsive behavior. 
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1.1 Obsessive Compulsive Disorder 
1.1.1  Burden of OCD 
Obsessive compulsive disorder (OCD) is a devastating, chronic psychiatric illness that has 
a lifetime prevalence of between 1-3% and affects an estimated 50 million people worldwide 
(Koran 2000). OCD is characterized by intrusive, recurrent thoughts (obsessions), and repetitive 
behaviors or repetitive mental acts (compulsions) that are often performed to reduce the anxiety 
associated with the obsessions (Pauls et al. 2014). An OCD patient’s urge to engage in these 
persistent behavioral patterns results in a poorer overall quality of life, an impairment in academic 
and work functioning, and a decrement in interpersonal relationships relative to healthy individuals 
(Koran et al. 2007; Koran, Thienemann, and Davenport 1996). OCD often presents in childhood, 
with a peak of approximately 10 years of age. 40% of childhood onset OCD cases continue into 
adulthood (Stewart et al. 2004). Valid first-line treatment strategies for OCD include cognitive 
behavioral therapy (CBT) as well as treatment with selective serotonin reuptake inhibitors (SSRIs). 
Relative to treatment strategies used for other anxiety disorders and depression, SSRI 
administration for OCD is most efficacious at higher doses and a prolonged treatment course of 
between 8-12 weeks (Bloch et al. 2008; Koran et al. 2007; Pittenger and Bloch 2014). However, 
even with optimal treatment (often involving combined CBT and pharmacotherapy), many patients 
continue to experience substantial symptoms and remission is rare (Pittenger et al. 2005). Given 
its chronic nature and treatment refractory nature, it is no surprise that individuals with OCD are 
10 times more likely to die by suicide than the general population (Fernández de la Cruz et al. 
2017). Together, these data highlight the overwhelming burden individuals with OCD suffer 
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through on a daily basis, and the need to further investigate the mechanisms underlying OCD and 
its treatments.  
1.1.2  Heritability of OCD 
Family studies of OCD have consistently suggested that OCD is familial (Geller 2006; 
Pauls 2010). Further, there is an increased rate of childhood-onset OCD if a first-degree relative 
has been diagnosed with the disorder compared to healthy individuals (Nestadt et al. 2001; Hanna 
et al. 2005). While this evidence strongly suggests that OCD travels in families, it cannot provide 
information about whether the root cause is genetic or environmental. Twin studies, by contrast, 
are more useful in determining whether genetic factors are involved in OCD. Twin studies have 
consistently suggested a genetic component to OCD (Pauls 2010). Heritability estimates of OCD 
as well as obsessive-compulsive characteristics demonstrate that genetic factors explain between 
27% to 47% of the phenotypic variance (Bolton et al. 2007; Pauls 2010; Tambs et al. 2009; van 
Grootheest et al. 2005). A recent meta-analysis of 14 published twin studies indicates that genetic 
variance, irrespective of symptom severity or sex, accounts for approximately 40% of the 
phenotypic variance of obsessive-compulsive behaviors, while shared environmental factors did 
not contribute to the variance significantly (Taylor 2011). Importantly, this study identified that 
non-shared environmental factors, potentially epigenetic or post-translational modifications, 
accounted for 51% of the phenotypic variance (higher than the estimate of genetic factors). In 
summary, ample data support the hypothesis that there is a genetic component to OCD, though 
they are likely not the sole trigger for the disorder.  
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1.1.3  Genetics of OCD: Developing role for the glutamatergic system 
1.1.3.1 Candidate gene studies 
Given that evidence suggests OCD is at least in part a genetic disorder, an active area of 
research over the past 30 years has been to uncover genes or genetic loci that are associated with 
OCD. Based on the involvement of monoaminergic signaling and serotonin in the treatment of 
OCD, with SSRIs continuing to be the most effective pharmacological treatment for OCD (Barr, 
Goodman, and Price 1993), as well as data suggesting that agonists of specific serotonin receptor 
subtypes can exacerbate OCD symptoms (Koran, Pallanti, and Quercioli 2001; Stern et al. 1998; 
Zohar et al. 1987), early candidate gene studies focused on monoaminergic genes. Interestingly, 
associations between the majority of these genes and OCD have been either weak or nonsignificant 
(see (Pauls 2010) for a detailed review), and none have been consistently replicated. Thus, 
researchers have turned to other potential pathways that may be playing a role in the development 
of OCD.  
 Recently, several promising findings have been made linking dysregulation of the 
excitatory neurotransmitter glutamate may be playing a role in OCD (Pittenger, Bloch, and 
Williams 2011). In 2006, two independent candidate gene studies identified associations between 
OCD and the glutamate transporter gene SLC1A1 (Arnold et al. 2006; Dickel et al. 2006). 
Additional studies have replicated and elaborated on this finding in a number of independent 
cohorts (Samuels et al. 2011; Shugart et al. 2009; Stewart et al. 2007), and genetic linkage studies 
have further implicated the genomic region (chromosome 9p) containing the SLC1A1 gene (Hanna 
et al. 2002). Expanding on this finding, Wendland and colleagues (2009) identified a haplotype of 
three linked single nucleotide polymorphisms (SNP) that were twice as prevalent in OCD patients 
as in controls. They then demonstrated that one specific SNP resulted in a 50% decrease in SLC1A1 
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mRNA expression in cell culture, suggesting that SLC1A1 expression in OCD patients may be 
reduced, though this has not yet directly been tested. Together, these data point to a functional role 
of SLC1A1 in OCD pathogenesis.  
Other candidate gene studies have implicated several glutamate receptors. Several studies 
have examined the relationship of GRIN2B, which encodes the glutamate ionotropic NMDA 
receptor 2B. NMDA receptors, and GRIN2B in particular, are critical for normal glutamatergic 
transmission and NMDA-mediated plasticity (Cho et al. 2009). An early study identified a 
significant association with OCD and variants within the 3’UTR of GRIN2B (Arnold et al. 2004), 
although several studies looking at this same locus in other populations did not find the same 
association (Alonso et al. 2012; Liu et al. 2012). An additional study looking at a different SNP 
found that the T-allele of SNP rs1019385 was significantly associated with ordering and checking 
OCD subtypes (Kohlrausch et al. 2016), raising the possibility that individual OC phenotypes may 
have different genetic underpinnings (Pauls et al. 2014). Genes encoding another group of 
ionotropic glutamate receptors, kainate receptors (GRIK), have also been associated with OCD. 
Several markers in the GRIK2 gene have been shown to be significantly associated with OCD, 
though the sample size of these studies is small (Delorme et al. 2004; Rajendram et al. 2017; 
Sampaio et al. 2011).  
1.1.3.2 Genome-wide association studies 
In addition to hypothesis driven candidate gene studies assessing the association of a select 
gene and OCD, unbiased genome analysis has been conducted in OCD through genome-wide 
association studies (GWASs). Although no single genetic locus has reached genome-wide 
significance in OCD GWAS as of yet (a fact generally believed to be due a lack of samples and 
insufficient power (Mattheisen et al. 2015)), the results of these experiments thus far have also 
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converged on glutamatergic signaling as a potential source of dysfunction in OCD. The first OCD 
GWAS, conducted by the International Obsessive-Compulsive Disorder Foundation Genetics 
Collaborative (IOCDF-GC), involved 1,465 cases, 5,557 ancestry matched controls, and 400 trios, 
and analyzed 469,410 autosomal SNPs. In this analysis two SNPs located in the DLGAP1 (discs 
large-associated protein 1) gene showed the strongest association with OCD (Stewart et al. 2013). 
DLGAP1 is a member of a family of post-synaptic density scaffolding proteins responsible for 
maintaining receptors at glutamatergic synapses (Rasmussen, Rasmussen, and Silahtaroglu 2017). 
A meta-analysis of all data from both case-control samples and trios identified a SNP near FAIM2 
(FAS apoptotic inhibitory molecule 2) as having the strongest association with OCD. Similar to 
DLGAP1, Faim2 in rats is known to be expressed in the post-synaptic density and colocalizes with 
the glutamate receptor GluR2 (Schweitzer, Suter, and Taylor 2002).  
In the second OCD GWAS, conducted by the OCD Collaborative Genetics Association 
Study (OCGAS), a new marker was identified on chromosome 9 near the PTPRD gene which was 
the most strongly associated with OCD (Mattheisen et al. 2015). PTPRD protein is a tyrosine 
phosphatase that is involved in the differentiation of glutamatergic synapses (Dunah et al. 2005; 
Woo et al. 2009; Takahashi and Craig 2013). It also interacts with SLITRK3, a post-synaptic 
adhesion molecule thought to regulate GABAergic synapse development (Takahashi et al. 2012), 
as well as SLITRK5 to regulate TrkB receptor trafficking (Song et al. 2015). Critically, despite 
examining entirely distinct populations, analysis of previously identified hit regions in the IOCDF-
GC study found that 12 of the 15 strongest signals showed associations in the same direction in 
the OCGAS GWAS. Additionally, while the exact genomic regions of both DLGAP1 and GRIK2 
identified in the IOCDF-GC were not identified in the OCGAS, two independent markers in each 
of these two genes were identified and were significantly associated with OCD, providing more 
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confidence that these genes may be relevant candidate genes for OCD (Mattheisen et al. 2015). 
Finally, a meta-analysis of the two studies has recently been completed and demonstrated that 
previously identified SNPs near DLGAP1, PTPRD, GRIK2, and FAIM2 were all strongly 
associated with OCD, albeit not significantly (p-values between 4.2 x 10-6 to 7.2 x 10-3). Further, 
meta-analysis revealed multiple SNPs in another ionotropic glutamate receptor gene GRID2, 
though future work must replicate this finding ((OCGAS) 2018). While in its early days, genome 
wide studies of OCD have repeatedly implicated glutamatergic genes in OCD. Additional 
increases in sample size will likely push these highly-implicated genes toward genome-wide 
significance, as well as reveal new genes that can be functionally evaluated.  
1.1.3.3 Post-mortem analysis of OCD associated genes 
Given the heritability of OCD (Pauls 2010), the reported substantial environmental 
influences that may result in epigenetic changes (Taylor 2011), and the strong evidence implicating 
dysfunctional glutamatergic neurotransmission in OCD (Fig.1-1) ((OCGAS) 2018), a logical 
question to ask is, are expression levels of these genes altered in OCD tissue?  
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Figure 1-1. Schematic of glutamatergic synapse and OCD-linked proteins 
Prototypical glutamatergic synapse, with a presynaptic axon terminal (top) releasing glutamate into the synaptic cleft. 
A dendritic spine on the post-synaptic neuron contains the postsynaptic density, which is enriched in synaptic proteins 
that regulate the excitatory postsynaptic response. Proteins in bold-italics have been genetically linked to OCD.  
Surprisingly, only a single study to date has attempted to answer this question. Jaffe and 
colleagues (2014) investigated the genetic neuropathology of obsessive-compulsive symptoms 
across a range of disorders typified by compulsive behaviors. Using microarray analysis on tissue 
obtained from the dorsolateral prefrontal cortex (DLPFC), the authors identified dozens of genes 
that were differentially expressed between OCD/Obsessive compulsive personality disorder 
(OCPD)/Tic cases and controls. Gene set enrichment tests implicated several distinct biological 
pathways, though the glutamate system did not appear significantly affected. This could have been 
due to several factors, including the combining of several diagnoses together,  the selection of the 
DLPFC, which has canonically not been considered a region involved in OCD pathogenesis 
(Menzies et al. 2008b; Pauls et al. 2014), as well as the difficulty in identifying significant 
 9 
differential transcript expression with a small number of subjects when using a transcriptomic 
approach such as microarray. These data, while interesting, beg several questions. First, what are 
the regions most commonly linked to OCD pathogenesis? Second, is expression of glutamatergic 
genes relevant for signaling in these brain regions? And third, how does disruption of one or more 
of these associated genes alter activity levels in these regions? 
1.1.4  Neural basis of OCD 
Over the past 30 years, numerous improvements have been made in our ability to image 
the human brain, which has led to significant advances in our understanding of many major 
neurological and psychiatric disorders (Silbersweig and Rauch 2017). Relative to other psychiatric 
illnesses and across a variety of different task conditions OCD has demonstrated a high degree of 
concordance across imaging studies in the regions that are associated with the disorder 
(Chamberlain et al. 2005). Both anatomical as well as functional studies strongly implicate 
dysfunction in cortico-striatal circuitry, specifically within the affective cortico-basal ganglia loop 
(Menzies et al. 2008b; Graybiel and Rauch 2000) that consists of the orbitofrontal cortex (OFC) 
and direct glutamatergic projection to the caudate nucleus/dorsal striatum. These segregated 
cortico-striatal loops, which run in parallel and connect cortical regions basal ganglia outputs via 
the striatum (Alexander, DeLong, and Strick 1986), have been identified in primates and are each 
thought to subserve relatively independent functions that together help to coordinate the execution 
of a motor plan (Haber 2003, 2016; Haber et al. 1995). The “affective-loop”, so called because of 
the known function of the OFC in the flexible control of emotional and motivational aspects of 
behavior (Balleine, Leung, and Ostlund 2011; Chamberlain et al. 2005; Chamberlain et al. 2008; 
Gallagher, McMahan, and Schoenbaum 1999; Milad and Rauch 2007; Saxena et al. 1999), has 
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been hypothesized to lead to the development of more cognitively based habits that may form the 
basis for obsessions (Graybiel and Rauch 2000).  
Figure 1-2. Frontocortico-striato-thalamo-cortical circuit dysfunction in OCD 
Proposed dysfunction in frontocortico-striato-thalamo-cortical circuits in OCD. Control subjects (left) have balanced 
output from frontocortical regions (e.g. lOFC, ACC) through the basal ganglia, leading to appropriate behavioral 
selection. An OCD subject (right) has a bias toward activation of the direct pathway, mediated by dopamine D1-
expressing (D1-) spiny projection neurons (SPNs) in the striatum. This activation is perpetuated in a feedback loop 
that results in overall thalamic disinhibition and possibly the engagement in compulsive behavior.  
A typical conceptualization of frontostriatal circuitry entails a direct and indirect pathway 
that are comprised of dopamine D1-receptor expressing spiny projection neurons (D1-SPNs) and 
dopamine D2-receptor expressing spiny projection neurons (D2-SPNs) (Fig.1-2). In healthy 
control individuals (Fig.1-2 left), it is thought that the excitatory direct pathway is modulated by 
the indirect pathway’s inhibitory function, allowing for appropriate behavioral selection. It has 
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been suggested that in OCD subjects an imbalance in direct and indirect pathway signaling leads 
to a bias toward the direct pathway (Fig.1-2 right), resulting in hyperactivity in the fronto-striatal 
loops (Pauls et al. 2014; Maia, Cooney, and Peterson 2008). This hyperactivity and direct pathway 
bias might drive obsessive and compulsive symptoms in multiple, non-mutually exclusive, ways. 
For example, disinhibition of the thalamus may decrease filtering of unwanted thoughts to emotion 
processing regions such as the OFC, leading to obsessive thoughts. At the same time, it is possible 
that hyperactivity in more motor fronto-striatal circuits may lead to the production of repetitive, 
compulsive behaviors. It is important to note, however, that these simplistic models are likely 
oversimplified, and cannot fully explain the heterogeneous nature of OCD. Further, key aspects of 
this model, chiefly the role of direct- and indirect-pathway projecting neurons in the striatum, 
cannot currently be directly tested in OCD patients.  
Although many regions that are not part of cortico-striatal circuits have been implicated in 
OCD (see (Menzies et al. 2008b) for a full review), and recent studies have pushed to expand these 
canonical circuits to include additional limbic regions (Milad and Rauch 2012a; Wood and Ahmari 
2015), the focus of this dissertation will be on the most well-replicated regions and circuit: the 
fronto-striatal circuit connecting the OFC and striatum.  
1.1.5  Functional CSTC disruption in OFC and striatum of OCD subjects 
Early studies used positron emission tomography (PET) to measure brain function via 
cerebral glucose metabolism demonstrated hypermetabolism (inferred as increased activity) in 
OCD subjects relative to controls within the OFC, both at rest and following provocation of OCD 
symptoms (Baxter et al. 1987; Baxter et al. 1988; Swedo et al. 1989; Rauch et al. 1994a). While 
not every study has found hypermetabolism in the OFC in OCD subjects (see (Saxena et al. 2001)), 
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a meta-analysis of PET studies found consistent evidence throughout the literature of 
hypermetabolism in both the OFC as well as the head of the caudate nucleus in OCD (Whiteside, 
Port, and Abramowitz 2004). Further support for the involvement of OFC and caudate 
hypermetabolism in OCD are data suggesting that successful pharmacological treatment 
normalizes hypermetabolism (Perani et al. 1995; Baxter et al. 1992; Saxena et al. 2003; Saxena et 
al. 1999; Rauch et al. 2002), though it is important to note that many OCD patients continue to 
experience significant symptoms even following optimal treatment (Pittenger and Bloch 2014).  
In addition to PET scan studies, many functional magnetic resonance imaging (fMRI) 
studies of OCD have also implicated cortico-striatal circuits and the regions that comprise them. 
In symptom provocation tasks, several studies have found increased blood oxygen-level dependent 
(BOLD) signal in both the OFC and caudate, suggestive of increased levels of activity within these 
regions in OCD (Breiter et al. 1996; Adler et al. 2000a). A meta-analysis of case-control fMRI 
studies conducted by Menzies and colleagues (2008b) demonstrated consistent activation of 
orbitofronto-striatal regions in OCD, though consistent patterns of activation were also identified 
in other brain regions. It is important to note that while many studies suggest that the OFC is 
hyperactive in OCD across a variety of conditions, other studies indicate that it may be hypoactive 
(perhaps depending on the medial/lateral extent being imaged), with symptom severity scores 
inversely correlated with the function of the more medial OFC (Rauch et al. 2007a). These data 
highlight that more formal studies are necessary to fully tease apart consistent differences in 
activity in OFC subregions in OCD. Finally, resting state analysis of the connectivity between the 
OFC and the dorsal striatum has found evidence for increased connectivity that is positively 
correlated with overall symptom severity (Beucke et al. 2013; Harrison, Soriano-Mas, Pujol, Ortiz, 
Lopez-Sola, et al. 2009). Together, these data support the contention that fronto-striatal circuits 
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are involved in OCD, and specifically suggest that hyperactivity in OFC and the dorsal striatum 
(caudate) may be involved.  
1.1.6  Neurochemical findings in cortico-striatal circuits in OCD 
The main neurotransmitters in cortico-striatal circuits are glutamate and GABA, as well as 
neuromodulatory input via serotonin and dopamine (Haber 2016). Given the correlational evidence 
implicating changes in activity in these regions in OCD (Pauls et al. 2014; Menzies et al. 2008b), 
researchers have examined whether there are alterations specifically in glutamatergic or 
GABAergic signaling. Early studies examined levels of glutamate in the cerebrospinal fluid (CSF) 
of OCD patients and control subjects, demonstrating that CSF glutamate levels were elevated in 
OCD patients (Chakrabarty et al. 2005). A follow-up study replicated and expanded on this 
finding, demonstrating that in a larger group of subjects, glutamate and glycine (a co-agonist of 
glutamate receptors) levels were elevated in the CSF of OCD subjects (Bhattacharyya et al. 2009). 
While these data are suggestive of a general glutamate imbalance in the CNS of OCD subjects, 
CSF findings cannot be generalized to specific regions and circuits.  
In order to make up for this deficiency and evaluate neurotransmitter concentrations in 
specific brains regions (though with significantly lower sensitivity and specificity) magnetic 
resonance spectroscopy (MRS) has been conducted in OCD subjects. MRS estimates the 
concentration of various small molecules in defined brain regions by detecting their distinct 
resonances within a magnetic field (Soares and Law 2009). While the technique isn’t able to easily 
disambiguate glutamate from another amino acid, glutamine, a composite measure Glx can be 
compared between OCD and control subjects. Early MRS studies were indicative of glutamate 
dysregulation in OCD, finding that there were elevations in Glx in the caudate in pediatric patients 
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with OCD, and that this elevation was normalized after SSRI treatment (Moore et al. 1998; 
Rosenberg et al. 2000). Similarly, in unmedicated adult OCD patients, Glx levels were elevated in 
the OFC and levels correlated with OCD symptom severity (Whiteside et al. 2006). However, 
more recent studies have not replicated these findings (see (Pittenger, Bloch, and Williams 2011) 
for thorough review). Together, these data are suggestive of glutamatergic dysfunction, possibly 
in cortico-striatal brain regions, in OCD. However, how these abnormalities directly relate to the 
devastating symptoms of OCD (obsessions and compulsions) remains unknown.  
1.2 Cortico-striatal dysfunction in OCD mouse models 
As outlined in Chapter 1.1, there is ample evidence for cortico-striatal and possibly 
glutamatergic dysfunction in OCD. However, it is difficult if not impossible to test how this 
dysfunction causally contributes to compulsive behavior in humans. Using rodent models, 
researchers are able to directly evaluate the role of and interplay between 1) specific genes and 
their contribution to compulsive behavior, 2) particular circuits and how they mediate OCD-like 
symptoms, and 3) compounds that improve or exacerbate OCD symptoms and the regions and cell 
types on which they act. Despite these promising benefits, it is important to note that it is not 
possible to fully model a complex, heterogeneous disorder such as OCD in animals. Indeed, one 
of the eponymous symptoms of the disorder, obsessions, cannot be assessed in a rodent. Therefore, 
it is critical to thoroughly evaluate how findings from a model map back onto the disorder itself.   
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1.2.1  Transgenic mouse models of OCD-like behavior 
Owing to the similarities in genetics and physiology between mice and humans, as well as 
the development of powerful tools to make genome editing easier with fewer off-target effects 
(Doyle et al. 2012), there has been a recent push to translate candidate genes identified in genetic 
studies of neuropsychiatric illnesses into mice (Donaldson et al. 2013). Indeed, several groups 
have recently independently generated mice that either underexpress (Zike et al. 2017; Gonzalez 
et al. 2017) or overexpress (Delgado-Acevedo et al. 2018) the most well-replicated OCD candidate 
gene, SLC1A1 (Arnold et al. 2006; Porton et al. 2013; Samuels et al. 2011; Shugart et al. 2009; 
Stewart et al. 2007). These studies demonstrate that SLC1A1 plays an important role in repetitive 
behavior (Zike et al. 2017), including grooming behavior, and that cortico-striatal circuits may be 
directly affected (Delgado-Acevedo et al. 2018). As additional genetic loci begin to consistently 
emerge from well-powered genetic studies of OCD, associated genes should be translated into 
rodent models for thorough mechanistic investigation. 
While these hypothesis driven studies are critical to our growing understanding of the 
pathophysiology of OCD, we are still limited in well-replicated candidate genes or significant 
GWAS hits to test using this back-translational approach. Instead, serendipitous discovery of 
transgenic mice that model OCD-like behavior and exhibit cortico-striatal deficits have been used 
to understand the basic mechanisms underlying compulsive behavior (Burguiere et al. 2015; 
Nagarajan et al. 2018; Welch et al. 2007a; Shmelkov et al. 2010). These mice have varying levels 
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1.2.1.1 Hoxb8 mutant mice 
One such mouse is the Hoxb8 knockout (KO) mouse. These mice were generated in an 
attempt to understand the role of homeobox (Hox) genes on neurodevelopment, and surprisingly 
demonstrated a 100% penetrant compulsive grooming phenotype that led to the development of 
skin lesions (Greer and Capecchi 2002). Interestingly, expression of Hoxb8 in wildtype mice was 
observed across a number of different brain regions, including the OFC and dorsal striatum 
(caudate/putamen). Intriguingly, a follow-up experiment characterized the origin of these Hoxb8-
positive cells, finding that they give rise to brain microglia and that a bone marrow transplant from 
irradiated Hoxb8 KOs was capable of reversing the compulsive grooming phenotype (Chen et al. 
2010). More recently, dysfunction in cortical and striatal regions was directly assessed in Hoxb8 
KO mice, with alterations in post-synaptic density length and thickness of both symmetric 
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(inhibitory) and asymmetric (excitatory) synapses in both the OFC and striatum. Functionally, 
impaired striatal synaptic LTP was detected at cortico-striatal synapses (Nagarajan et al. 2018). 
Further, they demonstrated a slight anxiety-like phenotype in KOs and that the anxiety phenotype 
and the compulsive grooming phenotype could be reversed with chronic administration of the 
SSRI fluoxetine.  
These data implicate both microglial dysfunction and an interaction with synaptic deficits 
in cortico-striatal signaling, which is especially interesting given that recent evidence suggests that 
Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infection 
(PANDAS), which often presents with sudden onset obsessive and compulsive symptoms, has 
been associated with differential antibody binding in the striatum (Frick et al. 2018; Bernstein et 
al. 2010). Future research should further explore the potential link between immune function, 
cortico-striatal circuitry, and obsessive-compulsive symptoms.  
1.2.1.2 Slitrk5 mutant mice 
Another serendipitous discovery involved the Slitrk5 knockout mouse. Slitrk proteins are 
transmembrane proteins that serve as axon guidance proteins and are involved in both the 
development of excitatory and inhibitory synapses (Takahashi and Craig 2013; Takahashi et al. 
2012). When Slitrk5 is globally knocked out from a mouse, mice develop both an anxiety-like and 
a compulsive grooming phenotype that results in the development of facial lesions (Shmelkov et 
al. 2010). Much like Hoxb8 mutants, the compulsive grooming phenotype was also reversed 
following treatment with the SSRI fluoxetine. Cortico-striatal alterations have also been observed 
in Slitrk5 KOs, with an increase in baseline activation of the OFC as measured by expression of 
the immediate early gene FosB. Additionally, a reduction in the expression of several critical 
glutamate receptors (GluR1, GluR2, GluN2A, GluN2B) was also reduced in the striatum of KO 
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mice, which may represent a compensatory change in response to the OFC hyperactivity 
(Shmelkov et al. 2010).  
Although direct links from Slitrk5 to OCD have not yet been made, it is of note that the 
protein encoded by the most strongly associated GWAS hit for OCD, PTPRD, interacts directly 
with several different Slitrk family members, including Slitrk5 to regulate TrkB receptors (Song et 
al. 2015). Further, Slitrk1 has been linked to Tourette’s syndrome, another disorder characterized 
by repetitive behaviors (Abelson, Kwan, et al. 2005; Proenca et al. 2011). Additional work is 
necessary to link Slitrks specifically to OCD, though preliminary unpublished evidence suggests 
the presence of rare non-synonymous mutations in Slitrk5 in OCD subjects (Song et al. 2017).  
1.2.1.3 Sapap3/Dlgap3 mutant mice 
Much like Slitrk5, another gene encoding a post-synaptic density protein that is enriched 
at cortico-striatal synapses, Sapap3 (synonymous with Dlgap3) was also unexpectedly found to 
have a potential role in compulsive behavior. Welch (2007a) and colleagues noted that when 
Sapap3 was globally knocked out, mice displayed anxiety-like behavior as well as a compulsive 
grooming phenotype that, similar to the Hoxb8 and Slitrk5 KOs, resulted in skin lesions. Again, 
both the anxiety-like phenotype as well as the compulsive grooming phenotype were reversed 
following fluoxetine administration. The phenotype was also localized to the medial striatum, with 
lentiviral rescue of wild-type Sapap3 through the dorsal/ventral extent of the medial striatum 
normalizing both the compulsive grooming and anxiety-like phenotype. Further, functional 
characterization of cortico-striatal synapses demonstrated reduced fEPSP amplitudes in KO mice 
compared to controls, and a shift in the subunit composition of NMDA receptors to a more 
immature subtype (increased NR2B subunit expression). Critically, follow-up work demonstrated 
that this synaptic dysfunction is specific to cortico-striatal and not thalamo-striatal (Wan et al. 
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2014). Elegant work by Corbit and colleagues (Corbit et al. 2019) recently evaluated the main 
cortical inputs to the striatum that might be leading to these synaptic changes, finding that 
compared to inputs from lateral OFC (lOFC), inputs from secondary motor cortex (M2) were 
strengthened in KO mice.  
Given these findings, there is substantial interest in whether Sapap3 (more commonly 
referred to as DLGAP3 in human literature) is associated with OCD. In a subset of OCD subjects, 
DLGAP3 was associated with pathological grooming (pathological skin picking, trichotillomania, 
nail-biting) (Bienvenu et al. 2009a). Similarly, in OCD subjects with comorbid trichotillomania, 
multiple rare missense mutations were identified in DLGAP3 (Zuchner et al. 2009), further 
cementing its association with pathological grooming and OCD. Additionally, SNPs in the gene 
encoding another DLGAP family member, DLGAP1, have been identified in two independent 
GWAS studies of OCD, though the associations have not reached genome-wide significance 
((OCGAS) 2018; Stewart et al. 2013). Together, these data suggest an involvement of DLGAP 
proteins in compulsive grooming both in humans and in mice, though additional molecular studies 
are needed to demonstrate a clear link to OCD.  
1.2.2  Optogenetic manipulation of cortico-striatal circuits 
With correlational evidence of alterations in the activity of and connectivity between 
fronto-cortical and striatal regions in OCD (Pauls et al. 2014; Menzies et al. 2008b), and evidence 
of functional changes in cortico-striatal circuits in transgenic models that display a compulsive 
grooming phenotypes (Nagarajan et al. 2018; Shmelkov et al. 2010; Welch et al. 2007a), a logical 
question is how do these circuit specific alterations causally contribute to compulsive behavior. 
Over the past 5 years, due primarily in part to the advent and optimization of optogenetics for 
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controlling activity in defined circuits and cell types (Boyden et al. 2005; Deisseroth and Schnitzer 
2013; Zhang, Wang, et al. 2007; Nagel et al. 2003), several studies have utilized optogenetics to 
investigate the neural circuits underlying OCD-like behaviors (see Appendix B /(Piantadosi and 
Ahmari 2015) for a thorough summary). Building off work demonstrating striatal dysfunction in 
Sapap3 KO mice, Burguiere and colleagues (2013) demonstrated baseline hyperactivity of the 
principle striatal output neuron, spiny projection neurons (SPNs), in the central striatum of KO 
mice relative to wildtype mice. Further, they found that selective stimulation of projections from 
the lOFC cell bodies, or their terminals in the central striatum could normalize the compulsive 
grooming phenotype. Interestingly, it appeared that selective stimulation of these lOFC terminals, 
somewhat paradoxically, reduced activity in the central striatum. A possible mechanism for this 
reduction was a synchronization of striatal fast spiking interneurons (FSIs), which exert profound 
feed-forward inhibition onto nearby SPNs despite only comprising of 1-3% of all striatal cells 
(Berke 2011, 2008; Gage et al. 2010; Owen, Berke, and Kreitzer 2018). These data highlight not 
only a critical role for a specific cortico-striatal circuit in controlling compulsive behavior, but also 
suggest specific dysfunction in genetically defined striatal cell types may be contributing.  
Further cementing a role for cortico-striatal hyperactivity in perseverative behavior, 
Ahmari et al. (2013) demonstrated that chronic stimulation of projections from the medial OFC 
(mOFC) to ventromedial striatum (VMS) of wildtype mice could induce a progressive and 
persistent increase in grooming. This increase in grooming was also correlated with a potentiation 
of mOFC to VMS evoked firing rates, both of which were normalized following fluoxetine 
treatment. Together, these data demonstrate that cortico-striatal circuit activity is involved in 
pathological grooming, though the precise activity patterns within these regions and the cell types 
that underlie this activity are currently unknown.  
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1.2.3  Using in vivo single-photon calcium imaging to investigate neural circuits 
The optogenetic strategies described above, while providing a causal link between 
compulsive and repetitive behavior within specific neural circuits, utilize non-physiological 
stimulation parameters to perturb the cells within these circuits. Given that the coordination and 
execution of complex behavioral patterns relies on precise timing of neural activity from multiple 
cell types, it is critical to be able to assess the dynamics of specific cell populations of interest in 
vivo. Only within this context can the impact of stimulation be truly interpreted.  
Multiple techniques are available for monitoring neural activity in vivo. In order to 
adequately assess the neural underpinnings of compulsive behavior, we required a method that 
meets three specific criteria:  
1. Simultaneous recording of hundreds of genetically distinct neurons in deep brain structures. 
2. Free range of motion to engage in spontaneous behaviors (e.g. grooming). 
3. Ability to accurately track neurons within and across sessions. 
Traditional methods to assess large-scale neural activity have utilized in vivo 
electrophysiology, which directly records the electrical potentials of individual or groups of cells 
(Hubel and Wiesel 2009; Grace and Bunney 1983; Buzsaki 2004). Electrophysiological techniques 
have unparalleled temporal specificity, allowing for precise correlation of neural activity with a 
behavior of interest. Further, estimation of action potential timing and number is far superior with 
electrophysiological measures than with any other current technique. However, currently available 
electrophysiological techniques that also permit a free range of motion for a mouse typically only 
produce on the order of dozens of cells recorded simultaneously. Additionally, the spatial location 
of these individual neurons is very challenging to ascertain, making tracking the same cell across 
the development of a behavior extremely challenging. Finally, while it has been used to great effect 
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(Kravitz, Owen, and Kreitzer 2013; Cardin et al. 2010; Cohen et al. 2012), it is often a laborious 
and low-yield procedure to combine optogenetics and electrophysiology to tag specific genetically 
defined populations of neurons, especially when the cell population is sparse.  
An alternative to electrophysiological recordings of neuronal activity is imaging of 
intracellular calcium fluctuations that occur during heightened periods of neural activity (Berridge, 
Bootman, and Roderick 2003; Grienberger and Konnerth 2012). Several methods for recording 
calcium signals exist, but all rely on the expression of genetically encoded calcium indicators 
(GECIs) and an image sensor to read the fluorescence signal. Significant GECI development has 
produced fluorophores with excellent signal to noise, though the relation of calcium signal in vivo 
to spiking activity is still an active area of investigation (Akerboom et al. 2012; Chen et al. 2013; 
Pnevmatikakis et al. 2016; Vogelstein et al. 2010). One method of recording calcium signals in 
vivo is through two-photon calcium imaging, which provides access to thousands of 
simultaneously recorded neurons with limited background signal, as well as accurate spatial 
information for each cell (Svoboda and Yasuda 2006). However, recording from deep brain 
structures remains challenging with two-photon imaging, and for successful imaging mice must 
be head-fixed to a microscope, limiting the ability to assess naturalistic behaviors (Dombeck et al. 
2007). Another commonly used method that has circumvented both the need for head fixation and 
limitation to superficial brain structures is fiber photometry, which records GECI signals through 
implanted lightweight fiber optics (Cui et al. 2014). However, this technique records bulk calcium 
signal with a complete lack of cellular resolution. 
The recent development of lightweight miniature epifluorescence microscopes has proven 
to be the precise tool necessary to answer the questions in this dissertation (Ghosh et al. 2011). 
First, the issue of imaging deep brain structures has been solved through the addition of a gradient 
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refractive index (GRIN) lens that is implanted directly into the rodent brain above an area of 
interest. Second, a lightweight miniature microscope (~2g) is able to be carefully affixed to the 
rodent’s head and can interface with the GRIN lens, allowing for mice to be freely moving during 
imaging (Resendez et al. 2016). Finally, the images produced, while significantly noisier than a 
two-photon recording, provides single-cell spatial resolution that can be accurately tracked across 
days (Sheintuch et al. 2017; Zhou et al. 2018). Combined, this tool allows us to specifically monitor 
sparse populations of neurons in deep brain structures that were previously inaccessible, and to 
understand how their activity contributes to normal and pathological behavioral states.  
1.3 Goals of the current dissertation 
The overarching goal of this thesis is to bridge a critical gap in our knowledge regarding 
preeminent hypotheses of OCD pathogenesis: glutamatergic dysfunction and functional 
abnormalities in fronto-striatal circuitry. First, I will test the hypothesis that glutamatergic genetic 
dysfunction is involved in OCD pathogenesis (Chapter 2). Using post-mortem tissue obtained from 
OCD subjects and matched comparison subjects, we will conduct the first post-mortem 
examination of the orbitofrontal cortex (OFC) and the striatum, the most commonly implicated 
brain regions in human imaging studies, looking specifically at excitatory and inhibitory 
transcripts, most of which have been previously genetically linked to OCD. Second, I will utilize 
a mouse (Sapap3-knockout) lacking a critical excitatory synaptic gene (DLGAP3/SAPAP3) that 
we demonstrate to be reduced in both cortex and striatum of OCD subjects and investigate the 
functional consequences of this reduction on activity in the OFC and striatum using in vivo 
miniature microscopy (Chapter 3). Finally, we will attempt to assess how genetically distinct 
 24 
populations of striatal neurons individually contribute to compulsive behavior in Sapap3-knockout 
mice (Chapter 4).  Together, these data will shed new light on the role of disrupted excitatory 
signaling in cortical and striatal regions in OCD, and how this disruption may contribute to 
compulsive behavior.  
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2.0 Decreases in excitatory synaptic gene expression in orbitofrontal cortex and striatum of 
subjects with obsessive compulsive disorder 
Obsessive compulsive disorder (OCD) is a severe illness that affects 2-3% of people 
worldwide. OCD neuroimaging studies have consistently shown abnormal activity in brain regions 
involved in decision-making (orbitofrontal cortex [OFC]) and action selection (striatum). 
However, little is known regarding molecular changes that may contribute to abnormal function. 
We therefore examined expression of synaptic genes in post-mortem human brain samples of these 
regions from eight matched pairs of unaffected comparison and OCD subjects. Total grey matter 
tissue samples were obtained from medial OFC (BA11), lateral OFC (BA47), head of caudate, and 
nucleus accumbens core (NAc). Quantitative polymerase chain reaction (qPCR) was then 
performed on a panel of mRNA transcripts encoding proteins related to excitatory synaptic 
structure, excitatory synaptic receptors/transporters, and GABA synapses. Relative to unaffected 
comparison subjects, OCD subjects had significantly lower levels of several transcripts related to 
excitatory signaling in both cortical and striatal regions: DLGAP3, DLGAP4, SLC1A1. However, 
most transcripts encoding excitatory synaptic proteins were selectively lower in OFC of OCD 
subjects and unchanged in striatum. Composite transcript level measures supported these findings 
by revealing that reductions in transcripts encoding excitatory synaptic structure proteins and 
excitatory synaptic receptors/transporters occurred primarily in OFC of OCD subjects. In contrast, 
transcripts associated with inhibitory synaptic neurotransmission showed minor differences 
between groups. The observed decreased levels of multiple glutamatergic transcripts across both 
medial and lateral OFC may suggest an upstream causal event. Together, these data provide the 
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first evidence of molecular abnormalities in brain regions consistently implicated in OCD human 
imaging studies. 
2.1 Introduction 
Obsessive compulsive disorder (OCD) affects 2-3% of people worldwide, and has been 
identified by the World Health Organization (WHO) as a leading cause of illness related 
disability(Kessler et al. 2005) due to its chronic and relapsing course. The substantial societal 
burden of OCD–an estimated $10 billion annual cost in the U.S (Eaton et al. 2008)–stems in part 
from sub-optimal pharmacotherapeutic treatments. First-line monotherapy with selective serotonin 
reuptake inhibitors (SSRIs) leads to remission in only 10-20% of patients, with 25% failing to 
experience any symptom improvement (Bollini et al. 1999; Pigott and Seay 1999). Development 
of more effective treatments has been limited by a lack of knowledge regarding the molecular 
pathology of the disorder. 
 
Neuroimaging studies have consistently identified cortical and striatal abnormalities in 
OCD (Graybiel and Rauch 2000). Specifically, structural MRI studies suggest that anatomical 
abnormalities in the orbitofrontal cortex (OFC) and striatum may contribute to OCD pathogenesis 
(Rotge et al. 2009a). Functional neuroimaging studies have also identified OFC and striatum as 
key loci of dysfunction in OCD, with most evidence suggesting hyperactivity in, and increased 
connectivity between, these regions (Pauls et al. 2014; Harrison, Soriano-Mas, Pujol, Ortiz, Lopez-
Sola, et al. 2009; Fitzgerald et al. 2011a; Menzies et al. 2008a; Whiteside, Port, and Abramowitz 
2004). Furthermore, hyperactivity in these critical regions is increased during symptom 
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provocation and decreased in response to successful SSRI therapy (Pauls et al. 2014; Rauch et al. 
2002), suggesting this abnormal activity may be involved in OCD symptomatology. Further 
evidence for a causal relationship between activity in cortico-striatal circuits and OCD 
pathophysiology comes from studies indicating that deep brain stimulation of ventral striatal 
targets both relieves OCD symptoms and reverses cortico-striatal hyperactivity (Rauch et al. 2006; 
Bourne et al. 2012). Finally, a causal relationship between OFC-striatal activity and OCD-relevant 
behaviors has been demonstrated using rodent models and optogenetics (Ahmari et al. 2013; 
Burguiere et al. 2013). Thus, current knowledge regarding circuit level disruptions in OCD is 
consistent across multiple lines of evidence and highlights abnormalities in OFC and striatum.  
Although the etiology of OCD is unknown, twin studies support a genetic contribution. A 
recent meta-analysis including 37 samples from 14 twin studies of obsessive-compulsive 
symptoms found that genetic factors accounted for 40% of the phenotypic variance; no significant 
contribution from shared environmental factors was noted (Taylor 2011). Unbiased genome-wide 
association studies (GWAS) indicate that genes encoding proteins found at or around excitatory 
synapses may account for this genetic contribution (Stewart et al. 2013; Mattheisen et al. 2015). 
Specifically, significant associations were observed with DLGAP1 (discs large-associated protein 
1), a post-synaptic density scaffolding protein family member, and ISM1, which is associated with 
expression of multiple genes related to glutamatergic signaling including members of the DLGAP 
family and glutamate receptors (Stewart et al. 2013). In a second OCD GWAS study, the most 
strongly associated marker was observed near the gene encoding PTPRD (protein tyrosine 
phosphatase delta), which promotes the differentiation of glutamatergic synapses (Takahashi and 
Craig 2013) and interacts with the post-synaptic adhesion molecule SLITRK3 (SLIT and NTRK-
like protein 3) (Mattheisen et al. 2015). Excitatory synapse involvement is also supported by the 
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well-replicated finding of an association between OCD and SLC1A1, which encodes the primary 
neuronal glutamate transporter (Dickel et al. 2006; Arnold et al. 2006; Porton et al. 2013; Samuels 
et al. 2011; Shugart et al. 2009; Stewart et al. 2007; Zike et al. 2017). Finally, studies in transgenic 
mice also indicate that dysregulation of glutamatergic synapses may lead to OCD-relevant cortico-
striatal dysfunction. Specifically, both Sapap3 (also known as Dlgap3) and Slitrk5 constitutive 
knockout mice display OCD-relevant compulsive grooming phenotypes and cortico-striatal 
hyperactivity that can be rescued with chronic fluoxetine treatment (Welch et al. 2007b; Burguiere 
et al. 2013; Shmelkov et al. 2010).  
Because alterations in excitatory neurotransmission are commonly associated with 
homeostatic changes in inhibitory neurotransmission, prior work has also examined γ-amino 
butyric acid (GABA) signaling in OCD. A small literature in humans supports a possible role for 
GABA-ergic dysfunction by demonstrating decreased mPFC GABA levels via magnetic 
resonance spectroscopy in subjects with OCD (Simpson et al. 2012), and increased mPFC GABA 
levels following a single ketamine infusion (Rodriguez et al. 2015). In addition, transcranial 
magnetic stimulation (TMS)-based neurophysiological indices suggest dysregulated GABA-
signaling in OCD patients (Richter et al. 2012). Tourette syndrome, which is highly comorbid with 
OCD(Du et al. 2010), has also been associated with reduced numbers of striatal GABAergic 
interneurons (both parvalbumin- and choline acetyltransferase-expressing subtypes (Kalanithi et 
al. 2005; Kataoka et al. 2010)). Preclinical evidence likewise supports a potential role for 
GABAergic alterations in repetitive behavior. For example, dysfunction in striatal parvalbumin 
positive interneurons has been linked to compulsive grooming behavior in Sapap3 knockout mice 
(Burguiere et al. 2013). In addition, simulation of post-mortem findings from Tourette syndrome 
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in mice via ablation of parvalbumin positive interneurons in the dorsal striatum leads to an increase 
in stress-induced grooming and anxiety (Xu, Li, and Pittenger 2016). 
Although the potential roles of glutamatergic and GABAergic signaling in OCD have been 
broadly investigated in human neuroimaging studies, only one prior study has directly explored 
the possible underlying molecular substrates of these signaling changes by quantifying gene 
expression in human post-mortem brain tissue (Jaffe et al. 2014). This study examined the 
dorsolateral prefrontal cortex (DLPFC) via microarray analyses in a group of subjects that had 
OCD, obsessive-compulsive personality disorder (OCPD), and/or tic disorder diagnoses. Although 
decreased parvalbumin levels (PVALB) were observed in OCD subjects compared to unaffected 
comparison subjects, gene set analyses did not reveal either glutamatergic or GABAergic 
neurotransmission as a top altered pathway. However, this study did not examine the OFC or 
striatum, which have been more commonly implicated in the OCD disease process (Breiter et al. 
1996; Rauch, Savage, Alpert, Fischman, et al. 1997) than the DLPFC (Menzies et al. 2008b). To 
assess whether glutamatergic and/or GABAergic signaling is altered in these brain regions, we 
quantified the expression of 16 genes whose protein products are critical for normal excitatory and 
inhibitory neurotransmission (Table 2-1) in post-mortem tissue samples from the medial OFC, 




2.2.1  Human post-mortem subjects 
Brain specimens (N=16) were obtained through the University of Pittsburgh Brain Tissue 
Donation Program during autopsies conducted by the Allegheny County Medical Examiner's 
Office (Pittsburgh, PA) after consent was given by next-of-kin. An independent panel of 
experienced clinicians examined clinical records, toxicology, psychological autopsy data, and 
structured interviews with family members to make consensus DSM-IV diagnoses. Unaffected 
comparison subjects underwent identical assessments and were determined to be free of any 
lifetime psychiatric illnesses. All procedures were approved by the University of Pittsburgh's 
Committee for the Oversight of Research and Clinical Training Involving Decedents and 
Institutional Review Board for Biomedical Research. To reduce biological variance, each subject 
with OCD (n=8) was matched for sex, and as closely as possible for age and RNA integrity number 
(RIN), with one unaffected comparison subject. Subject groups did not differ in mean age (t14 = 
0.2, p = .83), post-mortem interval (PMI; t14 = 0.6, p = .54), brain pH (t14 = 1.6, p = .13), RNA 
ratio (t14 = 0.3, p = .75), or RIN (t14 = 0.2, p = .87), (Table 2-2). 
2.2.2  Tissue collection and RNA extraction 
Standardized amounts (50 mm3) of gray matter were collected via a cryostat from four 
separate brain regions identified cytoarchitectonically: medial orbitofrontal cortex (mOFC, 
BA11), lateral orbitofrontal cortex (lOFC, BA47), head of the caudate nucleus, and the nucleus 
accumbens core. RNA was extracted using an RNeasy Plus Mini kit (QIAGEN, Valencia, CA). 
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RIN values were obtained using the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, 
CA). Each subject had a RIN value ≥ 7, indicative of high-quality, intact RNA. 
2.2.3  Selection of transcripts for expression analysis 
Using qPCR we examined the expression of 16 excitatory and inhibitory synaptic genes, 
the majority of which (11/16) have been genetically linked to OCD and OCD-related disorders 
(e.g. grooming disorders, skin picking, Tourette syndrome) (Table 2-1).  Transcripts were broadly 
grouped into three categories based on the function of their protein product: 1) excitatory synaptic 
structure: contains transcripts in the DLGAP and SLITRK families, both of which have established 
roles in synapse formation and stabilization; 2) excitatory synaptic receptors and transporters: 
contains two transcripts encoding ionotropic glutamate receptors (GRIA1 and GRIN2B), the 
vesicular glutamate transporter SLC17A7, and the excitatory amino acid transporter SLC1A1; and 
3) GABA synapse: contains the GABAergic synapse scaffolding protein GABARAP, two major 
GABA synthesizing enzymes (GAD1 and GAD2), two calcium binding proteins that characterize 
two functionally different classes of inhibitory interneurons found in the striatum and cortex 
(PVALB and CALB1), and the vesicular GABA transporter (SLC32A1). 
2.2.4  Quantitative PCR (qPCR) 
Complementary DNA (cDNA) was generated using 90ng of RNA per sample and qScript 
cDNA SuperMix (Quanta BioSciences, Gaithersburg, MD) following universal cycling conditions 
(65 to 59ºC touchdown and 40 cycles of 10s at 95ºC, 10s at 59ºC, and 10s at 72ºC). PCR products 
were amplified in triplicate on a Bio-Rad CFX96 Real-Time PCR system (Bio-Rad, Hercules, 
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California USA) using SYBR Green I nucleic acid gel stain. Subject pairs were run on the same 
qPCR plate to control for technical variance. Two housekeeping genes (β-Actin [ACTB] and 
Cyclophillin-A [PPIA]) were used to normalize target mRNA levels. Primer sequences for all 
housekeeping and target genes, as well as the transcript variants of each transcript amplified 
(identified using NCBI Primer-BLAST), can be found in Table 4. The difference in cycle threshold 
(dCT) for each target transcript was calculated by subtracting the geometric mean CT for the two 
reference genes (each run in triplicate) from the mean CT of the target transcript (mean of the three 
replicates). There were no significant differences in the geometric mean of CTs of the two 
housekeeping genes across all four brain regions (Fig.A-1). Because dCT represents the log2-
transformed expression ratio of each target transcript to the reference genes, the relative level of 
the target transcript for each subject is reported as 2-dCT (Vandesompele et al. 2002). 
2.2.5  Statistical Analysis 
To determine the OCD-associated expression patterns of transcripts, we employed a 
mixed-design analysis of covariance (ANCOVA). Brain region was considered a within-subjects 
variable with 4 levels (BA11, BA47, caudate nucleus, NAc), and OCD diagnosis was the between 
subjects factor. Main effects of OCD diagnosis and brain region, as well as the interaction between 
diagnosis and brain region, were tested using F tests for each individual transcript. Covariates 
included in each model were age, sex, PMI, and RIN. Data from all 8 subject pairs were analyzed 
in all regions unless noted in the text in cases of low transcript expression. In a minority of cases 
(6 total transcripts), data from the caudate and NAc of subject pair 8 were not collected due to low 
RNA yield (see Table 5 for detailed information about each transcript). If significant interactions 
were observed between diagnosis and brain region, post-hoc pairwise comparisons were conducted 
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using Sidak tests to control for overall type I error. Multiple comparison correction was conducted 
using the Benjamini-Hochberg procedure and a false discovery rate of 0.05 (Benjamini Y. 1995). 
For main effects and interactions, correction was made across 16 transcripts. For pairwise 
comparisons conducted only after a significant interaction, correction was made for 22 
comparisons. For individual transcript comparisons, uncorrected p-values are reported in the main 
text and corrected p-values are reported in Table 7.   
Composite scores of three groups of transcripts grouped broadly by the function of their 
encoded proteins (excitatory synaptic structure; excitatory synaptic receptors and transporters; 
GABA synapse) were computed. First, normalized (Z scored) expression levels were calculated 
for each transcript using (𝑍𝑍 =  𝑋𝑋−µ
𝜎𝜎
), where µ is mean of expression ratios for the unaffected 
comparison subjects for a given transcript, σ is standard deviation of expression ratio for the 
unaffected comparison subjects for a given transcript, and X is the individual transcript measure 
from an unaffected comparison or OCD subject. Z-scores were then summed for all excitatory 
synaptic structure, excitatory synaptic receptors and transporters, and GABA synapse measures 
(see Table 2-1: Transcript grouping) within a given diagnostic group for each brain region. Post-
hoc pairwise comparisons were conducted using Sidak tests to control for overall type I error. 
Multiple comparison adjustments were again made using the Benjamini-Hochberg analysis with a 
false discovery rate of 0.05. Both corrected and uncorrected comparisons are presented for 
composite scores in the main text, and full statistics can be found in Table 7.  
Individual t-tests were performed with the Holm-Sidak multiple comparison correction and 
an alpha of 0.05 to analyze the effect of 1) antidepressants at time of death, 2) presence of 
benzodiazepines at time of death, 3) comorbid MDD diagnosis, and 4) presence of tobacco use at 
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time of death on expression of transcripts in OCD subjects (Fig.A-2-4). Statistical analyses were 
performed using SPSS (SPSS, Inc.; Chicago, IL). 
2.3 Results 
2.3.1  Effect of OCD diagnosis on expression of excitatory synaptic structure transcripts in 
cortical and striatal regions 
Regional patterns of expression of excitatory structural transcripts implicated in OCD and 
grooming disorders were first examined (Fig.2-1). Several of these transcripts displayed lower 
expression in OCD subjects compared to unaffected comparison subjects selectively in OFC, and 
not striatum. First, although expression of the scaffolding protein transcript DLGAP1 was 
unaffected by diagnosis (F1,10 = 2.8, p = .13) or region (F3,30 = 1.8, p = .17), the interaction between 
these two factors was significant (F3,30 = 3.5, p = .03). Post-hoc tests then revealed that mean 
DLGAP1 levels were significantly lower in BA47 (-48%, F1,10 = 5.1, p = .05) but not different in 
BA11, caudate, and NAc (p > .05)] (Fig.2-1A). In addition, expression of another DLGAP family 
member, DLGAP2, significantly differed by diagnosis (F1,10 = 34.4, p = .0001) and brain region 
(F3,30 = 3.5, p = .03), with a significant interaction (F3,30 = 5.4, p = .004). Post-hoc pairwise 
comparisons of simple main effects showed lower DLGAP2 in OCD subjects selectively in BA11 
(-43%: F1,10 = 27.7, p = .0004) and BA47 (-41%: F1,10 = 15.8, p = .003) [expression was not 
significantly different in caudate/NAc (p > .05)] (Fig.2-1B). A third transcript, SLITRK3 (Fig.2-
1F), showed a similar pattern, with expression significantly affected by diagnosis (F1,8 = 21.7, p = 
.002), a trend towards a brain region effect (F2,16 = 2.9, p = .08), and an interaction between 
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diagnosis and brain region (F2,16 = 4.2, p = .03). Post-hoc contrasts indicated lower SLITRK3 levels 
in BA11 (-42%: F1,8 = 34.3, p = .0004) and BA47 (-32%: F1,8 = 7.8, p = .02), but not in caudate (-
24%: F1,8 = 2.3, p = .17; too low to detect in NAc).  
Several excitatory synaptic structural transcripts also showed lower expression in both 
OFC and striatum of OCD subjects compared to unaffected comparison subjects. First, although 
ANCOVA revealed a significant effect of diagnosis on DLGAP3 expression (F1,10 = 7.0, p = .03), 
there was no effect of brain region (F3,30 = 1.9, p = .16) or interaction between diagnosis and region 
(F3,30 = 0.2, p = .90) (Fig.2-1C). Similarly, levels of DLGAP4 (Fig.2-1D) were lower in both OFC 
and striatum [significant effect of diagnosis (F1,10 = 7.4, p = .02) and brain region (F3,30 = 3.3, p = 
.04); no interaction (F3,30 = 1.3, p = .30)]. Notably, SLITRK1 was the only excitatory synaptic 
structure transcript tested which showed no differences in expression related to diagnosis (Fig.2-
1E) (F1,8 = 3.0, p = .12) or brain region (F3,24 = 2.4, p = .09), and no interaction between the two 
factors (F3,24 = 1.0, p = .40).  
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Figure 2-1. Expression of excitatory synaptic structure transcripts in OFC and striatum of OCD subjects and 
unaffected comparison subjects.  
qPCR analysis of excitatory synaptic structure transcripts across two orbitofrontal (BA11 and BA47) and two striatal 
(caudate and NAc) brain regions in OCD. Unaffected comparison subjects and OCD subjects are represented by black 
open circles and red open triangles, respectively. A line drawn between a circle and a triangle indicates a matched 
pair. Horizontal bars indicate group means. Percentages indicate the percentage difference in transcript level of the 
OCD subject relative to the unaffected comparison subject. Post-hoc significance following significant interactions is 
indicated by brackets; **p<0.01, *p<0.05. 
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2.3.2  Effect of OCD diagnosis on expression of transcripts encoding excitatory synaptic 
receptors and transporters in cortical and striatal regions 
We next assessed levels of transcripts encoding glutamate receptors and transporters 
(Fig.2-2). Expression of the transcript GRIA1, which encodes the GluR1 subunit of the AMPA 
receptor, was lower in OFC and striatum of OCD subjects (Fig.2-2A) [effect of diagnosis (F1,8 = 
9.0, p = .02); no effect of region (F3,24 = 1.0, p = .39) or interaction (F3,24 = 1.6, p = .21)]. Similarly, 
expression of GRIN2B, which encodes the NR2B subunit of the NMDA receptor, was lower in 
OCD subjects (Fig.2-2B) [main effect of diagnosis (F1,8 = 6.9, p = .03); no effect of region (F3,24 
= 1.8, p = .17) or interaction (F3,24 = 1.1, p = .36)]. A significant main effect of diagnosis on 
expression of SLC1A1, a glutamate transporter that has been associated with OCD, was also 
observed (F1,10 = 5.0, p = .05) (Fig.2-2C). This transcript also displayed a significant effect of brain 
region (F3,30 = 3.2, p = .04) and an interaction (F3,30 = 3.7, p = .02); subsequent pairwise 
comparisons indicated SLC1A1 in OCD subjects was lower only in BA47 (-34%: F1,10 = 7.9, p = 
.03), although a trend was also observed in BA11 (-37%: F1,10 = 3.9, p = .08). Finally, we measured 
levels of SLC17A7, which encodes the pre-synaptic vesicular glutamate transporter 1 (VGLUT1). 
Consistent with previous work (Vigneault et al. 2015), SLC17A7 was undetectable in striatum; 
however, levels were lower in both OFC regions in OCD subjects [significant effect of diagnosis 
(F1,10 = 12.4, p = .005), no effect of brain region (F1,10 = 0.02, p = .89), and no interaction (F1,10 = 
0.02, p = .89) (Fig.2-2D)]. 
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Figure 2-2. Expression of transcripts encoding excitatory synaptic receptors and transcripts in OFC and 
striatum of OCD subjects and unaffected comparison subjects.  
qPCR analysis of transcripts encoding excitatory synaptic receptors and transporters across two orbitofrontal (BA11 
and BA47) and two striatal (caudate and NAc) brain regions in OCD. Unaffected comparison subjects and OCD 
subjects are represented by black open circles and red open triangles, respectively. Lines represent matched pairs. 
Horizontal bars indicate group means. Percentages indicate the percentage difference in transcript level of the OCD 
subject relative to the unaffected comparison subject. Post-hoc significance following significant interactions is 
indicated by brackets; *p<0.05, #p<.1. 
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2.3.3  Effect of OCD diagnosis on expression of GABA synapse transcripts in cortical and 
striatal regions 
To determine if OCD was associated with alterations in GABAergic transcript levels in 
OFC and striatum, we first quantified levels of the two major GABA synthesizing enzymes, GAD1 
(Fig.2-3A; GAD67) and GAD2 (Fig.2-3B; GAD65). ANCOVA revealed a significant effect of 
diagnosis (F1,10 = 6.9, p = .03) and brain region (F3,30 = 4.3, p = .01) on GAD1 levels, with an 
interaction between the two factors (F3,30 = 7.2, p = .001). Post-hoc comparisons revealed that 
OCD subjects had significantly elevated GAD1 in BA11 (+99%: F1,10 = 9.5, p = .01), with no other 
region differing by diagnosis (p > .05). In contrast, there was no effect of diagnosis on GAD2 levels 
(F1,10 = 2.6, p = .14), although we did observe a significant effect of brain region (F3,30 = 3.9, p = 
.02) and a trend toward a significant interaction (F3,30 = 2.9, p = .052). 
We also examined transcripts encoding parvalbumin and calbindin (PVALB and CALB1), 
calcium-binding proteins used as markers of cortical and striatal interneuron subtypes. Although 
diagnosis had no detectable effect on PVALB levels (F1,10 = 2.8, p = .13), an effect of brain region 
(F2,20 = 5.6, p = .01) and an interaction between region and diagnosis (F2,20 = 4.9, p = .02) were 
observed [note; PVALB expression was too low to detect in the NAc, consistent with previous 
studies (Bernacer, Prensa, and Gimenez-Amaya 2012)]. Pairwise comparisons suggested increased 
levels of PVALB in BA11 of OCD subjects, although the effect was not significant (+41%: F1,14 = 
2.9, p = .11). Similarly, no effect of diagnosis (F1,10 = .84, p = .38) and a significant effect of brain 
region (F3,30 = 24.7, p = .0001) were observed on CALB1 levels; however, there was no significant 
interaction (F3,30 = 1.3, p = .27). 
Given the lower levels of transcripts that encode excitatory post-synaptic structural proteins 
in OCD (Fig.2-1), we also examined GABARAP, which encodes a protein involved in GABA 
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receptor scaffolding (Fig.2-3E). In contrast to the excitatory transcripts, no effect of OCD 
diagnosis (F1,8 = .2.8, p = .13), brain region (F3,24 = 2.3, p = .10), or interaction (F3,24 = 1.3, p = 
.30) was observed for GABARAP. Levels of SLC32A1, which encodes the vesicular inhibitory 
amino acid transporter, were also not significantly affected by diagnosis (Fig.2-3F; F1,8 = .004, p 











Figure 2-3. Expression of GABA synapse transcripts in OFC and striatum of OCD subjects and unaffected 
comparison subjects 
qPCR analysis of GABA synapse transcripts across two orbitofrontal (BA11 and BA47) and two striatal (caudate and 
NAc) brain regions in OCD. Unaffected comparison subjects and OCD subjects are represented by black open circles 
and red open triangles, respectively. Lines represent matched pairs. Horizontal bars indicate group means. Percentages 
indicate the percentage difference in transcript level of the OCD subject relative to the unaffected comparison subject. 
Post-hoc significance following significant interactions is indicated by brackets; *p<0.05. 
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2.3.4  Composite measures of transcript expression across cortical and striatal regions in 
OCD 
To determine the relative contribution of each brain region to the observed changes in 
transcript levels, we computed composite summary scores from the normalized expression ratios 
of the transcripts grouped into three categories: excitatory synaptic structure-, excitatory synaptic 
receptors and transporters-, and GABA synapse-related (Fig.2-4). ANCOVA showed a significant 
main effect of OCD diagnosis on the excitatory synaptic structure transcript composite measure 
(F1,10 = 21.2, p = .001; corrected p = .003), a trend towards a main effect of region (F3,30 = 2.9, p 
= .052; corrected p = .08), and a significant diagnosis-by-region interaction (F3,30 = 5.2, p = .005; 
corrected p = .008). Pairwise comparisons revealed significantly reduced levels of excitatory 
synaptic structure transcripts in BA11 (F3,30 = 11.9, p = .006; corrected p = .02) and BA47 (F3,30 
= 28.1, p = .0003; corrected p = .002) of OCD subjects, with no changes in caudate and NAc (p > 
.05) (Fig.2-4A). Similarly, the excitatory synaptic receptor/transporter composite measure showed 
significant reductions in BA11 and BA47 of OCD subjects, but no changes in caudate or NAc 
[main effect of diagnosis (F1,8 = 21.2, p = .002; corrected p = .003); trend effect of region (F3,24 = 
2.5, p = .081; corrected p = .08; significant interaction (F3,24 = 4.7, p = .01; corrected p = .01); 
BA11 post-hoc (F1,8 = 34.4, p = .0004; corrected p = .002); BA47 post-hoc (F1,8 = 11.4, p = .01; 
corrected p = .02); caudate and NAc (p > .05)] (Fig.2-4B). However, the GABA synapse composite 
measure indicated that GABA-related transcript levels in OCD subjects were elevated in BA11 
compared to unaffected comparison subjects, (F1,10 = 11.4, p = .007; corrected p = .02), but 
unchanged in BA47, caudate, and NAc (p > .05) [main effect of diagnosis (F1,10 = 6.1, p = .03; 
corrected p = .03); main effect of region (F3,30 = 4.9, p = .007; corrected p = .02); significant 
interaction (F3,30 = 8.7, p = .0003; corrected p = .0009)] (Fig.2-4C). 
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Figure 2-4. Composite measures of excitatory synaptic structure, excitatory synaptic receptors and 
transporters, and GABA synapse transcripts across cortical and striatal regions in OCD. 
(A) In OCD subjects, composite measures of excitatory structural transcripts were lower in BA11 and BA47 relative
to unaffected comparison subjects. No differences were observed in either the caudate or NAc. (B) Composite scores
of excitatory receptors and transporters were reduced in BA11 and BA47 and unchanged in caudate and NAc in OCD
subjects. (C) GABA composite scores were elevated in BA11 and unchanged in BA47, caudate, and NAc of OCD
subjects (C). Post-hoc significance following significant nteractions is indicated by brackets; *p<0.05.
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2.4 Discussion 
Glutamatergic synaptic dysfunction in cortical and striatal brain regions has been suggested 
as a contributor to the pathophysiology of OCD, but evidence to date has been indirect. Using 
qPCR in human post-mortem tissue, we now support this hypothesis by demonstrating decreased 
levels of transcripts encoding excitatory synaptic proteins in OFC and striatal regions in OCD 
subjects (Figs. 2-1 and 2-2). Composite scores in OCD subjects revealed that these significant 
reductions in both the excitatory synaptic structure and excitatory synaptic receptors/ transporters 
transcript groupings were preferentially localized to OFC (BA11 and BA47) and not detected in 
striatum (caudate and NAc) (Fig.2-4A-B). More subtle increases in GABA synapse transcripts 
were also identified in OFC, but these were observed selectively in BA11 (Fig.2-3 and Fig.2-4C). 
Together, these data provide the first evidence of potential molecular dysfunction in brain regions 
consistently implicated in human imaging studies of OCD (Harrison, Soriano-Mas, Pujol, Ortiz, 
Lopez-Sola, et al. 2009; Rotge et al. 2009a).  
2.4.1  Decreased levels of three key excitatory synaptic structure transcripts are observed 
in OFC and striatum 
Several of the observed down-regulated transcripts have previously been linked to OCD 
(Pauls et al. 2014; Stewart et al. 2013), including DLGAP3. This gene encodes the post-synaptic 
scaffolding protein most commonly known as SAPAP3, and has been linked to OCD and 
associated disorders through genetic studies (Bienvenu et al. 2009b; Boardman et al. 2011; 
Zuchner et al. 2009) [though see (Boardman et al. 2011)]. In human postmortem tissue from OCD 
subjects, we found that DLGAP3 expression was significantly decreased across all four cortical 
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and striatal regions tested (Fig.2-1A-D). This finding is consistent with the fact that Sapap3 
knockout mice, which constitutively lack the Sapap3 gene, display compulsive behavior, and 
provides further support for the hypothesis that decreases in SAPAP3 protein are involved in the 
generation of compulsive behavior in humans (Burguiere et al. 2013; Welch et al. 2007b; Harrison, 
Soriano-Mas, Pujol, Ortiz, Lopez-Sola, et al. 2009). In addition, the same expression pattern was 
seen with DLGAP4. Interestingly, other DLGAP family members showed decreased levels 
specifically in OFC. Expression of DGLAP1, which has recently been identified as the locus of 
two of the most strongly associated single nucleotide polymorphisms (SNPs) in case-control OCD 
GWAS (Mattheisen et al. 2015; Stewart et al. 2013), was selectively decreased only in OFC and 
not striatum (Fig.2-3A); the same pattern was observed for DLGAP2 (Fig.2-3B). These data raise 
the possibility that different DLGAP family members could differentially impact particular OCD 
symptom domains based on the regional localization of their alterations in expression. 
In addition, in OFC of OCD subjects, we observed a selective reduction in expression of 
another gene that has been associated with OCD: SLC1A1 (Fig.2-2C), which encodes the neuronal 
glutamate transporter EAAT3. SLC1A1 was first implicated in OCD pathophysiology by two 
reports identifying genetic variants in two independent patient populations (Arnold et al. 2006; 
Dickel et al. 2006). Subsequent studies have replicated these findings, although identified variants 
have not always been consistent(Samuels et al. 2011; Shugart et al. 2009; Stewart et al. 2007). 
Interestingly, our finding of reduced levels of SLC1A1 in OFC of OCD subjects relative to 
unaffected comparison subjects is not aligned with the fact that the most consistently associated 
SNP in OCD is predicted to result in increased expression of SLC1A1 (Porton et al. 2013; Zike et 
al. 2017). To address this discrepancy, future post-mortem brain studies could examine expression 
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levels of recently-identified SLC1A1 variants that may serve as negative regulators of 
SLC1A1/EAAT3 function in cortex and striatum (Porton et al. 2013).   
2.4.2  Downregulation of multiple excitatory synaptic transcripts in OFC suggests an 
upstream causal event 
As discussed above, our data can be used to make inferences about the potential role of 
particular genes in OCD pathology. However, the most striking finding is the simultaneous down-
regulation of multiple excitatory synapse-related transcripts in both medial (BA11) and lateral 
OFC (BA47) (Fig.2-4A-B). Although it is possible that each transcript change is an independently 
occurring event, this pattern of expression suggests the possibility of an upstream factor leading to 
abnormal coordinated excitatory synapse gene regulation across the OFC. One potential 
explanation is altered expression of an upstream “master regulator” gene that influences expression 
of transcripts associated with post-synaptic excitatory synapse function. Alternatively, due to the 
diversity of transcripts that were down-regulated, these changes may reflect an overall decrease in 
number or size of synaptic contacts or dendritic spines in OFC. In turn, this would fit with one of 
the most consistent findings in structural imaging studies of OCD: a reduction in volume of both 
left and right OFC (Rotge et al. 2009a; Atmaca et al. 2006; Atmaca et al. 2007a). Precedent for 
this is observed in other neuropsychiatric illnesses such as schizophrenia, in which dendritic spine 
loss is one of the greatest indices of gray matter loss (Selemon and Goldman-Rakic 1999; Penzes 
et al. 2011; Glausier and Lewis 2013). 
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2.4.3  Synthesis of downregulation of glutamatergic transcripts with existing literature 
As discussed above, our findings appear consistent with the structural imaging literature. 
What becomes more challenging is integrating these data with the existing functional imaging 
literature demonstrating hyperactivity in OFC at baseline and with symptom provocation in OCD 
patients (Menzies et al. 2008a). At face value, the results seem contradictory, since one might 
expect that downregulation of excitatory transcripts in OFC would be consistent with overall 
decreases in OFC activity. This apparent discrepancy could be explained in several ways. First, 
there are examples in which knockout of excitatory post-synaptic density proteins leads 
(potentially counter-intuitively) to both increased neural activity and compulsive grooming 
behavior: 1) Constitutive knockout of Sapap3 leads to striatal hyperactivity; 2) Constitutive 
knockout of Slitrk5 results in OFC hyperactivity (Shmelkov et al. 2010; Welch et al. 2007b; 
Burguiere et al. 2013). However, causal links between Sapap3 and Slitrk5 down-regulation in 
specific brain regions and hyperactivity have not yet been demonstrated. Second, our observed 
decreased levels of excitatory synaptic transcripts could be compensating for changes in neural 
activity in upstream structures. For example, functional imaging studies demonstrate hyperactivity 
and increased gray matter volume in the thalamus of OCD subjects (Rotge et al. 2009a). Increased 
thalamo-cortical drive in OCD patients could therefore be the primary driver of OFC hyperactivity, 
and lead to compensatory down-regulation of excitatory post-synaptic proteins at thalamo-cortical 
synapses. In this scenario, OFC hyperactivity could still be observed if this compensation is not 
sufficient to counteract the increased thalamic drive. If this is the case, we would predict that our 
observed decrease in excitatory transcript levels in OCD subjects is localized to cortical neurons 
receiving projections from thalamus, and not neurons in cortical output layers. Thus, our 
observations from the post-mortem OCD brain lend themselves to directly testable novel 
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hypotheses regarding OCD pathophysiology. Our data also highlight the importance of moving 
beyond the targeted set of transcripts tested here, which were mostly selected due to their previous 
genetic links to OCD and related disorders, and investigating the molecular pathology of OCD on 
a larger scale–i.e. the transcriptome or proteome.  
2.4.4  Potential caveats 
When interpreting this study, it is important to note several limitations. First, the sample 
size is small, with eight pairs of OCD and unaffected comparison subjects. In order to maximize 
our statistical power to detect differences related to brain region and OCD diagnosis, we have 
matched our subjects as closely as possible for factors that can affect expression of mRNA (e.g. 
age, sex, and RIN). No significant effects of these or other post mortem factors were observed in 
our cohort (Table 2-2). Other limitations include our current inability to rule out the possibility 
that comorbid diagnoses other than MDD (Fig.A-4; see Table 6) may be affecting mRNA 
expression due to a lack of statistical power. In particular, this dataset does not allow us to 
determine if comorbid anxiety disorders in subjects with OCD are contributing to the observed 
decreases in excitatory synaptic transcript expression. Future studies with a comparator group 
matched for anxiety disorders will be necessary to make this determination. Similarly, due to lack 
of power, we are limited in our ability to determine whether medications or other substances 
contribute to the observed differences in gene expression, although exploratory analyses did not 
identify any significant impact of antidepressant use, benzodiazepine use, or tobacco use at time 
of death in OCD subjects (Fig.A-2,A-3,A-5). It is also important to note that the use of targeted 
qPCR to conserve statistical power in our small sample prevented us from exploring whether 
subjects with OCD have different levels of expression of alternatively spliced transcripts compared 
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to unaffected subjects. Although the primary protein coding isoform was always amplified, primer 
pairs for several transcripts also amplified multiple splice variants (see Table A-4 for details). Our 
targeted qPCR approach was unable to determine if expression of these transcript variants differs 
by diagnosis or region. It is therefore possible that the observed excitatory transcript 
downregulation in orbitofrontal cortex could be accompanied by compensatory upregulation of 
alternative transcripts not studied here, which could limit the functional impact of the observed 
transcriptional changes and affect interpretation of our results. This possibility could be addressed 
in future studies using RNA sequencing (RNAseq). Finally, although some of the effects in Figures 
2-1 to 2-3 would not survive Benjamini-Hochberg correction for multiple comparisons due to our 
limited sample size and power (see Table 7 for uncorrected and corrected p-values for all 
comparisons), this is mitigated by survival of the significant effects of the aggregate analysis 
following correction (Fig.2-4). Thus, the composite analysis demonstrates that differential 
expression of transcripts was most prominent in orbitofrontal regions in subjects with OCD.  
Despite these potential caveats, this report is, to the authors’ knowledge, the first 
identification of molecular dysfunction in either orbitofrontal or striatal brain regions in OCD. This 
targeted examination will therefore serve as the foundation for future better-powered studies that 
will allow us to examine the potential impact of comorbidities, medication status, and disease 
heterogeneity on expression of excitatory synaptic transcripts. 
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Table 2-1. Target transcripts and their reported involvement in OCD- and related disorders 
aTranscript grouping used for calculation of composite measures (see Methods) 
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Table 2-2. Summary of demographic and postmortem characteristics of human subjects. 
Demographic and postmortem characteristics for 8 subjects with OCD and 8 unaffected comparison subjects. PMI: 
post-mortem interval. ATOD: at time of death. SD: standard deviation. 
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3.0 Functional analysis of orbitofrontal cortex and central striatal activity during 
compulsive behavior and following treatment 
3.1 Introduction 
Obsessive-compulsive disorder (OCD) is a chronic and debilitating psychiatric illness that 
affects between 2-3% of individuals worldwide. The World Health Organization (WHO) recently 
listed OCD as a leading cause of illness related disability (Ayuso-Mateos 2006), and it is the fourth 
most common psychiatric illness (Bloch et al. 2006). Adding to its disease burden, OCD is a 
chronic disorder that often begins in adolescence or early adulthood (Evans, Lewis, and Iobst 2004; 
Fitzgerald et al. 2011b). While its pathophysiology is still unknown, imaging studies consistently 
identify hyperactivity in key cortical and striatal brain regions– including OFC and caudate 
nucleus– in both pediatric (Fitzgerald et al. 2011b) and adult (Fitzgerald et al. 2011b; Menzies et 
al. 2008b) OCD patients. Additionally, not only are individual nodes within fronto-striatal circuitry 
hyperactive, some studies have shown increased functional connectivity between OFC and 
striatum, suggesting enhanced synchronization between these regions (Nakamae et al. 2014; Sakai 
et al. 2011; Harrison, Soriano-Mas, Pujol, Ortiz, Lopez-Sola, et al. 2009). Because of its consistent 
dysregulation, this orbitofronto-striatal network has been theorized to be an "OCD circuit" 
(Graybiel and Rauch 2000), and continues to be one of the most empirically well-supported circuit 
models in psychiatry (Gillan et al. 2015; Menzies et al. 2008b). Further supporting the role for this 
specific cortico-striatal circuit are data demonstrating that successful reduction in symptoms 
following treatment with the first-line pharmacotherapy of selective serotonin re-uptake inhibitors 
(SSRIs) is correlated with a reduction in hyperactivity in both the OFC and caudate nucleus of 
 53 
OCD patients  (Saxena et al. 1999; Benkelfat et al. 1990; Swedo et al. 1989). However, it is 
important to note that SSRI treatment response is quite poor in most subjects with OCD, with only 
between 10-15% of patients fully remitting following a full treatment course. These data highlight 
the need to investigate mechanisms by which SSRIs are acting and the specific scenarios in which 
they are working or failing.  
Despite strong correlational evidence for functional alterations in cortical and striatal brain 
regions in OCD, a paucity of data exists demonstrating how these functional abnormalities may be 
generated, and how (if at all) they relate to compulsive behavior. In order to begin to answer this 
question, I have utilized a model system, the Sapap3-knockout (Sapap3-KO), that displays 
excellent validity for investigation of OCD-relevant behaviors according to established preclinical 
criteria (Chadman, Yang, and Crawley 2009). First, Sapap3-KO mice have good face validity, in 
that they display a compulsive grooming phenotype that, similar to what is observed in humans, 
persists even in the face of negative consequences as measured by the development of facial lesions 
(Welch et al. 2007b). Second, the Sapap3-KO model has good construct validity, with the 
compulsive behavioral phenotype being localized to the medial striatum (Welch et al. 2007b), as 
well as striatal hyperactivity (Burguiere et al. 2013). Importantly, cortico-striatal dysfunction is 
recapitulated in the model, with stimulation of lateral OFC (lOFC) inputs to the central striatum 
reducing the compulsive behavior as well as the striatal hyperactivity, likely through the 
entrainment of striatal fast spiking interneurons (FSIs) (Burguiere et al. 2013). Finally, the model 
also displays predictive validity, as treatment with the SSRI fluoxetine was capable of reducing 
compulsive grooming (Welch et al. 2007b), though the mechanism behind this reduction has not 
yet been explored.  
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Here, we propose that in Sapap3-KO mice central striatal hyperactivity is the result of a 
reduction of input from layer 5 lOFC pyramidal cells to the central striatum specifically at the 
onset of a grooming bout. Further, we predict that the SSRI fluoxetine will normalize the 
hyperactivity observed in the central striatum at grooming onset in Sapap3-KO mice and this be 
reflected by a reduction in the overall number of striatal SPNs activated during grooming. 
Completion of these experiments will shed new light on the circuit and network level generation 
of compulsive behavior.  
3.2 Methods 
3.2.1  Animals 
All procedures were carried out in accordance with the guidelines for the care and use of 
laboratory animals from the NIH and with approval from the University of Pittsburgh Institutional 
Animal Care and Use Committee (IACUC). Sapap3-knockout (Sapap3-KO) and wildtype 
littermates were generated through breeding using Sapap3 heterozygous mutants (Sapap3+/-). Mice 
were maintained on a 100% C57BL/6 background. Male and female Sapap3-KO and wildtype 
littermates were used for all experiments. Mice in all cohorts were approximately 4-6 months old 
at the time of initial surgery. For lOFC experiments, 9 Sapap3-KO and 8 Sapap3-WT mice were 
used. For experiments in the central striatum, 11 Sapap3-KO and 8 Sapap3-WT mice were used 
(a subset of these containing 5 Sapap3-KO and 5 WT mice matched across days for fluoxetine 
experiments). For experiments using channelrhodopsin to stimulate cell bodies in the central 
striatum, wildtype C57BL/6 mice were used.  
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3.2.2  Stereotactic surgery 
For all surgeries, mice were anesthetized using 5% isoflurane mixed with oxygen and 
maintained on 1-2% isoflurane for the duration of surgery. Mice were placed on a small-animal 
stereotactic instrument (Kopf Instruments) and secured using ear bars and a bite bar. Hair was 
removed from the dorsal surface of the head with hair clippers and the incision area was scrubbed 
with a betadine solution. A large incision was then made exposing the dorsal portion of the skull. 
All measurements were made relative to an interpolated bregma. Viral injections were performed 
using a fixed needle Hamilton syringe (Cole-Parmer Scientific, Vernon Hills IL, USA) connected 
to sterile polyethylene tubing affixed to a metal cannula and a Harvard Apparatus Pump 11 Elite 
Syringe Pump (Harvard Apparatus, Holliston MA, USA). Implanted lenses or ferrules were 
secured in place with one or two 0.45mm skull screws placed just in front of the lambdoid suture. 
Following completion of each surgery, mice were injected with sub cutaneous (s.c.) carprofen 
(10% w/v in 0.9% saline) and administered topical antibiotic ointment (TAO) and lidocaine around 
the headcap. Mice were then placed on a heating pad and given DietGel (ClearH2O, Portland ME, 
USA) and monitored until they were fully recovered from anesthesia. Mice were administered 
carprofen s.c. and received lidocaine and TAO treatments for 3 days post-surgery. For all surgical 
procedures mice were kept group housed with littermates unless conspecific fighting was noted, 
in which case the aggressive mouse was isolated for the duration of the experiment. 
3.2.2.1 Calcium imaging surgical methods 
In calcium imaging experiments, all wildtype and Sapap3-KO mice underwent a series of 
two procedures, conducted according to (Resendez et al. 2016) with several minor changes. For 
experiments in the lOFC, 800nl of a virus encoding GCaMP6f under the synapsin promotor 
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(AAV5-synapsin-GCaMP6f-WPRE-SV40, titer 1.82x1012; Penn Vector Core) was injected into 
the lOFC (AP: +2.6, ML: -1.2, DV: -1.65) of mice. Immediately after injection of virus into the 
lOFC, a 500µm, 6mm length gradient refractive index lens (ProView GRIN lens, Inscopix Pala 
Alto, CA USA) was lowered just dorsal to the viral injection target (AP: +2.6, ML: -1.2, DV: -
1.55) to allow for visualization of cells in the target region.  
For experiments in the central striatum, 800nl of a virus encoding GCaMP6m under the 
synapsin promotor (AAV9-synapsin-GCaMP6m-WPRE-SV40, addgene) was injected into the 
central striatum (AP: +0.65, ML: -1.8, DV: -2.9 & -3.0) of mice. Injections were done in a two-
step manner, with 400nl of virus injected at DV -2.9 and 400nl of virus injected at DV -3.0. 
Immediately after injection of virus into the central striatum, a 500µm, 6mm length gradient 
refractive index lens (ProView GRIN lens, Inscopix Pala Alto, CA USA) was lowered just dorsal 
to the viral injection target (AP: +0.65, ML: -1.8, DV: -2.85) to allow for visualization of cells in 
the target region. Acrylic dental cement (Lang Dental, Wheeling IL, USA) was then used to secure 
the lens in place and seal the entire lens during the virus incubation period (4-6 weeks).  
For simultaneous optogenetic terminal stimulation and calcium imaging of the central 
striatum, 350nl of a virus encoding the redshifted opsin Chrimson under the synapsin promotor 
(AAV9-synapsin-ChrimsonR-tdT, addgene, titer: 2.23x1013) was first injected into the lOFC (AP: 
+2.7, ML: -1.55, DV: -1.65). Immediately after injection of Chrimson, a second skull window was 
drilled above the central striatum. As in our previous central striatal experiments, 800nl of a virus 
encoding GCaMP6m under the synapsin promotor (AAV9-synapsin-GCaMP6m-WPRE-SV40, 
addgene) was injected into the central striatum (AP: +0.65, ML: -1.8, DV: -2.9 & -3.0) and a 
500µm, 6mm length gradient refractive index lens (ProView GRIN lens, Inscopix Pala Alto, CA 
USA) was lowered just dorsal to the viral injection target (AP: +0.65, ML: -1.8, DV: -2.85).  
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After 4-6 weeks for viral incubation, a second procedure was performed during which mice 
in each experiment were again anesthetized with isoflurane and secured to a stereotactic apparatus 
using ear cuffs. Using a Dremel, excess dental cement was carefully removed exposing the 
ProView GRIN lens. The top of the ProView lens was then cleaned with compressed air and lens 
paper, removing all dental cement dust. A magnetic microscope baseplate (Part ID:1050-002192, 
Inscopix) was then attached to the miniaturized microscope (nVistaHD 2.0 epifluorescence 
microscope or nVoke 1.0 epifluorescence microscope, Inscopix) and lowered into place above the 
GRIN lens with the 475nm blue LED gain and power set to their maximum. The optimal field of 
view was then determined by focusing on visible cells or other gross landmarks (blood vessels). 
Once an optimal field of view was obtained, the baseplate was cemented in place and a plastic 
Microscope Baseplate Cover (Part ID:1050-002193; Inscopix) was attached to prevent debris from 
blocking the lens.  
3.2.2.2 Optogenetic activation of central striatum surgical methods 
Wildtype C57BL/6 mice were injected bilaterally with either 500nl of a virus (University 
of North Carolina Vector Core Facility, viral titer ~3.1x1012) encoding channelrhodopsin (AAV2-
hsyn-ChR2-eYFP) or eYFP (AAV2-hysn-eYFP) into the central striatum (AP: +0.65, ML: -1.9, 
DV: -3.0). Immediately after bilateral injections, polished ceramic ferrules were placed over the 
viral injection holes (AP: +0.65, ML: -1.9) and lowered slowly into position above the viral 
injection target (DV: -2.65). A layer of Loctite (Loctite, Westlake OH, USA) and several layers of 
dental cement were then used to secure the two ferrules in place and mice were allowed to recover 
for 4 weeks of viral incubation.  
 58 
3.2.3  Drug preparation and administration 
(±)Fluoxetine hydrochloride (Fluoxetine) was obtained through the NIMH Chemical 
Synthesis and Drug Supply Program. 
3.2.3.1 lOFC fluoxetine administration 
For lOFC imaging experiments, fluoxetine was administered via drinking water according 
to established methods (Ahmari et al. 2013). Briefly, bottles were placed in each cage and drinking 
was monitored for 3 consecutive days. Based on the average daily consumption and the average 
weight of the mice in each cage, 18 mg/kg of fluoxetine hydrochloride was mixed with autoclaved 
drinking water and stored in black bottles to prevent degradation. Drinking was continually 
monitored weekly, and doses were adjusted as-needed to maintain an average dose of 18 mg/kg 
fluoxetine per cage. On average, each cage was given 40 mg fluoxetine / 250 ml of drinking water. 
Bottles were changed every 4 days to avoid any degradation of the fluoxetine. Body weight was 
monitored weekly. After 4 weeks of administration, fluoxetine was removed from cages and mice 
were given a two-week washout from the drug to monitor whether grooming behavior and neural 
activity differences returned to baseline levels.  
3.2.3.2 Central striatum fluoxetine administration 
For central striatum imaging, fluoxetine was administered intraperitoneally (i.p.) according 
to previous reports which report a reduction in Sapap3-KO grooming following treatment (Welch 
et al. 2007a). Fluoxetine hydrochloride (5 mg/kg) in a 0.9% saline solution (10 ml/kg) was injected 
i.p. daily for 7 days to WT and Sapap3-KO mice. Fluoxetine injections occurred between 4:00PM 
and 6:00PM daily while behavioral testing occurred beginning at 9:00AM on testing days. After 7 
 59 
days of injections, mice were given a two-week washout from fluoxetine to monitor whether 
grooming behavior and neural activity differences returned to baseline levels.  
3.2.4  Behavioral apparatus and assessment of grooming behavior 
A custom-built behavioral apparatus was constructed for the accurate simultaneous 
assessment of spontaneous (e.g. grooming) behavior and neural activity (Fig.3-1A) via in vivo 
calcium imaging. A clear plexiglass sheet was suspended over a behavioral acquisition camera 
(Point Grey Blackfly, FLIR Integrated Imaging Solutions). A clear acrylic chamber (8”x8”x12”) 
was placed above the camera such that a mouse could be visualized at every angle. Behavioral 
acquisition was conducted at 40 Hz using SpinView (Point Grey) software and detailed frame 
information was sent directly to a central data acquisition box (LabJack U3-LV, Labjack 
Corporation, Lakewood CO USA). A randomly flashing (30s ITI) LED visible in the behavioral 
video controlled by custom scripts via an Arduino (Arduino Leonardo, Somerville MA, USA) and 
sending TTL pulses to the LabJack was used for alignment of behavior and calcium data.  
Following acquisition, video was converted and compressed (maintaining accurate frame 
rate information) into .MP4 format using the open source software HandBrake. Videos were then 
imported into Noldus The Observer XT (Noldus, Leesburg VA, USA) and grooming behavior was 
scored frame by frame. Grooming behavior was scored according to previous reports (Kalueff et 
al. 2016) by an observer blind to experimental condition (genotype and drug treatment). A mouse 
was considered to be grooming if it engaged in any of the following behaviors (Fig.3-1B) 1) Facial 
grooming, when a mouse touches its face, whiskers, or head with its forepaws. 2) Body grooming, 
when a mouse licks its flank or its ventral surface. 3) Hind leg scratching, when a mouse uses one 
of its hind legs to scratch its flank. The beginning of a grooming bout was defined as the frame 
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when a mouse made a movement to begin grooming (e.g. a face grooming bout began the frame a 
mouse lifted its paw off the ground to touch its face). The end of a grooming bout was defined as 
the frame when a mouse ceased grooming (e.g. a body grooming bout ended when a mouse moved 
its snout from its flank). Grooming bout starts separated by less than one second were collapsed 
into the previous bout. Thus, the minimum amount of time possible between grooming bouts for 
all experiments was one second.  
Figure 3-1. Pictoral example of grooming behavior and experimental setup 
(A) Unfettered ability to engage in naturalistic behavior and the ability to accurately code this behavior was critical
for completion of these experiments. In order to achieve this, mice were placed into a clear acrylic chamber with the
microscope attached. Behavioral video was recorded from below and behavioral and calcium data was sent to a central
data acquisition system. (B) Grooming behaviors were coded frame by frame at 40 Hz, according to established
methods (modified from (Kalueff et al. 2016)).
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3.2.5  In vivo calcium imaging in freely moving mice 
After at least 1 week of recovery from baseplate surgery, mice were habituated to the 
attachment of the microscope. In order to attach the microscope securely to the baseplate, mice 
were lightly scruffed and the miniature nVistaHD 2.0 microscope was connected to the magnetic 
baseplate and secured with a set screw. During habituation, optimal focus, field of view, and LED 
power and gain settings were determined visually by assessing the presence of clearly defined 
putative neurons. A caliper was used to accurately measure the precise microscope focus such that 
multiple imaging sessions were conducted with the same field of view. In addition to habituation 
to the microscope, mice were also placed into the acrylic chamber under low light conditions for 
a period of 5-10 minutes once daily for three days prior to imaging.  
Following habituation, mice were given a 40 minute baseline behavior and imaging 
session. Under low light the microscope was attached and mice were placed into a temporary 
holding cage. Mice were given 3-5 minutes after attachment of the scope for recovery from 
scruffing and to allow any rapid photobleaching to occur. After this period, mice were carefully 
placed into the clear acrylic chamber. LabJack data acquisition was then begun, immediately 
followed by behavioral SpinView recordings, and finally nVistaHD software began recording 
compressed greyscale tiff images at 20 Hz. As with the behavioral frame acquisition, individual 
calcium frame information was also sent to the LabJack for subsequent alignment of behavior and 
calcium data. For all mice, analog gain of the image sensor was set between 1 and 4 while the 470 
nm LED power was set between 10 to 30% transmission range. These settings were kept consistent 
for each mouse throughout all subsequent imaging sessions.  
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3.2.6  Calcium imaging data processing 
All imaging pre-processing was performed using Mosaic software (version 1.2.0, Inscopix) 
via custom Matlab (MATHWORKS, Natick MA, USA) scripts. Videos were spatially 
downsampled by a binning factor of 4 (16x spatial downsample) and temporally downsampled by 
a binning factor of 2 (down to 10 frames per second). Lateral brain motion was corrected using the 
registration engine TurboReg (Ghosh et al. 2011), which uses a single reference frame to match 
the XY positions of each frame throughout the video. Motion corrected 10 Hz video of raw calcium 
activity was then saved as a .TIFF and used for cell segmentation. 
Using custom Matlab scripts, the motion corrected .TIFF video was then processed using 
the Constrained Non-negative Matrix Factorization approach (CNMFe), which has been optimized 
to isolate signals from individual putative neurons from microendoscopic imaging (Zhou et al. 
2018). The CNMF method is able to simultaneously denoise, deconvolve, and demix imaging data 
(Pnevmatikakis et al. 2016) and represents an improvement over previously used algorithms based 
on principle component analysis (Zhou et al. 2018). The primary improvement comes from 
accurate estimation and subtraction of both local and global background fluorescence signal, 
providing better separation of densely packed cells and cleaner overall calcium signal from 
individual putative cells. Putative neurons were identified and manually sorted by an observer 
blind to genotype according to previously established criteria (Resendez et al. 2016). For the data 
presented in this dissertation, I report the non-denoised temporal traces (referred to as the “raw” 
trace in CNMFe) without any deconvolution. For each individual cell, the raw fluorescence trace 
was Z-scored to the average fluorescence and standard deviation of that same trace. Thus, 
fluorescence units presented here are referred to as “Z-scored fluorescence”.   
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3.2.7  Calcium imaging analysis 
Custom Matlab (MATHWORKS) scripts were used to conduct analysis of grooming-
related calcium activity. Grooming behavior (state events) was exported as timestamps (grooming 
start and grooming stop) and aligned to Ca2+ time by recording 5 consecutive LED pulses (point 
events). The offset of Noldus behavior time to nVista Ca2+ time was then subtracted off leaving 
the same number of frames for both the behavior and Ca2+ fluorescence. Grooming timestamps 
were then transferred to a binary/continuous trace of the same length and sampling rate (10 Hz) as 
each Ca2+ trace via logical indexing (grooming = 1, not-grooming = 0). Timestamps for behavior 
are converted to the closest matching frame in the calcium recording (maximum error of one frame 
or ± 100ms at 10 Hz). Calcium activity could then be aligned to the start and end of a grooming 
bout, or the transition point between grooming bouts (≤ 1s between a grooming bout ending and a 
grooming bout beginning).  
3.2.7.1 Unbiased event-related activity classification 
In order to perform unbiased classification of an individual cells responsiveness (activated, 
inhibited, or unaffected) to a behavioral event (e.g. grooming onset) we adapted a strategy used in 
(Jimenez et al. 2018) using custom Matlab (MATHWORKS) scripts. First, each individual cell’s 
raw Ca2+ was aligned to the onset of each grooming bout (Fig.3-2A). These traces were then 
averaged across all bouts within a given mouse (Fig.3-2B). For each individual cell, raw Ca2+ 
traces 10 seconds prior to grooming onset and 10 seconds after grooming onset (200 total samples 
at 10 Hz, 100ms per sample) were shuffled in time for each sample (200x) removing any temporal 
information that was previously in each trace but maintaining the variance within each grooming 
bout (Fig.3-2C). This shuffle was then performed 1000 times per cell to obtain a null distribution 
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of grooming associated Ca2+ activity. A cell was considered responsive to grooming onset if its Z-
normalized Ca2+ fluorescence amplitude between -0.5s before grooming onset to 3s after grooming 
onset exceeded a 1 standard deviation threshold from the null distribution (Fig.3-2D).  
Individual Ca2+ traces classified as activated or inhibited could then be averaged across 
genotype and directly compared within and across sessions, providing an assessment of how cells 
















Figure 3-2. Schematic illustrating cell classification strategy. 
Individual raw Ca2+ traces from three representative putative neurons were aligned to grooming (A) and averaged 
across all grooming bouts (B) in a given behavioral session. For each cell (representative example of the middle blue 
cell), each bin was randomly shuffled  200x (C, left) resulting in a shuffled trace with the same variance as the raw 
data (C, right). For each individual cell, this shuffle was then performed 1000 times, resulting in a null Ca2+ distribution 
(D, left). Ca2+ fluorescence amplitude of the average trace across grooming trials (D, right) was then compared to the 
null distribution, and cells that exceeded ±1 SD of the null distribution were classified as event modulated.  
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3.2.7.2 Accurate cell matching across sessions 
Putative neurons were matched using a probabilistic modeling method detailed in 
(Sheintuch et al. 2017). The cell matching occurred across two sessions and was performed using 
the following steps. First, centroid location for all cells were projected onto a single image. Slight 
rotation and translation difference between sessions were adjusted to achieve maximal cross-
correlation between sessions. Probablistic modeling was then employed to determine which model 
(centroid distance vs spatial correlation) was optimal for each set of data. For all data, the spatial 
correlation model yielded the best results and was thus used to match cells across sessions. For 
final alignment, the spatial correlation (not the joint model) was used, and correlation values for 
nearest neighbors was set at individually for each animal depending on the intersection of the two 
models.  
3.2.7.3 Optogenetic activation of central striatal SPNs 
For direct manipulation of SPNs in the central striatum WT mice we bilaterally activated 
the central striatum using channelrhodopsin (Boyden et al. 2005; Fenno, Yizhar, and Deisseroth 
2011; Zhang, Wang, et al. 2007). Mice were habituated to experimenter handling for 1 week prior 
to 3 days of habituation to being plugged in to bilateral fiber optic adapter cables. During 
habituation, mice were plugged in and placed into a clear plexiglass chamber (8”x8”x12”) for 5 
minutes under low light conditions. Immediately prior to the experimental day, both optical fibers 
were adjusted such that 5 mW of laser power was output at the tip of the fiber. Mice were connected 
again to bilateral fibers and placed into the same chamber attached to a bilateral commutator. 
Behavior was tracked via a camera (PointGrey) below the arena.  
After a minute in the chamber, a pseudorandomized stimulation paradigm began controlled 
by custom Arduino (Arduino Leonardo, Somerville MA, USA) scripts (Fig.3-10B). Mice received 
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10s of constant 473 nm light stimulation with an average interpulse interval of 30s (range 25s to 
35s). After 51 pulses of stimulation (35 minutes), the experiment terminated.  
3.2.7.4 Optogenetic activation of lOFC terminals in central striatum 
Simultaneous imaging and optogenetic experiments were carried out in the same manner 
as described in 3.2.5 Calcium imaging in freely moving mice, with several minor changes. 
Stimulation of lOFC terminals was achieved through the delivery of 600nm amber light delivered 
through the objective lens as GCaMP-positive cells are simultaneously being excited with 460nm 
blue light (Stamatakis et al. 2018). After mice were placed into the chamber and calcium imaging 
began, the 600 nm optogenetic LED (OG-LED) was turned on. OG-LED stimulation consisted of 
15 pulse trains of 20 Hz stimulation for 20 s. Each 20 Hz train was followed by a 30 s interval of 
no stimulation. Each session lasted 15 minutes in total.  
3.2.8  Statistical analysis 
Statistical analysis was carried out using custom Matlab scripts (MATHWORKS) or 
GraphPad Prism 8.0 (GraphPad Software, San Diego CA, USA). Throughout this dissertation 
results in text are reported as mean ± standard deviation (SD) and data presented on figures are 
mean ± standard error of measurement (SEM) unless otherwise noted.  
3.2.8.1 Statistical analysis of grooming behavior 
Baseline grooming behavior was analyzed using two-tailed independent samples t-tests. 
For the analysis of behavior following fluoxetine administration, a two-way repeated measures 
analysis of variance (ANOVA) was used. Main effects and interaction terms are reported 
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throughout, and in cases of significant interactions, post-hoc comparisons were made using Sidak’s 
multiple comparison correction. A corrected alpha was set to 0.05. 
3.2.8.2 Statistical analysis of calcium imaging data 
In order to evaluate the effect of genotype and treatment on grooming evoked Ca2+ 
fluorescence averaged across individual cells, unpaired two-tailed t-tests were conducted at each 
time bin (100 ms). Due to our high N with dozens to hundreds of cells in each condition, a 
conservative Bonferroni correction was performed (𝛼𝛼 =  0.05
𝑚𝑚
). The critical p value (α = 0.05) was 
divided by the total number of time bins (each bin = 100ms) to be compared (m), resulting in 
adjusted critical values between 0.000025 and 0.00005, depending on the exact comparison.   
For comparison of proportions of classified cells during baseline imaging sessions, two-
tailed independent samples t-tests were used. To assess the effect of fluoxetine treatment on the 
proportions of classified cells, two-way repeated measures ANOVA were used. When a significant 
interaction between genotype and drug treatment was observed, post-hoc tests were conducted 
using Sidak’s multiple comparisons test. A corrected alpha was set to 0.05. 
For nVoke activation of central striatal cells, the response for each cell to 20s of OG-LED 
stimulation was averaged across presentations (15 total presentations). This average was then 
compared with an unpaired t-test to the periods immediately preceding (10s before) and following 
(10s after) stimulation. A cell was determined to be significantly modulated if the p ≤ 5x10-45.  
3.2.8.3 Statistical analysis of optogenetic data 
In order to evaluate whether optogenetic stimulation of central striatal SPNs increased the 
probability that mice would engage in grooming-like behaviors, we conducted a two-way 
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ANOVA. Grooming probability data were first binned into 500ms increments (5 seconds before 
the onset of the laser to 20 seconds after laser onset), and all 50 bins were compared between eYFP 
and ChR2 mice. Post-hoc comparisons were made using the stringent Bonferroni multiple 
comparison test (corrected critical p-value of 0.001).  
In order to evaluate whether optogenetic activation of lOFC terminals in the central 
striatum was capable of altering grooming probability in WT and KO mice, we conducted a one-
way repeated measures ANOVA comparing grooming probability during a pre-stimulation period 
to a period during stimulation and post-stimulation. Post-hoc comparisons were made using 
Sidak’s multiple comparisons test.  
3.3 Results 
3.3.1  Sapap3-knockout mice display compulsive grooming 
Consistent with prior reports that relative to WT littermates, Sapap3-KO mice overgroom 
(Welch et al. 2007a), we observe that the compulsive phenotype is maintained following 
microendoscope implantation into the lOFC and attachment of the 2 gram miniature microscope 
(Fig.3-3A). Relative to WT counterparts, Sapap3-KO mice (purple bars) displayed increases in 
overall time spent grooming (Fig. 3-3B; t(15) = 3.564, p = 0.0028), total number of grooming 
bouts (Fig. 3-3C; t(15) = 3.759, p = 0.0019), and the number of transitions between grooming 
subtype per individual grooming bout, a measure of grooming microstructure organization (Fig. 
3-3D; t(15) = 3.840, p = 0.0016).  
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We observe a qualitatively similar pattern of behavior in mice with GCaMP6m virus 
injections and implantations into the central striatum (Fig.3-3E). Relative to WT mice, Sapap3-
KO mice (orange bars) spent more time grooming (Fig.3-3F; t(18) = 3.508, p = 0.0025), engaged 
in more individual grooming bouts (Fig3-3G; t(18) = 2.556, p = 0.0199), and made more transitions 
per bout (Fig.3-3H; t(18) = 2.413, p = 0.0267) relative to WT littermates.  
Figure 3-3. Sapap3-KO mice display compulsive grooming phenotype with miniature microscope attached. 
(A) Sapap3-KO mice implanted with lenses in the lOFC (purple bars) spend more time during a 40 minute session
grooming, (B) engage in more individual grooming bouts, and (C) make more transitions between grooming subtypes
per individual grooming bout compared to WT littermate controls (**p ≤ .01, * p≤ .05, n = 8 WT and 9 Sapap3-KO
mice in lOFC, change to report stats in legend and means in text).
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3.3.2  lOFC activity is reduced at grooming onset in Sapap3-KO mice 
In order to evaluate whether lOFC activity in response to grooming was different in WTs 
and KOs, we injected GCaMP6f into the lOFC and placed a lens just above layer 5 of lOFC (Fig. 
3-4A). Qualitative examination of heat plots across all cells in all mice (WT: 718 cells, average 
cells/mouse = 90 ± 41. KO: 1123 cells, 125 ± 30 average cells/mouse) appears to suggest more 
variability in response to grooming onset in WT mice relative to KOs (Fig.3-4B). In order to 
qualitatively evaluate the change in we examined differences in z-scored calcium fluorescence in 
the peri-grooming period (500ms before to 3000ms after grooming onset). Interestingly, we found 
that z-score calcium fluorescence during the peri-grooming period was significantly lower in KO 
mice relative to WT mice (Fig.3-4C; WT: 0.040 ± 0.4176 vs KO: 0.0075 ± 0.2623, p = 0.020 two-
tail t-test) suggesting that activity in the lOFC is reduced at groom onset in KOs relative to WTs. 
This reduction appears to be specific to the onset of grooming and not present at baseline, as no 
changes in non-grooming calcium event rates were detected (data not shown). Indeed, when a 
mouse engaged in a grooming bout, we observed a significant increase in calcium event rate in 
WT mice calculated as a percentage change from non-grooming event rate with no change in KO 
mouse event rate during grooming (Fig.3-4D; WT: +22.28 ± 21.61%, KO: +1.667 ± 17.55%, p = 
0.0465 two-tail t-test). Together, these data suggest that at baseline layer 5 lOFC pyramidal 
neurons are hypoactive in KOs relative to WTs at the onset of grooming.  
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Figure 3-4. Grooming-onset associated activity is reduced in Sapap3-KO mice relative to WTs 
(A) Representative histological image and surgery schematic showing GCaMP6f injection and expression as well as
lens placement for imaging of layer 5 lOFC pyramidal neurons. (B) Heatplots of all cells aligned to the onset of a
grooming bout in a WT (left) and Sapap3-KO mice (right). Cells are sorted by average peri-grooming fluorescence.
(C) Z-score fluorescence during the peri-grooming period across all cells in WT and Sapap3-KO mice (t(1025) =
2.340, p = 0.020). (D) Percentage change in calcium event rate (event/s) from non-grooming rates to grooming rates
(t(15) = 2.170, p = 0.0465). *p≤.05, n = 718 WT cells and n = 1123 Sapap3-KO cells.
3.3.3  Sapap3-knockout mice have increased numbers of lOFC neurons activated at 
grooming onset relative to WT mice 
Observing that overall lOFC activity was reduced at grooming onset in KO mice, we next 
set out to examine what might be contributing to this reduction. Given our single cell resolution, 
we classified putative pyramidal cells as either activated, inhibited, or unaffected by grooming 
(Jimenez et al. 2018). Comparing only units with significant increases in activity at grooming 
onset, we observed that, similar to overall lOFC output, activated cell amplitude in the KOs was 
reduced relative to WTs (Fig.3-5A top). Interestingly, the amplitude of significantly grooming 
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inhibited units was also blunted in KO mice compared to WT mice, which is inconsistent with the 
overall reduction in lOFC output we observed on average (Fig.3-4B).  
In addition to evaluating amplitude differences, we can also test whether the number of 
cells categorized as significantly grooming modulated is also significantly changed. Based on our 
finding of reduced overall lOFC activity in KO mice, we predicted that significantly less cells 
would be classified as activated in WTs relative to KOs. Surprisingly, we found that there was no 
difference in the percentage of cells activated during grooming in WTs compared to KOs (Fig.3-
5C; WT: 10 ± 7% vs KO: 12 ± 7%, p = 0.5549). Instead, we observed a significant increase in the 
percentage of cells that are inhibited during grooming onset in KOs relative to WTs (KO 17 ± 9% 
vs WT: 6 ± 6%, p = 0.0086). Thus, these data suggest that an overall reduction in lOFC activity is 
associated with an increase in the number of cells that are significantly inhibited during grooming 
in KO mice relative to WT mice. This may mean that downstream structures, including the 





Figure 3-5. Sapap3-KO mice have more cells inhibited during grooming relative to WT mice. 
(A) Sapap3-KO mice have reduced amplitude of cells activated during grooming (top; all significant t ≥ 5.20, p ≤
0.000046) and cells inhibited during grooming (bottom; all significant t ≥ 4.191, p ≤ 0.000041) relative to WT mice.
(B) Representative contour image of putative lOFC pyramidal neurons in a WT mouse (left) and the average
proportion of cells responsive or non-responsive at grooming start (right). (C) Representative contour image of
putative lOFC pyramidal neurons in a Sapap3-KO mouse (left) and the average proportion of cells activated (t(15) =
0.6039, p = 0.5549), inhibited (t(15) = 3.020, p = 0.0086), or non-responsive at grooming start (right) black bars
indicate bins where p ≤ 0.00005, **p≤.01, n = 8 WT and 9 Sapap3-KO mice).
It is important to note that the observed increase in the percent of inhibited cells identified 
at grooming onset in Sapap3-KO mice was not simply driven by the disparity in the number of 
grooming bouts KO and WT mice engage in. When the number of bouts was restricted to the mean 
of the WTs (40 randomly chosen grooming bouts), there was still a significant increase in the 
percentage of groom-start inhibited units in the KO mice relative to WT mice (Fig.3-6A; KO: 
15.75 ± 9.18% vs WT: 5.75 ± 5.50%, p = 0.0363). Further, no changes were observed in WT cell 
classification, and no changes in the percentage of activated cells were observed as well (p ≥ 0.05), 
with the absolute values of the averages being nearly identical to our previous analysis (Fig.3-5B). 
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Additionally, there was no correlation in KO mice between grooming bout number and the 
percentage of inhibited cells detected (Fig.3-6B; R = 0.08, p = 0.84). These data indicate that the 
increase in groom-onset inhibited cells observed in KOs is not simply an artefact of the genotype 
difference in grooming bouts. 
Figure 3-6. Groom-onset inhibited cell increase is not solely driven by increased bout number. 
(A) Capping the number of grooming bouts (40 total bouts) for cell classification in KO mice still produces a
significant elevation compared to groom-onset inhibited cells in WT mice (t(15) = 2.299, p = 0.0363). (B) No
correlation between the percentage of inhibited cells and the number of grooming bouts in KOs (R = 0.08, p = 0.84)
*p ≤ 0.05, n = 8 WT and 9 KO mice.
3.3.4  Central striatal activity is increased at grooming onset 
A major downstream target of layer 5 lOFC pyramidal neurons is the central striatum 
(Corbit et al. 2019). Given that cortical projection neurons synapse preferentially onto striatal fast 
spiking interneurons (Bennett and Bolam 1994; Berke 2011), and  lOFC projections to central 
striatum have previously been shown to entrain striatal FSIs in Sapap3-KO mice (Burguiere et al. 
2013), we predicted that central striatal activity would be transiently increased at grooming onset 
in KO mice compared to WT mice due to a lack of inhibitory tone from FSIs. In order to answer 
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this question, we recorded calcium signals from putative SPNs in the central striatum using 
GCaMP6m driven by a synapsin promotor (Fig.3-7A). When we analyzed activity across all 
putative SPNs in all mice, we found that, as predicted, central striatal activity around grooming 
onset was elevated significantly in KO mice compared to WT mice (Fig. 3-7B; significant epochs 
indicated by black bar). This transient increase in fluorescence in KO mice appears to be specific 
to the onset of grooming, as overall calcium event rates during non-grooming times across the 
session was not significantly different between WTs and KOs (Fig.3-7C left; WT: 0.1013 ± 0.021 
vs, KO: 0.1128 ± 0.025 events/s). By contrast, event rates during grooming were significantly 
elevated in KO mice relative to WT mice (Fig.3-7C right; WT: 0.1071 ± 0.021 vs KO: 0.1381 ± 
0.033 events/s). Further, we calculated the percentage change in calcium event rate from pre-
grooming (-5 to 0s before grooming) immediately post-grooming (0 to 5s post groom) and found 
that KOs had a significantly elevated percentage change in calcium event rate compared to WTs 
(Fig.3-7D; WT: 6.623 ± 11.67% vs KO 19.02 ± 12.10%, two-tail t-test).  
Figure 3-7. Central striatum is hyperactive at grooming onset in Sapap3-KO mice 
(A) Schematized illustration of viral injection and lens placement into central striatum. Histological image of lens
placement at GCaMP6m expression. (B) Z-scored calcium fluorescence at grooming onset (dashed line) in WT and
Sapap3-KO mice (all significant t(2577)  ≥ 4.1651, p ≤ 0.0000321, two-tail t-test). (C left) Calcium event rate during
non-grooming time (t(17) = 1.065, p = 0.3019, two-tail t test) and during grooming times (C, right; t(17) = 2.314, p =
0.0334, two-tail t-test) in WT and Sapap3-KO mice. (D) Percentage change from pre-grooming calcium event rates
to post-grooming calcium event rates (5s before and 5s after groom onset) in WT and Sapap3-KO mice (t(17) = 2.237,
p = 0.0390, two-tail t-test). Bars indicate significance at p ≤ 0.00005, *p≤0.05. n = 8 WT and 11 Sapap3-KO mice.
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3.3.5  More SPNs are recruited at grooming onset in Sapap3-KO mice 
Given our observation of overall increased central striatal activity in KO mice at grooming 
onset relative to WT mice, we wanted to investigate how such an increase may be generated. One 
possibility is that the amplitude of individual spiny projection neurons activated during grooming 
is increased in KO mice compared to WTs. Interestingly, we observe that this doesn’t appear to be 
the case, with no significant differences in activated cell amplitude observed in the peri-grooming 
period between WTs and KOs (Fig. 3-8A; all epochs t(356) ≤ 3.6022, all p ≥ 0.000360). Similarly, 
hyperactivity could be manifest by a reduction in the amplitude of significantly inhibited units. We 
also do not observe this to be the case, with no difference in amplitude observed at any epoch 
around grooming onset (Fig. 3-8C; all epochs all t(187) ≤ 1.8394, all p ≥ 0.0036).  
Interestingly, when we examined the numbers of activated and inhibited cells in each 
genotype, it was apparent that compared to WT mice (Fig.3-8B WT representative contour image) 
KO mice had many more putative SPNs that were transiently activated at grooming onset (Fig.3-
8D KO representative contour image). Looking at all cells across all mice (Fig.3-8B right, we find 
a significant increase in the percentage of cells activated in KO mice (19.63 ± 5.80% activated) 
compared to WT mice (9.34 ± 3.02% inhibited, two-tail t-test). No changes were observed in the 
percentage of significantly inhibited during grooming in WTs compared to KOs (WT: 5.30 ± 
3.04% vs KO: 8.80 ± 4.40%, two-tail t-test) Together, these data suggest that hyperactivity in the 
central striatum of KO mice is manifest through an increase in the numbers of cells activated during 
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grooming, not by changes in amplitude of individual units that are significantly modulated by the 
behavior.  
Figure 3-8. Greater percentage of SPNs are active at groom onset in Sapap3-KO mice 
(A) Average amplitude of significantly groom onset activated units in WT and Sapap3-KO mice  (all t(356) ≤ 3.6022,
all p ≥ 0.000360). (C) Average amplitude of significantly groom onset inhibited units in WT and Sapap3-KO mice
(all t(187) ≤ 1.8394, all p ≥ 0.0036). (B-D) contour images of representative WT (top) and Sapap3-KO (bottom) mouse
during a baseline grooming session. Average percentage of cells identified as activated (t(17) = 4.577, p = 0.0003,
two-tail t-test), inhibited (t(17) = 1.927, p = 0.0708, two tail t-test), or unaffected in WT and Sapap3-mice. ***p≤0.001.
As in the lOFC, we wanted to ensure the observed increase in activated cells was not simply 
due to the basal genotype difference in the number of grooming bouts engaged in. In order to do 
this, we limited the number of KO grooming bouts to the average of the WTs (30 randomly selected 
grooming bouts) and examined whether this altered the percentages of grooming-modulated cells 
(Fig.3-9A). As in the lOFC, we did not observe any significant change in the percentages of cells 
classified as grooming onset activated, inhibited, or unaffected in KO mice when restricting the 
number of bouts to 30 (all t(10) > 1.542, p > 0.05, paired t-test). As was the case when we 
considered all bouts, a significant difference was observed in the percentage of grooming-onset 
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activated cells in KOs restricted to 30 bouts and WT mice (Fig.3-9A; WT: 9.4 ± 3.02% activated 
vs. KO: 16.43 ± 6.53 activated, p = 0.0113, two-tail t-test). Further, no significant correlation was 
observed between grooming bout number and the percentage of activated cells identified in KO 
mice (Fig.3-9B; R = 0.07, p = 0.83, two-tailed Pearson R). Together, these data suggest that the 
increase in the percentage of cells activated during grooming in KO mice is a biological 
phenomenon and not an artefact of an increase in grooming bouts.  
Figure 3-9. Groom-onset activated SPN increase is not an artefact of bout number 
(A) Percentages of cells activated (t(17) = 4.577, p = 0.0003, two-tail t-test), inhibited (t(17) = 1.927, p = 0.07, two-
tail t-test), and unaffected at grooming onset in WT and Sapap3-KO mice. (B) Correlation between grooming bout
number and the percentage of activated cells in Sapap3-KO mice (R = 0.07, p = 0.83, Pearson’s R). *p≤0.05.
3.3.6  Optogenetic activation of central striatal SPNs produces grooming-like behavior in 
WT mice 
Our data thus far suggest that a transient increase in central striatal activity, produced by 
an overall increase in the number of activated SPNs, occurs at the onset of compulsive grooming 
in KO mice. In order to evaluate whether we could recapitulate grooming behavior via direct 
activation of central striatal cell bodies, we injected WT mice bilaterally with AAV5-synapsin-
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ChR2 or an eYFP control virus and implanted fibers just dorsal to viral injections (Fig. 3-10A-B). 
Optogenetic stimulation of CS cells was delivered for 10s in a pseudorandom fashion (constant 
473nm stimulation), with an average interpulse interval of 30s (Fig. 3-10C). When we plotted the 
probability that a mouse would groom at a given time bin (500ms bins) and examined the peri-
stimulus period, we observed a robust increase in the probability that ChR2 mice would engage in 
a grooming-related movement (flank-licking, elliptical stroke movement, see Fig.3-1A) only 
during active stimulation (Fig. 3-10C; all t(650) ≥ 3.961, p ≤ 0.0041, Bonferroni’s multiple 
comparisons test). By contrast, there was no change in the probability of engaging in a grooming-
like movement during laser stimulation in eYFP mice. Examining only ChR2+ mice (Fig.3-10D) 
indicates that most mice displayed a robust increase in grooming-related movement probability 
immediately at the onset of stimulation on most laser pulse trials.  
 Importantly, the increase in grooming-related movement probability occurred 
immediately at the onset of laser stimulation in ChR2 mice, mirroring our finding of a transient 
increase in CS activity at the onset of grooming in KO mice. These data suggest that driving 






Figure 3-10. Optogenetic activation of the central striatum produces grooming-related movements 
(A) Mice were bilaterally injected with either AAV5-syn-eYFP (n = 6) or AAV5-syn-ChR2 (n = 9) and implanted
with fiber optic ferrules just above injection site in the central striatum. Representative histological image of virus and
fiber placements (right). (B) Schematic illustration of stimulation paradigm and subsequent behavioral analysis
strategy. Laser on times indicated in blue (C). Probability of engaging in a grooming-related movement in ChR2 and
eYFP mice in response to laser onset (shaded blue) (main effectvirus: F(1,13) = 0.3280, p = 0.5766, main effectstimulation 
time: F(49,637) = 3.589, p = 0.0001, interactionvirus x stimulation time: F(49, 637) = 4.189, p = 0.0001) (D) Individual ChR2+
mouse probability of engaging in a grooming related movement in response to laser stimulation (shaded blue). Black
bar indicates p ≤ .001 with Bonferroni correction).
3.3.7  Fluoxetine treatment reduces compulsive grooming in Sapap3-KO mice 
Fluoxetine (Prozac) is the first line treatment for OCD, though its effects in vivo on the 
physiology of neurons in either the lOFC or striatum, two of the most commonly linked regions to 
OCD, are mostly unknown. Previously, it has been demonstrated that a week of fluoxetine 
administration was capable of reducing compulsive grooming behavior in Sapap3-KO mice, 
though the mechanism of this reduction remains unclear (Welch et al. 2007b). Behaviorally, we 
see that fluoxetine is indeed capable of reducing compulsive grooming in mice with miniature 
microscopes attached. After 4 weeks of 20 mg/kg fluoxetine treatment in drinking water, lOFC 
implanted KO mice spent significantly less time grooming (t(14) = 4.491, p =  0.001, Sidak’s 
test), engaged in less grooming bouts (t(14) = 6.758, p =  0.0001, Sidak’s test), without any 
change in the number of transitions made between grooming subtypes per bout (t(14) = 1.976, p = 
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0.1317, Sidak’s test) relative to WT mice (Fig.3-11A-C). These data suggest that chronic 
administration of fluoxetine was capable of reducing compulsive behavior in KO mice without 
affecting WT behavior (all t ≤ 1.791, all p ≥ 0.1809).  
Sub-chronic (7 days) administration of 5 mg/kg fluoxetine i.p., which has previously been 
validated in KO mice (Welch et al. 2007b), produced qualitatively very similar reductions in 
grooming to 4-week treatment in drinking water (Fig.3-11D-G. Compared to WT mice, KO mice 
spent significantly less time grooming (t(8) = 5.584, p = 0.0010, Sidak’s test), engaged in less 
grooming bouts (t(8) = 2.633, p = 0.0592, Sidak’s test), and a significant reduction in 
transitions:bouts ratio (t(8) = 2.917, p = 0.0384, Sidak’s test). Again, WT behavior was unaffected 
by fluoxetine administration (all t(8) ≤ 1.030, p ≥ 0.5551). Combined, our data suggest that two 
different fluoxetine doses and treatment regimens result in qualitatively similar reductions in 










Figure 3-11. Fluoxetine reduces compulsive grooming in Sapap3-KO mice 
(A) Effects of 4 weeks fluoxetine treatment in lOFC implanted mice on time spent grooming (main effectgenotype:
F(1,14) = 10.33, p = 0.0063, main effecttreatment: F(1,14) = 13.29, p = 0.0026, interactiongenotype x treatment: F(1,14) = 7.318, 
p = 0.0171) (B) number of grooming bouts engaged in (main effectgenotype: F(1,14) = 7.127, p = 0.0183, main
effecttreatment: F(1,14) = 36.54, p = 0.0001, interactiongenotype x treatment: F(1,14) = 12.33, p = 0.0035) and (C)
transition:bouts ratio (main effectgenotype: F(1,14) = 15.02, p = 0.0017, main effecttreatment: F(1,14) = 5.151, p = 0.0396,
interactiongenotype x treatment: F(1,14) = 0.2758, p = 0.6077). (D) Effects of 7 days fluoxetine treatment in CS implanted
mice on time spent grooming grooming (main effectgenotype: F(1,8) = 12.55, p = 0.0076, main effecttreatment: F(1,8) =
13.71, p = 0.0060, interactiongenotype x treatment: F(1,14) = 17.59, p = 0.0030) (E) number of grooming bouts engaged in
( main effectgenotype: F(1,8) = 3.941, p = 0.0824, main effecttreatment: F(1,8) = 3.465, p = 0.0997, interactiongenotype x
treatment: F(1,8) = 3.465, p = 0.0997) and (F) transitions:bouts ratio (main effectgenotype: F(1,8) = 4.343, p = 0.0707, main
effecttreatment: F(1,8) = 1.781, p = 0.2188, interactiongenotype x treatment: F(1,8) = 7.793, p = 0.0235). ***p < 0.001, **p <
0.01, **p < 0.05.
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3.3.8  Neurons are accurately matched across days 
Putative pyramidal neurons in lOFC and SPNs in the central striatum were aligned across 
sessions using the recently developed CellReg algorithm (Sheintuch et al. 2017). Overall 
alignment across sessions was quite accurate, with stringent spatial correlations cutoffs set 
individually for each mouse (average R = 0.78). This yielded an average in all mice of 59% of cells 
tracked across sessions (Fig.3-12B). Model accuracy was assessed by examining the intersection 
of the model estimating the probability nearby cells were the same (probsame) and the model 
estimating nearby cells were different (probdifferent). No differences were identified across 
genotypes in lOFC implanted mice in the accuracy of cell matching (p > 0.05), and the Probsame 
average was above 0.85 for both groups (Fig.3-12C). Similarly, no changes were observed in 
central striatal imaged mice on the accuracy of cell matching (p ≥ 0.05) and the probabilitysame 
average across genotypes was above 0.90 (Fig.3-12D). These data suggest that on average across 
all mice in both regions, cell matching across sessions (4 weeks in the lOFC and one week in the 





Figure 3-12. Putative neurons are accurately matched across two sessions. 
(A) Representative contour image from two sessions (blue and red) recording calcium signals of putative lOFC
pyramidal neurons. Cells matched across session colored in purple. (B) Percentage of cells successfully matched
across sessions for lOFC implanted mice (n  = 16, meancells = 59.32%, rangecells = 47.5% to 71.5%). (C) No differences
in genotype for the probability that cells would be classified as the same unit across sessions in lOFC (probsame WT
mean = 0.86 ±.13; probdiff WT mean = 0.047 ±.029; probsame KO mean = 0.88 ±.07; probdiff KO mean = 0.06 ±.02).
(D) No differences in genotype for the probability that cells would be classified as the same unit across sessions in
central striatum (probsame WT mean = 0.91 ±.13; probdiff WT mean = 0.036 ±.032; probsame KO mean = 0.95 ±.041;
probdiff KO mean = 0.07 ±.025).
3.3.9  Fluoxetine reduces the number of inhibited cells in Sapap3-KO mice 
We next investigated whether chronic administration of fluoxetine in drinking water was 
capable of reducing the neural correlate of compulsive grooming, chiefly the increase in the 
percentage of cells inhibited in the lOFC at grooming onset in KO mice. Using our accurate cell 
matching across 4 weeks of fluoxetine treatment (Fig.3-13A-B) we are able to assess how cells 
change their response to the onset of grooming. On average, after 4 weeks of fluoxetine KO mice 
had significantly fewer grooming-onset inhibited units compared to their baseline session (Fig.3-
13C; KObaseline: 17 ± 9% vs. KOweek 4 FLX: 9 ± 7% inhibited, t(15) = 4.012, p = 0.0023, Sidak’s test). 
By contrast, no changes were observed in the percentage of cells activated at grooming onset in 
KO mice after fluoxetine treatment (KObaseline: 12 ± 7% vs. KOweek 4 FLX: 11 ± 5% activated, t(15) 
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= 0.5287, p = 0.8438, Sidak’s test). Fluoxetine had no significant effect on the percentages of cells 
modulated by grooming onset in WT mice (all t(15) ≤ 0.5551, p ≥ 0.8294, Sidak’s test).  
Comparing the amplitude of inhibited cell signal between cells identified as inhibited during the 
baseline session, and the amplitude from those same cells 4 weeks later reveals a significant 
increase in the average signal in KO mice (Fig.3-13D; all t(220) = 4.4214, p = 0.0000154, two-tail 
t-test). 
We next sought to assess how this reduction in amplitude was generated by examining how 
the classification of individual cells changed as a function of fluoxetine treatment. Interestingly, a 
similar proportion of cells in both WTs and KOs that were classified as activated during the 
baseline session became unaffected after 4 weeks of fluoxetine treatment (Fig.3-13F; WT: 6.17 ± 
2.85% vs. KO: 8.09 ± 6.21%, t(26) = 0.7505, p = 0.7081, Sidak’s test). By comparison, a 
significantly greater percentage of cells in KO mice changed their classification from inhibited at 
baseline to unaffected after fluoxetine treatment (WT: 4.76 ± 4.20% vs. KO: 13.02 ± 4.67%, t(26) 
= 3.234, p = 0.0066, Sidak’s test). While overall cells in both genotypes exhibited diverse 
responses to 4 weeks of fluoxetine treatment (Fig.3-13G), of all 9 possible outcomes for a cell the 
only significant difference between WTs and KOs was an increase in the percentage of cells that 
changed from inhibited at baseline to unaffected after fluoxetine (all other p ≥ 0.22). Together, 
these data suggest that fluoxetine may be acting on specific ensembles of cells that reduced their 
activity at grooming onset in KO mice and attenuating this reduction, possibly leading to an overall 
increase in lOFC activity at grooming onset.  
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Figure 3-13. Fluoxetine reduces the percentage of cells inhibited during grooming in Sapap3-KO mice. 
(A-B) Representative contour image of a Sapap3-KO mouse at baseline and after 4 weeks of fluoxetine treatment. 
Example trace averaged across grooming bouts of a strongly inhibited cell at baseline (right) and after 4 weeks of 
fluoxetine where the cell is categories as unaffected (cell indicated by black arrow). (C) Effect of 4 weeks fluoxetine 
on inhibited cell percentages in KOs and WTs (main effectgenotype: F(1,15) = 6.916, p = 0.0189. main effecttreatment: 
F(1,15) = 9.963, p = 0.0065. interactiongenotype x treatment: F(1,15) = 5.516, p = 0.033, 2-way repeated measures ANOVA). 
No effect of either gentype or treatment on activated cell percentages (all F(1,15)  ≤ 0.2205,  all p ≥ 0.6454). (D) 
Change in amplitude of cells previously identifed as inhibited at baseline in Sapap3-KO mice after 4 weeks of 
fluoxetine treatment (all t(220) = 4.4214, p = 0.0000154, two-tail t-test) in response to grooming onset (dashed line). 
(E) Effect of fluoxetine on the overall change from baseline in the percentage of inhibited cells detected in WT and
KO mice (t(13) = 2.412, p = 0.040, two-tailed t-test). (F) Effect of fluoxetine on the overall change from baseline in
the percentage of activated cells detected in WT and KO mice (t(13) = 0.4924, p = 0.6306, two-tailed t-test). (G)
Breakdown of cell classification changes following fluoxetine in WT and KO mice, change from inhibitedbaseline to
unaffectedweek 4 (t(13) = 3.494, p = 0.0040. all other possibilities p ≥ 0.05). Black bar indicates p ≤ 0.00005, **p <
0.01, *p < 0.05.
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3.3.10  Fluoxetine reduces the percentage of SPNs activated during grooming in Sapap3-
KO mice 
Given the reduction in the number of putative lOFC pyramidal cells inhibited at grooming 
onset in KO mice after 4 weeks of fluoxetine administration, we next wanted to evaluate whether 
this produced an increased drive to the central striatum and perhaps an overall reduction in the 
number of cells activated at the onset of compulsive behavior. Through our accurate cell matching, 
we are able to assess how individual SPNs change their responsiveness after fluoxetine treatment. 
Qualitatively, we observe that in KO mice there appears to be a reduction in the number of cells 
that are classified as activated after 7 days of fluoxetine treatment (Fig.3-14A-B), with cells that 
were activated at baseline no longer displaying a transient increase in activity at grooming onset 
following fluoxetine treatment. We also find that after 7 days of fluoxetine treatment (Fig.3-14C), 
there is a reduction in the percentage of grooming-onset activated SPNs in KO mice relative to 
their baseline (KObaseline: 26.13 ± 5.76% vs. KOday 7 FLX: 15.32 ± 8.97%, t(8) = 3.016, p = 0.033 
Sidak’s multiple comparisons test) with no significant change in WT mice (WTbaseline: 9.92 ± 
4.36% vs. WTday 7 FLX: 6.57 ± 3.80%, t(8) = 0.933, p = 0.612, Sidak’s multiple comparisons test). 
No changes were observed following fluoxetine treatment in the percentages of cells classified as 
inhibited (all t ≤ 0.69, p ≥ 0.76). Further, we found that compared to WT mice (Fig.3-14D), KO 
mice had a significantly greater proportion of cells change from activated at baseline to unaffected 
after 7 days of fluoxetine treatment relative to WT mice (WT: 9.27 ± 4.43% vs. KO: 19.2 ± 7.21%, 
t(8) = 2.62, p = 0.031, unpaired t-test) as well as a trend toward an increase in the percentage of 
cells that shifted from activated to inhibited (WT: 0.227 ± 0.508% vs. KO 1.86 ± 1.66%, t(8) = 
2.11, p = 0.068, unpaired t-test). It is worth noting that there was also a significant increase in the 
percentage of cells that changed classification from unaffected to inhibited in KO mice after 7 days 
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of fluoxetine relative to WTs (WT: 4.57 ± 2.82 vs. KO: 10.9 ± 4.30%, t(8) = 2.77, p = 0.024, 
unpaired t-test), suggesting that perhaps a shift away from a compulsive network of activated units 
occurred. Finally, we found that the percentage change in calcium event rates from pre- to post-
grooming was reduced in KO mice after 7 days of fluoxetine treatment (Fig.3-14E; KObaseline: 
26.95 ± 11.99 vs. KOday 7 FLX: 10.30 ± 5.12%, t(8) = 2.92, p = 0.045, Sidak’s multiple comparison 
test). No changes were observed in WT mice (WTbaseline: 15.24 ± 6.72% vs. WTday 7 FLX: 7.74 ± 
9.92%). These data suggest that fluoxetine may be effective at reducing overall striatal 











Figure 3-14. Fluoxetine reduces central striatal hyperactivity in Sapap3-KO mice 
(A) (left) Representative contour image of a Sapap3-KO mouse contour image at baseline colored to indicate cell
classification during grooming (right) Average calcium fluorescence across grooming trials of a single activated cell
indicated by black arrow. (B) (left) Representative contour image of the same Sapap3-KO mouse contour image
following 7 days of fluoxetine treatment (right) Average calcium fluorescence across grooming trials of the same cell
post-fluoxetine treatment, indicating it is no longer classified as activated. (C) Effect of fluoxetine on the percentage
of grooming-onset activated cells in WT and Sapap3-KOs (main effectgenotype: F(1,8) = 18.8, p = 0.0025; main
effecttreatment: F(1,8) = 7.8, p = 0.0235; interactiongenotype x treatment: F(1,8) = 2.167, p = 0.1792, two-way repeated
measures ANOVA). No effect of genotype or treatment on the percentage of grooming-onset inhibited units (all F(1,8)
≤ 0.3836, p ≥ 0.5529, two-way repeated measures ANOVA). (D) Breakdown of cell classification changes following
fluoxetine in WT and KO mice, change from unaffectedbaseline to  activatedday 7 FLX: (t(8) = 2.77, p = 0.024, unpaired t-
test); from activatedbaseline to unaffectedday 7 FLX: (t(8) = 2.62, p = 0.031, unpaired t-test); and from activatedbaseline to
inhibitedday 7 FLX: (t(8) = 2.11, p = 0.068, unpaired t-test). (E) Percentage change in calcium event rate from the pre-
grooming period (-5 to 0s before grooming onset) to post grooming (0 to 5s after grooming onset) in WT and Sapap3-
KO mice (main effectgenotype: F(1,8) = 2.527, p = 0.1559; main effecttreatment: F(1,8) = 9.923, p = 0.0162; F(1,8) = 3.228, 
p = 0.044, two-way repeated measures ANOVA). **p≤0.01, *p≤0.05, #p≤0.1.
3.3.11  lOFC terminal stimulation may reduce grooming in Sapap3-KO mice 
Our data thus far suggest that at baseline, KO mice have reduced input to the central 
striatum, which may result in disinhibition of SPNs due to a lack of excitation of striatal FSIs, as 
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has been previously suggested (Burguiere et al. 2013). After fluoxetine treatment we observe an 
increase in lOFC activity and a reduction in central striatal activity. We next wanted to test whether 
optogenetically increasing lOFC input specifically to the central striatum would result in decreased 
grooming in KO mice and an increase in the number of inhibited SPNs. We found that activation 
of lOFC terminals in the central striatum of WT and KO mice was sufficient to modulate SPN 
activity (Fig.3-15A). In each mouse we detected a small percentage of cells that were both 
activated and transiently inhibited at the onset of terminal stimulation (Fig.3-15B). Interestingly, 
when we looked across all mice (Fig.3-15C), we did not detect any differences in the percentage 
of cells that were activated (WT: 4 ± 3.27% vs. KO 3.5 ± 3.42%, t(6) = 0.212, p = 0.8394, unpaired 
t-test) or inhibited (WT: 2.75 ± 2.5% vs. KO: 1.25 ± 0.5%, t(6) = 1.18, p = 0.2839, unpaired t-test) 
by terminal activation. We next sought to examine whether lOFC terminal stimulation altered 
grooming behavior in WT and KO mice (Fig.3-15D). When we examined the probability a mouse 
would be engaged in a grooming bout, we found that as expected KO grooming probability was 
higher overall than WT grooming probability. Further, KO mice appeared to show a slight 
reduction in the probability of grooming during lOFC terminal stimulation (reduction from 0.22 
probability to 0.15). No such change during the stimulation period was detected in the WT mice, 
with grooming probability remaining a constant 0.07. When we averaged grooming probabilities 
in KO mice across pre-stimulation (-20 to 0s), during stimulation (0 to 20s), and post-stimulation 
(20 to 40s), we found a significant reduction in grooming probability in KO mice during 
stimulation (Fig.3-15E; KOoff: 0.229 ± 0.261 vs. KOon: 0.176 ± 0.230, t(6) = 4.17, p = 0.012, 
Sidak’s multiple comparison test). These data provide preliminary evidence that selectively 
enhancing lOFC input to the central striatum in KO mice might transiently reduce compulsive 
behavior.  
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Figure 3-15. lOFC terminal stimulation in Sapap3-KO mice may reduce compulsive behavior 
(A) Contour image of a putative SPNs in the central striatum indicating neurons activated (red), inhibited (blue), or
unaffected by optogenetic stimulation of lOFC terminals via Chrimson. (B) Four neurons from the mouse in (A) that
were activated by terminal stimulation (amber light) noted in red. Two neurons inhibited during stimulation noted in
blue. (C) Percentage of cells activated (t(6) = 0.212, p = 0.8394, unpaired t-test) and inhibited (t(6) = 1.18, p = 0.2839, 
unpaired t-test) by terminal stimulation in WT (white) and Sapap3-KO mice (purple). (D) Probability of grooming
across all WT and Sapap3-KO mice expressing Chrimson in lOFC terminals projecting to the central striatum. (E)
Probability of grooming during 20s of terminal stimulation (On) versus pre-stimulation (-20 to 0s) and post-
stimulation (20 to 40s) periods (main effectstimulation: F(2,6) = 9.58, p = 0.014, one-way repeated measures ANOVA).
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3.4 Discussion 
Cortico-striatal circuits have long been implicated in OCD pathophysiology, however how 
activity patterns in key cortical and striatal brain regions give rise to compulsive behavior remains 
poorly understood. In the present study, we find that neurons in lOFC are less active in response 
to grooming onset in Sapap3-KO mice relative to WT mice. Further, we demonstrate that 
amplitudes of individual lOFC neurons that are modulated during grooming (both neurons 
activated and inhibited at groom onset) are reduced in KO mice, and that they have substantially 
more grooming-inhibited units observed than WTs. We also examined activity associated with 
compulsive behavior in major target of lOFC projections, the central striatum (Corbit et al. 2019; 
Burguiere et al. 2013). Interestingly, in the central striatum we observe an overall increase in 
activity at grooming onset in KO mice relative to WTs, with an overall increase in the proportion 
of cells activated at grooming onset. We also demonstrate that transiently increasing central striatal 
SPN activity via ChR2 could produce grooming-related movements and that specifically 
stimulating lOFC terminals in the central striatum may reduce compulsive grooming in KO mice. 
Together, these results shed new light on how compulsive behaviors may be generated in the brain.  
While the OFC is among the most frequent regions associated with OCD via neuroimaging 
studies (Fitzgerald et al. 2011b; Menzies et al. 2008b; Rotge et al. 2009a; Zhang et al. 2016; 
Chamberlain et al. 2008), our understanding of its in vivo participation in compulsive behaviors is 
limited.  Canonically, the OFC is associated with behavioral flexibility associated with changes in 
action value (Balleine, Leung, and Ostlund 2011) and has previously been demonstrated to be 
critically involved in the ability for rodents to switch from goal-directed to habitual behavior 
(Gremel and Costa 2013), a switch hypothesized to be at the core of OCD symptomatology 
(Graybiel and Rauch 2000). Interestingly, a reduction in lOFC to dorsomedial striatum terminal 
 94 
activity has been demonstrated to be necessary for development of habitual behavior (Gremel et 
al. 2016). This finding is broadly consistent with our observation of reduced lOFC activity at the 
onset compulsive grooming behavior, which suggests that in KO mice a decrease in behavior-
related lOFC activity might lead to a lack of ability to flexibly adapt behavior away from a self-
injurious compulsive behavior. Assessment of in vivo lOFC activity in Sapap3-KO mice has been 
mixed, with one study suggesting no change in baseline activity between WTs and KOs (Burguiere 
et al. 2013) and another demonstrating subtle alterations in LFP oscillations (Lei et al. 2019). 
However, neither study evaluated lOFC activity during spontaneous compulsive behavior.  Despite 
this, our findings of reduced grooming-onset activity in the lOFC are consistent with the 
observation that optogenetic activation of lOFC cell bodies or their terminals in the central striatum 
reduced compulsive grooming behavior in a conditioned grooming paradigm in Sapap3-KO mice 
(Burguiere et al. 2013). Overall, our data are strongly suggestive of reduced lOFC drive to the 
central striatum.  
Striatal hyperactivity is associated both with OCD and compulsive behaviors in patient 
populations (Fitzgerald et al. 2011b; Harrison, Soriano-Mas, Pujol, Ortiz, Lopez-Sola, et al. 2009; 
Menzies et al. 2008b) as well as in mouse models (Ade et al. 2016; Ahmari et al. 2013; Burguiere 
et al. 2013; Shmelkov et al. 2010). Our observations expand on these findings by positing that 
increased striatal activity is specific to compulsive behavior onset, and may be the result of an 
increase in recruitment and subsequent activation of specific SPN ensembles at grooming onset 
rather than changes in the amplitude of individual SPNs – an important distinction when 
considering the effect of striatal output on downstream structures. Indeed, an overall increase in 
striatal gain has been associated with habit formation (O'Hare et al. 2016) and also with compulsive 
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behavior in Sapap3-KO mice (Ade et al. 2016). However, it is worth noting that these studies were 
conducted in the dorsolateral striatum, and not the central striatum.  
Figure 3-16. Schematic synthesizing findings in lOFC and central striatum at baseline. 
In the lOFC, overall activity at grooming onset is reduced in KO mice relative to WTs, likely due to an increase in the 
proportion of cells that are inhibited. This leads to reduced drive to central striatal FSIs. Reduced excitatory drive of 
central striatal FSIs in KOs disinhibits local SPNs, resulting in a greater proportion of SPNs activated during grooming 
and an increase in overall striatal drive (thickness of lines and rings corresponds to amplitude of signal).  
On the surface, it may seem that our finding of a grooming-onset associated reduction in 
lOFC activity is at odds with our observation of increased central striatal activity in Sapap3-KO 
mice relative to WTs, given its nature as a direct glutamatergic projection. However, a key 
prediction of this model is that lOFC inputs synapse preferentially on striatal parvalbumin positive 
fast spiking interneurons (FSIs), which monosynaptically inhibit nearby SPNs (Gittis et al. 2010; 
Koos and Tepper 1999; Tepper et al. 2010), over SPNs (Fig.3-16). Previously a bias toward 
inhibition of FSIs over SPNs has been demonstrated in other cortico-striatal projections (Mallet et 
al. 2005; Ramanathan et al. 2002). Although these observations haven’t been made specifically in 
the lOFC to central striatum cortico-striatal projection, support for the existence of this same 
phenomenon comes from causal experiments demonstrating that when lOFC cell bodies or their 
terminals in Sapap3-KO are activated via optogenetics, an entrainment of central striatal FSIs 
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occurs and a concomitant reduction in SPN hyperactivity is observed (Burguiere et al. 2013). 
Given their substantial inhibition of many local SPNs (Gittis et al. 2010; Koos and Tepper 1999), 
FSIs are well suited to mediate cortical input to the central striatum and regulate overall striatal 
gain, which has been demonstrated across a variety of circuits and behaviors and is thought to be 
critical for striatal information processing (Lee et al. 2017; Gage et al. 2010; Berke 2011, 2008). 
Critically, the impact of striatal FSIs on SPN activity has been demonstrated to be greatest during 
choice execution (Gage et al. 2010), providing a potential substrate for grooming-onset associated 
differences in striatal activity in WTs and KOs.  
Striatal FSIs may also be involved in mediating the treatment response to fluoxetine we 
observed in the present set of experiments. Previously, it was demonstrated that fluoxetine could 
reduce the compulsive grooming phenotype in Sapap3-KO mice, but the mechanism by which this 
occurred was not identified (Welch et al. 2007b). Our studies suggest that a reduction in central 
striatal activity and decrease in the proportion of grooming-onset activated SPNs occurs on the 
same time scale as the reduction in compulsive behavior. Consistent with potential FSI 
involvement in the mechanisms of fluoxetine, FSIs have been reported to be directly excited by 
serotonin through actions on 5-HT2 receptors (Blomeley and Bracci 2009). Further, after 
fluoxetine exposure there is enhanced integration of gamma frequency inputs onto FSIs that 
translates to a greater probability of FSI spiking (Athilingam et al. 2017). Importantly, fluoxetine 
itself is capable of directly activating cortical FSIs, which share many physiological and 
anatomical properties to cortical FSIs (Berke 2011), in a 5-HT2 receptor dependent manner 
(Blomeley and Bracci 2009). Unpublished data suggest a similar phenomenon occurs in striatal 
FSIs, with fluoxetine (100 µM) enhancing FSI firing rate at a series of current steps (Fig.A7). 
Thus, it seems plausible that the reduction in the number of activated central striatal SPNs we 
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observe in vivo following fluoxetine treatment may be driven by two simultaneously occurring 
changes: 1) an overall increase in lOFC drive, and 2) direct actions of fluoxetine to increase the 
excitability and depolarize striatal FSIs, thereby reducing recruitment of nearby SPNs at grooming 
onset. Future experiments should evaluate the precise activity patterns of FSIs during compulsive 
behavior in Sapap3-KO mice, and whether their activity is necessary for the therapeutic response 
to fluoxetine.  
Taken together, our findings provide novel insights into how compulsive behavior may be 
generated, focusing on two brain regions most often associated with OCD pathophysiology, the 
OFC and striatum. These experiments generate many testable hypotheses that can further elucidate 
the microcircuitry responsible for the generation of compulsive behavior. 
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4.0 Dissecting the role of genetically distinct striatal cell types on compulsive grooming 
behavior 
4.1 Introduction 
Obsessive compulsive disorder (OCD) is a chronic and debilitating psychiatric illness that 
affects between 1-3% of people worldwide. While the precise pathogenesis of OCD is still 
unknown, structural and functional imaging studies conducted in OCD patients repeatedly 
implicate dysfunction in cortico-striatal circuits necessary for regulating action selection (Rotge et 
al. 2009a; Rauch, Savage, Alpert, Fischman, et al. 1997; Saxena, Bota, and Brody 2001; Maia, 
Cooney, and Peterson 2008). Convergent findings from rodent research has provided a causal link 
that hyperactivity broadly within these circuits (specifically between the orbitofrontal cortex 
(OFC) and striatum) can contribute to compulsive behavior (Ahmari et al. 2013; Burguiere et al. 
2013).  
These findings and others have led to the development of hypotheses positing imbalance 
between the parallel “direct” and “indirect” pathways into and out of the basal ganglia in OCD 
(Pauls et al. 2014; Maia, Cooney, and Peterson 2008), similar to what has been suggested in 
canonical disorders of the basal ganglia, such as Huntington’s and Parkinson’s disease (Wichmann 
and DeLong 1996). While it is difficult to conceptualize how an imbalance in nonmotor 
direct/indirect pathways may manifest in OCD patients, it has been proposed that excess direct 
pathway activity may result in a positive feedback loop where obsessive thoughts lock into a 
specific sensorimotor pattern that is difficult to interrupt (Maia, Cooney, and Peterson 2008). The 
advent of tools to precisely assess direct and indirect pathway function in rodent models has shed 
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new light on the function of striatal dopamine D1-receptor expressing direct-pathway projecting 
(D1-SPN) and dopamine D2-receptor expressing indirect-pathway projecting (D2-SPN) neurons 
in modulating Parkinsonian states (Kravitz et al. 2010; Mastro et al. 2017), and more recently on 
how these cell types might act in concert in vivo during Parkinsonian conditions and following 
treatment with L-DOPA (Parker et al. 2018). Critically, these two populations of SPNs are subject 
to feed forward inhibition mediated by parvalbumin (PV)- positive fast spiking interneurons (FSIs) 
(Berke 2011; Gage et al. 2010; Owen, Berke, and Kreitzer 2018), and thereby tune SPN activity 
to task-relevant events (O'Hare et al. 2016; Lee et al. 2017).  
However, the investigation of direct and indirect pathway balance in vivo in affective 
cortico-striatal loops and how they might contribute to compulsive behavior has not yet been 
explored. Early pharmacological work examining the contribution of direct pathway activation via 
D1-receptor specific drugs suggests that D1 agonists are capable of producing excessive grooming 
(Molloy and Waddington 1987; Page and Terry 1997; Starr and Starr 1986a) in rodents, while D2-
receptor antagonists have been reported to be effective augmentation strategies to selective 
serotonin reuptake inhibitors (SSRI) in OCD (Bloch et al. 2006). Consistent with this evidence, a 
recent study using ex vivo calcium imaging to examine direct and indirect pathway balance in 
Sapap3-knockout (Sapap3-KO) mice, which display an SSRI-sensitive OCD-like compulsive 
grooming phenotype (Welch et al. 2007a) as well as cortico-striatal abnormalities (Corbit et al. 
2019; Welch et al. 2007a; Burguiere et al. 2013; Chen et al. 2011; Wan et al. 2014; Wan, Feng, 
and Calakos 2011), identified a bias toward direct pathway activation (Ade et al. 2016). FSIs have 
also been implicated in the Sapap3 phenotype, as stimulation of lOFC terminals in the central 
striatum may entrain FSIs (Burguiere et al. 2013) and restore normal feed-forward inhibition. 
These data suggest a potentially complex interplay in the striatal microcircuit during compulsive 
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behavior. In the present set of experiments, we attempt to examine the contribution of D1- and D2-
SPNs, as well as striatal FSIs to compulsive grooming behavior in Sapap3-KO mice.  
4.2 Methods 
4.2.1  Animals 
All procedures were carried out in accordance with the guidelines for the care and use of 
laboratory animals from the NIH and with approval from the University of Pittsburgh Institutional 
Animal Care and Use Committee (IACUC). Sapap3-knockout (Sapap3-KO) and wildtype 
littermates expressing the cre-recombinase (cre) transgene were generated by breeding Sapap3 
heterozygous mutants (Sapap3+/-) with heterozygous D1-cre mice (D1-cre+/-) or heterozygous PV-
cre mice (PV-cre+/-). Subsequent Sapap3+/-::cre+/- (either D1-cre+/- or PV-cre+/-) were mated with a 
Sapap3+/- mouse, allowing for the generation of cre positive Sapap3-WT mice (Sapap3+/+:: cre+/-) 
and cre positive Sapap3-KO mice (Sapap3-/-:: cre+/-). Mice were maintained on a 100% C57BL/6 
background. Male and female Sapap3-KO and wildtype littermates were used for all experiments. 
Mice in all cohorts were approximately 4-6 months old at the time of initial surgery.  
4.2.2  Stereotactic surgery 
For all surgeries, mice were anesthetized using 5% isoflurane mixed with oxygen and 
maintained on 1-2% isoflurane for the duration of surgery. Mice were placed on a small-animal 
stereotactic instrument (Kopf Instruments) and secured using ear bars and a bite bar. Hair was 
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removed from the dorsal surface of the head with hair clippers and the incision area was scrubbed 
with a betadine solution. A large incision was then made exposing the dorsal portion of the skull. 
All measurements were made relative to an interpolated bregma. Viral injections were performed 
using a fixed needle Hamilton syringe (Cole-Parmer Scientific, Vernon Hills IL, USA) connected 
to sterile polyethylene tubing affixed to a metal cannula and a Harvard Apparatus Pump 11 Elite 
Syringe Pump (Harvard Apparatus, Holliston MA, USA). Implanted lenses or ferrules were 
secured in place with one or two 0.45mm skull screws placed just in front of the lambdoid suture. 
Following completion of each surgery, mice were injected with sub cutaneous (s.c.) carprofen 
(10% w/v in 0.9% saline) and administered topical antibiotic ointment (TAO) and lidocaine around 
the headcap. Mice were then placed on a heating pad and given DietGel (ClearH2O, Portland ME, 
USA) and monitored until they were fully recovered from anesthesia. Mice were administered 
carprofen s.c. and received lidocaine and TAO treatments for 3 days post-surgery. For all surgical 
procedures mice were kept group housed with littermates unless conspecific fighting was noted, 
in which case the aggressive mouse was isolated for the duration of the experiment. 
4.2.2.1 In vivo microendoscopy surgical methods 
For experiments in the central striatum in D1-cre / Sapap3 mice as well as PV-cre / Sapap3 
mice, 800nl of a virus encoding cre-dependent GCaMP6m (AAV9-Syn-Flex-GCaMP6m-WPRE-
SV40, titer 2.55 x1012) was injected into the central striatum (AP: +0.65, ML: -1.8, DV: -2.9 & -
3.0) of mice. Injections were done in a two-step manner, with 400nl of virus injected at DV -2.9 
and 400nl of virus injected at DV -3.0. For D1-cre / Sapap3 experiments, immediately after 
injection of virus into the central striatum, a 500µm, 6mm length gradient refractive index lens 
(ProView GRIN lens, Inscopix Pala Alto, CA USA) was lowered just dorsal to the viral injection 
target (AP: +0.65, ML: -1.8, DV: -2.85) to allow for visualization of cells in the target region. For 
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PV-cre / Sapap3 experiments, a 1mm diameter, 4mm long GRIN lens was lowered into the central 
striatum immediately following viral injection. For experiments using a D2-promotor driven 
GCaMP6m (AAV8-D2SP-GCaMP6m, gift from Deisseroth lab) reported to have specific 
expression in D2-SPNs (Zalocusky et al. 2016) was injected into the central striatum of WT and 
KO mice (two step injection, as above). A 500µm, 6mm length gradient refractive index lens 
(ProView GRIN lens, Inscopix Pala Alto, CA USA) was then lowered just dorsal to the viral 
injection target (AP: +0.65, ML: -1.8, DV: -2.85). For all GRIN lens implants, acrylic dental 
cement (Lang Dental, Wheeling IL, USA) was used to secure the lens in place and seal the entire 
lens during the virus incubation period (4-6 weeks).  
For surgeries imaging striatopallidal projecting D2-SPNs with retrograde GCaMP7, 400nl 
of AAV-hsyn-GCaMP7 (titer 1.85 x1013) was injected into the external segment of the globus 
pallidus (GPe; AP: 0.0, ML: -2.0, DV: -3.5). After 4-6 weeks for viral incubation, a second 
procedure was performed during which mice in each experiment were again anesthetized with 
isoflurane and secured to a stereotactic apparatus using ear cuffs. Using a Dremel, excess dental 
cement was carefully removed exposing the ProView GRIN lens. The top of the ProView lens was 
then cleaned with compressed air and lens paper, removing all dental cement dust. A magnetic 
microscope baseplate (Part ID:1050-002192, Inscopix) was then attached to the miniaturized 
microscope (nVistaHD 2.0 epifluorescence microscope, Inscopix) and lowered into place above 
the GRIN lens with the 475nm blue LED gain and power set to their maximum. The optimal field 
of view was then determined by focusing on visible cells or other gross landmarks (blood vessels). 
Once an optimal field of view was obtained, the baseplate was cemented in place and a plastic 
Microscope Baseplate Cover (Part ID:1050-002193; Inscopix) was attached to prevent debris from 
blocking the lens.  
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4.2.3  Drug preparation and administration 
(±)Fluoxetine hydrochloride (Fluoxetine) was obtained through the NIMH Chemical 
Synthesis and Drug Supply Program. Fluoxetine was administered intraperitoneally (i.p.) 
according to previous reports which report a reduction in Sapap3-KO grooming following 
treatment (Welch et al. 2007a). Fluoxetine hydrochloride (5 mg/kg) in a 0.9% saline solution (10 
ml/kg) was injected i.p. daily for 7 days to WT and Sapap3-KO mice. Fluoxetine injections 
occurred between 4:00PM and 6:00PM daily while behavioral testing occurred beginning at 
9:00AM on testing days. After 7 days of injections, mice were given a two-week washout from 
fluoxetine to monitor whether grooming behavior and neural activity differences returned to 
baseline levels.  
4.2.4  Behavioral apparatus and assessment of grooming behavior 
A custom-built behavioral apparatus was constructed for the accurate simultaneous 
assessment of spontaneous (e.g. grooming) behavior and neural activity (Fig.3-1A) via in vivo 
calcium imaging. A clear plexiglass sheet was suspended over a behavioral acquisition camera 
(Point Grey Blackfly, FLIR Integrated Imaging Solutions). A clear acrylic chamber (8”x8”x12”) 
was placed above the camera such that a mouse could be visualized at every angle. Behavioral 
acquisition was conducted at 40 Hz using SpinView (Point Grey) software and detailed frame 
information was sent directly to a central data acquisition box (LabJack U3-LV, Labjack 
Corporation, Lakewood CO USA). A randomly flashing (30s ITI) LED visible in the behavioral 
video controlled by custom scripts via an Arduino (Arduino Leonardo, Somerville MA, USA) and 
sending TTL pulses to the LabJack was used for alignment of behavior and calcium data.  
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Following acquisition, video was converted and compressed (maintaining accurate frame 
rate information) into .MP4 format using the open source software HandBrake. Videos were then 
imported into Noldus The Observer XT (Noldus, Leesburg VA, USA) and grooming behavior was 
scored frame by frame. Grooming behavior was scored according to previous reports (Kalueff et 
al. 2016) by an observer blind to experimental condition (genotype and drug treatment). A mouse 
was considered to be grooming if it engaged in any of the following behaviors (Fig.3-1B) 1) Facial 
grooming, when a mouse touches its face, whiskers, or head with its forepaws. 2) Body grooming, 
when a mouse licks its flank or its ventral surface. 3) Hind leg scratching, when a mouse uses one 
of its hind legs to scratch its flank. The beginning of a grooming bout was defined as the frame 
when a mouse made a movement to begin grooming (e.g. a face grooming bout began the frame a 
mouse lifted its paw off the ground to touch its face). The end of a grooming bout was defined as 
the frame when a mouse ceased grooming (e.g. a body grooming bout ended when a mouse moved 
its snout from its flank). Grooming bout starts separated by less than one second were collapsed 
into the previous bout. Thus, the minimum amount of time possible between grooming bouts for 
all experiments was one second.  
4.2.5  In vivo calcium imaging in freely moving mice 
After at least 1 week of recovery from baseplate surgery, mice were habituated to the 
attachment of the microscope. In order to attach the microscope securely to the baseplate, mice 
were lightly scruffed and the miniature nVistaHD 2.0 microscope was connected to the magnetic 
baseplate and secured with a set screw. During habituation, optimal focus, field of view, and LED 
power and gain settings were determined visually by assessing the presence of clearly defined 
putative neurons. A caliper was used to accurately measure the precise microscope focus such that 
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multiple imaging sessions were conducted with the same field of view. In addition to habituation 
to the microscope, mice were also placed into the acrylic chamber under low light conditions for 
a period of 5-10 minutes once daily for three days prior to imaging.  
Following habituation, mice were given a 40-minute baseline behavior and imaging 
session. Under low light the microscope was attached and mice were placed into a temporary 
holding cage. Mice were given 3-5 minutes after attachment of the scope for recovery from 
scruffing and to allow any rapid photobleaching to occur. After this period, mice were carefully 
placed into the clear acrylic chamber. LabJack data acquisition was then begun, immediately 
followed by behavioral SpinView recordings, and finally nVistaHD software began recording 
compressed greyscale tiff images at 20 Hz. As with the behavioral frame acquisition, individual 
calcium frame information was also sent to the LabJack for subsequent alignment of behavior and 
calcium data. For all mice, analog gain of the image sensor was set between 1 and 4 while the 470 
nm LED power was set between 10 to 30% transmission range. These settings were kept consistent 
for each mouse throughout all subsequent imaging sessions. 
4.2.6  Calcium imaging analysis 
Custom Matlab (MATHWORKS) scripts were used to conduct analysis of grooming-
related calcium activity. Grooming behavior (state events) was exported as timestamps (grooming 
start and grooming stop) and aligned to Ca2+ time by recording 5 consecutive LED pulses (point 
events). The offset of Noldus behavior time to nVista Ca2+ time was then subtracted off leaving 
the same number of frames for both the behavior and Ca2+ fluorescence. Grooming timestamps 
were then transferred to a binary/continuous trace of the same length and sampling rate (10 Hz) as 
each Ca2+ trace via logical indexing (grooming = 1, not-grooming = 0). Timestamps for behavior 
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are converted to the closest matching frame in the calcium recording (maximum error of one frame 
or ± 100ms at 10 Hz). Calcium activity could then be aligned to the start and end of a grooming 
bout, or the transition point between grooming bouts (≤ 1s between a grooming bout ending and a 
grooming bout beginning).  
4.2.6.1 Unbiased event-related activity classification 
In order to perform unbiased classification of an individual cells responsiveness (activated, 
inhibited, or unaffected) to a behavioral event (e.g. grooming onset) we adapted a strategy used in 
(Jimenez et al. 2018) using custom Matlab (MATHWORKS) scripts. First, each individual cell’s 
raw Ca2+ was aligned to the onset of each grooming bout (Fig.3-2A). These traces were then 
averaged across all bouts within a given mouse (Fig.3-2B). For each individual cell, raw Ca2+ 
traces 10 seconds prior to grooming onset and 10 seconds after grooming onset (200 total samples 
at 10 Hz, 100ms per sample) were shuffled in time for each sample (200x) removing any temporal 
information that was previously in each trace but maintaining the variance within each grooming 
bout (Fig.3-2C). This shuffle was then performed 1000 times per cell to obtain a null distribution 
of grooming associated Ca2+ activity. A cell was considered responsive to grooming onset if its Z-
normalized Ca2+ fluorescence amplitude between -0.5s before grooming onset to 3s after grooming 
onset exceeded a 1 standard deviation threshold from the null distribution (Fig.3-2D).  
Individual Ca2+ traces classified as activated or inhibited could then be averaged across 
genotype and directly compared within and across sessions, providing an assessment of how cells 
encoding grooming were different as a factor of genotype or drug treatment.  
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4.2.7  Statistical analysis 
Statistical analysis was carried out using custom Matlab scripts (MATHWORKS) or 
GraphPad Prism 8.0 (GraphPad Software, San Diego CA, USA). Throughout this dissertation 
results in text are reported as mean ± standard deviation (SD) and data presented on figures are 
mean ± standard error of measurement (SEM) unless otherwise noted.  
4.2.7.1 Statistical analysis of grooming behavior 
Baseline grooming behavior was analyzed using two-tailed independent samples t-tests. 
For the analysis of behavior following fluoxetine administration, a two-way repeated measures 
analysis of variance (ANOVA) was used. Main effects and interaction terms are reported 
throughout, and in cases of significant interactions, post-hoc comparisons were made using Sidak’s 
multiple comparison correction. A corrected alpha was set to 0.05. 
4.2.7.2 Statistical analysis of calcium activity 
In order to evaluate the effect of genotype and treatment on grooming evoked Ca2+ 
fluorescence averaged across individual cells, unpaired two-tailed t-tests were conducted at each 
time bin (100 ms). Due to our high N with dozens to hundreds of cells in each condition, a 
conservative Bonferroni correction was performed (𝛼𝛼 =  0.05
𝑚𝑚
). The critical p value (α = 0.05) was 
divided by the total number of time bins (each bin = 100ms) to be compared (m), resulting in 
adjusted critical values between 0.000025 and 0.00005, depending on the exact comparison.   
For comparison of proportions of classified cells during baseline imaging sessions, two-
tailed independent samples t-tests were used. To assess the effect of fluoxetine treatment on the 
proportions of classified cells, two-way repeated measures ANOVA were used. When a significant 
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interaction between genotype and drug treatment was observed, post-hoc tests were conducted 
using Sidak’s multiple comparisons test. A corrected alpha was set to 0.05. 
4.3 Results 
4.3.1  D1-SPN activity is increased post-grooming onset in Sapap3-KO mice 
In order to evaluate whether central striatal D1-SPN activity at grooming onset differs 
between double transgenic D1-cre/Sapap3 WT and KO mice, we expressed a cre-mediated 
GCaMP6m and implanted a GRIN lens just dorsal to our viral injection target (Fig.4-1a). As 
expected, we found that KO mice spent significantly more time grooming (WT: 179.2 ± 86.99s vs 
KO: 790 ± 550.5s, unpaired t-test) and engaged in significantly more grooming bouts (WT: 38.38 
± 14.97 bouts vs KO: 92.33 ± 48.62 bouts, unpaired t-test) than WT littermates (Fig.4-1b). 
Grooming-onset evoked calcium activity in D1-SPNs was significantly elevated in the period 
immediately post-grooming in Sapap3-KO mice relative to WT mice (Fig.4-1c; all significant time 
bins t(2189) ≥ 2.109, p ≤ 0.0351, Sidak’s post-hoc test). Not only was calcium activity elevated in 
WTs relative to KOs at groom onset, but KO mice displayed a significant increase in calcium event 
rate during the period immediately following grooming compared to the period preceding 
grooming (Fig.4-1d; KO pre-grooming: 0.0801 ± 0.0359 events/s vs KO post-grooming: 0.0934 ± 
0.03597 events/s, t(11) = 3.068, p = 0.0213, Sidak’s multiple comparisons test) whereas WT mice 
had no significant change in calcium event rate (WT pre-grooming: 0.1013 ± 0.0259 events/s vs 
WT post-grooming: 0.1006 ± 0.0305 events/s, t(11) = 0.1551, p = 0.9855, Sidak’s multiple 
comparisons test). Relative to WTs, the percentage change in D1-SPN event rates from a pre-
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grooming period was significantly elevated (WT: 0.7583 ± 6.575% vs KO: 19.51 ± 18.99%, t(12) 
= 2.621, p = 0.0223, unpaired t-test). Together, these data suggest that D1-SPN activity in KO 
mice is elevated while they engage in compulsive grooming behavior. 
Figure 4-1. D1-SPNs are hyperactive in vivo following grooming onset. 
(a) Schematic of cre-mediated GCaMP6m expression in D1-SPNs of WT and Sapap3-KO mice. (b) Time spent
grooming (t(12) = 3.130, p = 0.0087, unpaired t-test) and number of grooming bouts (t(12) = 2.991, p = 0.0113,
unpaired t-test) in WT and Sapap3-KO mice. (c) Grooming-onset associated calcium fluorescence in WT and Sapap3-
KO mice (main effectgenotype: F(1,11) = 0.02031, p = 0.8892, main effecttime: F(198, 2178) = 0.6943, p = 0.9995,
interactiongenotype x time: F(198,2178) = 1.841, p = 0.0001, two-way repeated measures ANOVA). (d) Calcium event
rate (event/s) during the period immediately preceeding grooming (-5s to 0s) and immediately following grooming
(0s to 5s) in WT and Sapap3-KO mice (main effectgenotype: F(1,11) = 0.6470, p = 0.04382, main effecttime: F(1,11) =
4.604, p = 0.055, main effectgenotype x time: F(1,11) = 5.553, p = 0.0380, two-way repeated measures ANOVA). (e)
Percent change in calcium event rate (pre-grooming – post-grooming) in WT and Sapap3-KO mice (t(12) = 2.621, p
= 0.0223). n = 7 WT mice and 6 Sapap3-KO mice. **p <0.01, *p<0.05.
 110 
4.3.2  Changes in activity and recruitment of D1-SPNs as a function of timing of grooming 
sequence 
With the overall change in calcium fluorescence in D1-SPNs observed predominantly 
following grooming bout onset, we next sought to examine whether the event-associated activity 
of significantly modulated D1-SPNs was different at various peri-grooming bout periods (Fig.4-
2). We first examined calcium fluorescence in D1-SPNs during the immediate pre-grooming (-
0.5s prior to grooming onset) to immediate post grooming (2s post-grooming) period (Fig.4-2a-c). 
Interestingly, we found that Z-scored fluorescence of significantly activated D1-SPNs during this 
period was lower in KO mice relative to WT mice (Fig.4-2a; all significant t ≥ -5.153, p ≤ 
0.0000405, unpaired t-test). There was no difference in amplitude of groom-onset inhibited units 
between WT and KO D1-SPNs (Fig.4-2b; all t(119) ≥ 3.9867, p ≥ 0.000116, unpaired t-test). 
Relative to WTs (Fig.4-2c), KO mice had a significantly greater percentage of cells inhibited at 
grooming onset compared to WT mice (WT: 5.857 ± 2.27% vs KO: 9.667 ± 3.07%, unpaired t-
test), with no changes in the percentages of activated D1-SPNs (WT: 11.286 ± 7.30% vs KO: 11.17 
± 4.62%, unpaired t-test).  
Given our finding of an increase in calcium fluorescence in D1-SPNs during grooming 
rather than locked to grooming onset (Fig.4-2c), we evaluated whether there were differences in 
modulated grooming within a post-grooming (+0.5 to 4s) window in WT and KOs. Interestingly, 
we observed that while the amplitude of WT activated D1-SPNs was attenuated during this period 
(Fig4-2d) relative to their activity at grooming onset (Fig.4-2a), this was not the case in KO mice. 
This reduction equated in no difference in amplitude of D1-SPNs in the post-grooming onset 
period in WTs and KOs (all t(98) ≤ 0.8718, p ≥ 0.000148, unpaired t-tests). Amplitude of 
significantly inhibited D1-SPNs (Fig.4-2e) was also unchanged in this post-grooming window (all 
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t(56) = 4.1566, p = 0.000112, unpaired t-tests). While there were no differences in D1-SPN 
amplitude in this post-grooming period, we found that there were significant shifts in the 
percentages of modulated cells in WTs and KOs (Fig.4-2f). We found that the percentage of D1-
SPNs activated during grooming was increased in KO mice relative to WTs (WT: 6.29 ± 3.64% 
vs. KO: 14.33 ± 8.48%, unpaired t-test) while there was no longer a difference in the percentage 
of grooming inhibited D1-SPNs (WT: 6.57 ± 3.05% vs. KO: 4.50 ± 3.27%, unpaired t-test). These 
data indicate that at grooming onset, D1-SPN activity is reduced in KO mice relative to WT mice, 








Figure 4-2. Sapap3-KO mice have sustained activity of D1-SPNs during grooming 
(a) Z-scored fluorescence of significantly activated D1-SPNs in the pre-grooming (-0.5s) to immediate post-grooming
(2s) period (green shading) in WT and Sapap3-KO mice (all significant t ≥ -5.153, p ≤ 0.0000405, unpaired t-test).
(b) Z-scored fluorescence of significantly inhibited D1-SPNs in the pre-grooming to immediate post-grooming period
in WT and Sapap3-KO mice (all t(119) ≥ 3.9867, p ≥ 0.000116, unpaired t-test). (c) Percentages of significantly
modulated D1-SPNs at grooming onset in WT and Sapap3-KO mice (activated cells: t(11) = 0.034, p = 0.973;
inhibited cells: t(11) = 2.568, p = 0.026, unpaired t-tests). (d) Post-grooming (green shading, +0.5s to 2s post-
grooming) activated D1-SPN amplitude (all t(98) ≤ 0.8718, p ≥ 0.000148, unpaired t-tests) and (e) inactivated D1-
SPN amplitude (all t(56) = 4.1566, p = 0.000112, unpaired t-tests) in WT and Sapap3-KO mice. (f) Percentages of
significantly modulated D1-SPNs post-grooming onset in WT and Sapap3-KO mice (activated cells: t(11) = 2.29, p
= 0.042; inhibited cells: t(11) = 1.18, p = 0.262, unpaired t-tests). n = 7 WT and 6 Sapap3-KO mice. Bar indicates p
<0.00005, **p<0.01
4.3.3  Fluoxetine reduces overall increase in D1-SPN activity 
We have previously demonstrated that 7 days of fluoxetine treatment, the first line 
pharmacotherapy for OCD, was capable of reducing overall striatal in KO mice, though its effects 
on subtypes of SPNs is unknown. We first found that fluoxetine reduced the amount of time KO 
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mice spent grooming (KO baseline: 790.2 ± 550.5s vs KO Day 7 FLX: 516.6 ± 424.3s, t(11) = 
3.757, p = 0.0063, Sidak’s multiple comparisons test) and the number of grooming bouts engaged 
in (KO baseline: 92.33 ± 48.62 buts vs. KO Day 7 FLX 55.83 ± 31.86 bouts, t(11) = 2.648, p = 
0.0448, Sidak’s multiple comparisons test) relative to WT mice (Fig.4-3a-b). Interestingly, we 
found that 7 days of fluoxetine was capable of preventing an the previously observed increase in 
D1-SPN calcium event rate (Fig.4-3c) associated with the onset of grooming in KO mice (KO pre-
grooming: 0.118 ± 0.036 events/s vs KO post-grooming: 0.126 ± 0.041 events/s, t(11) = 0.7731, p 
= 0.7038, Sidak’s multiple comparisons test) with no changes in WTs (p ≥ 0.05). Compared to 
baseline, where KO mice exhibited a substantial increase in D1-SPN calcium event rates at 
grooming onset (Fig.4-3d), fluoxetine elicited a trend-level reduction in post-grooming calcium 
event rates in KO mice (KO baseline: 21.899 ± 20.469% vs. KO Day 7 FLX: 6.165 ± 20.799%, 
t(11) = 2.281, p = 0.0851, Sidak’s multiple comparison test). No significant effect of fluoxetine on 
calcium event rate change was observed in WT mice (p ≥ 0.05). These data indicate that, similar 
to what is observed in all central striatal SPNs, fluoxetine is capable of reducing increased D1-




Figure 4-3. Fluoxetine reduces D1-SPN hyperactivity during grooming in KO mice. 
(a) Time spent grooming in WT and Sapap3-KO mice (main effectgenotype: F(1,11) = 6.988, p = 0.0288, main
effecttreatment: F(1,11) = 9.469, p = 0.0105, interactiongenotype x treatment: F(1,11) = 5.940, p = 0.0330, two-way repeated
measures ANOVA) (b) Number of grooming bouts in WT and Sapap3-KO mice (main effectgenotype: F(1,11) = 8.121,
p = 0.0158, main effecttreatment: F(1,11) = 5.467, p = 0.0393, interactiongenotype x treatment: F(1,11) = 2.395, p = 0.1500,
two-way repeated measures ANOVA). (c) Calcium event rate (event/s) during the period immediately preceeding
grooming (-5s to 0s) and immediately following grooming (0s to 5s) in WT and Sapap3-KO mice (main effectgenotype:
F(1,11) = 0.1683, p = 0.06895, main effecttime: F(1,11) = 0.1975, p = 0.6655, interactiongenotype x time: F(1,11) = 0.4754,
p = 0.5043, two-way repeated measures ANOVA). (d) Percentage change in calcium event rate between pre-grooming
and post-grooming periods in WT and KO mice (main effectgenotype: F(1,11) = 3.551, p = 0.0862, main effecttreatment:
F(1,11) = 2.431, p = 0.1473, interactiongenotype x treatment: F(1,11) = 5.198, p = 0.0139, two-way repeated measures
ANOVA). n = 7 WT and 6 Sapap3-KO mice, **p<0.01, *p<0.05,#p<0.1.
4.3.4  D2-SPN imaging in vivo 
Several methods were utilized to assess the activity of D2-SPNs in vivo during compulsive 
behavior with very limited success. One attempt was made using a virus that would express 
GCaMP6m under the D2-receptor promotor (AAV8-D2SP-GCaMP6m), which was previously 
used successfully to image D2-SPNs in the nucleus accumbens of rats using fiber photometry 
(Zalocusky et al. 2016). While we found this virus to be specific for D2-SPNs in mice, the intensity 
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of the activity in vivo was not sufficient to quantify either via fiber photometry or single photon 
microendoscopy as described in this thesis (data not shown).  
In parallel, we tried a second approach, relying on the segregation in downstream targets 
of D1- and D2-SPN in the non-ventral striatum. Specifically, inhibitory dorsal striatum D2-SPNs 
project almost exclusively to the globus pallidus external segment (GPe), allowing us to use a 
retrogradely trafficked GCaMP in order to visualize GPe-projecting D2-SPNs (Fig.4-4a-top). 
Unfortunately, despite good viral targeting in the GPe of multiple mice both with and without lens 
implants (Fig.4-4a-bottom), we were unable to detect calcium in vivo and subsequent analysis of 
the tissue revealed no retrogradely infected D2-SPN cell bodies across the entire striatum (Fig.4-
4b, depicted image of mouse with no lens implantation). It is unclear why no retrograde transport 
was detected in the striatum (despite transport being detected in other GPe projecting regions (data 
not shown)), though it suspected that tropism of current generation retrograde-AAVs may not 
allow specific pathways to be targeted, despite the anatomical connections being able to be mapped 
using traditional retrograde methods (e.g. cholera toxin) (personal correspondence M.R. Bruchas 
& G.D. Stuber). Given these difficulties, future experiments will utilize an inefficient double-
transgenic strategy similar to what was used in our experiments characterizing D1-SPNs, utilizing 
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mice that express cre-recombinase in adenosine 2a (A2A)-positive striatopallidal projecting spiny 
projection neurons (Tecuapetla et al. 2014).  
Figure 4-4. Absence of retrograde-GCaMP7 transport in the striatum 
(a) (top) Depiction of retrograde-AAV strategy to infect GPe-projecting central striatal neurons. (bottom)
Representative image of a GPe injection of retrograde-GCaMP7 (green) showing infection of GPe neurons. (b) (top)
After 5 weeks of viral expression, GCaMP7 should be retrogradely transported to cell bodies upstream of the GPe,
including D2-SPNs in the central striatum. (bottom) Absence of retrograde-GCaMP7 labeling across the striatum after
5 weeks of viral expression (blue = DAPI).
4.3.5  Central striatal FSI activity is not different at grooming onset 
One possible explanation for sustained activation of D1-SPNs in KO mice during grooming 
would be a difference in the activity of striatal fast-spiking interneurons, which mediate feed-
forward inhibition onto neighboring SPNs (Berke 2011; Owen, Berke, and Kreitzer 2018), in 
relation to compulsive grooming onset. In order to investigate this possibility, we injected a cre-
mediated GCaMP6m into the central striatum of a one double-transgenic PV-cre/Sapap3-WT and 
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one PV-cre/Sapap3-KO mouse. Because only between 1-3% of striatal cells are FSIs, we 
implanted a larger diameter GRIN lens (1mm) to maximize our ability to image such a sparse cell 
population (Fig.4-5a). As expected, we found few putative FSIs in our field of view (Fig.4-5b), 
observing 8 cells in a WT mouse and 12 cells in a KO mouse (Fig.4-5b-top). These approximate 
numbers are in line with what would be expected in the literature (1-3% of all cells) given a 1mm 
diameter lens (~300-500 cells visible) in the medial portion of the striatum (Parker et al. 2018). 
Further, we found that compared to SPNs (obtained in experiments conducted in Chapter 3), 
putative FSIs exhibited characteristic broader and higher amplitude waveforms (Fig.4-5b-bottom), 
typical of higher firing neurons expressing GCaMP (Gritton et al. 2019).  
We found no difference in the calcium event rates of neurons obtained from one WT and 
one KO mouse during non-grooming times (Fig.4-5c; WT: 0.036 ± 0.027 events/s vs. KO 0.044 ± 
0.045 events/s) or during grooming (WT: 0.080 ± 0.053 events/s vs. KO: 0.095 ± 0.083 events/s), 
though overall FSIs in both genotypes increased their activity during grooming (main effecttime: 
F(1,16) = 7.609, p = 0.0140, two-way repeated measures ANOVA). We next evaluated normalized 
calcium fluorescence at grooming onset in a WT and KO mouse in response to grooming onset 
and found no difference in Z-normalized calcium fluorescence in FSIs in WTs and KOs (Fig.4-5d; 
all t(18) ≤ 1.72, p ≥ 0.102, unpaired t-tests). While we are underpowered to draw firm conclusions 
only analyzing a small number of putative FSIs in a single WT and KO mouse, preliminarily it 
appears that there are no differences in the calcium activity of FSIs during grooming behavior by 
genotype.  
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Figure 4-5. Preliminary evidence that in vivo activity of central striatal FSIs in a Sapap3-KO mouse is normal 
(a) Schematic representing the cre-mediated strategy for imaging a sparse population PV+ putative central striatal
FSIs in WT and KO mice (b) (top) Representative maximim projection image of all pixels recorded in a 30 minute
grooming session. Contour image of identified putative FSIs overlayed in blue. (bottom) Representative traces of
putative SPNs (Chapter 3) demonstrating characteristic narrow waveforms and lower amplitude (black).
Representative traces of putative FSIs demonstrating wider and higher amplitude waveforms (blue). Calcium event
rates during non-grooming and grooming times in a single WT (n = 8 cells) and single KO (n = 12 cells) mouse (main
effectgenotype: F(1,16) = 0.271, p = 0.6099; main effecttime: F(1,16) = 7.609, p = 0.0140; interactiongenotype x time: F(1,16)
= 0.040, p = 0.8435, two-way repeated measures ANOVA). Z-scored calcium fluorescence in FSIs recorded from a
WT and KO mouse aligned to grooming onset (all t(18) ≤ 1.72, p ≥ 0.102, unpaired t-tests). *p<0.05.
4.4 Discussion 
In the present set of experiments, we tested the hypothesis that central striatal hyperactivity 
observed in vivo in Sapap3-KO mice at the onset of compulsive grooming (Chapter 3) was driven 
by hyperactivity in direct-pathway projecting D1-SPNs. Consistent with this hypothesis, we 
observed an increase in D1-SPN calcium event rates during compulsive grooming behavior and 
an increase in D1-SPN calcium fluorescence (Fig.4-1). However, this increase was not identified 
immediately at grooming onset, rather post-grooming onset while the mouse was engaged in the 
compulsive behavior (Fig.4-2) and was associated with an increase in the percentage activated D1-
SPNs. Treatment with the SSRI fluoxetine (Prozac), the first-line pharmacotherapy for OCD, also 
significantly reduced both compulsive grooming behavior as well as the hyperactivity observed 
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during the compulsive behavior (Fig.4-3). Together these data are the first in vivo evidence of how 
genetically distinct striatal neurons (D1-SPNs) are regulating compulsive behavior, and hint at a 
complex role for the striatal microcircuit.  
Since the 1980s, cortico-basal ganglia circuits have been implicated in OCD through 
neuroimaging studies (Baxter et al. 1996; Breiter and Rauch 1996; Harrison, Pujol, Cardoner, 
Deus, Alonso, Lopez-Sola, et al. 2013; Harrison, Soriano-Mas, Pujol, Ortiz, Lopez-Sola, et al. 
2009; Insel and Winslow 1992; Milad and Rauch 2007; Nakao et al. 2005; Rauch et al. 1994a; 
Rotge et al. 2009a; Saxena et al. 1998). These specific circuits, sometimes referred to as the “OCD 
circuit” because of its well-replicated nature (Graybiel and Rauch 2000), are comprised of 
projections from frontal cortical regions to the dorsal striatum (caudate nucleus and putamen), and 
have most often been demonstrated to be hyperactive both at baseline and following symptom 
provocation (for a thorough review, see (Menzies et al. 2008b) and (Maia, Cooney, and Peterson 
2008)). This hyperactivity has been hypothesized to be the result of a bias toward activation of the 
direct pathway through the basal ganglia, which results in an overall disinhibition of cortical motor 
programs that might contribute to repetitive behaviors (e.g. compulsions) (Maia, Cooney, and 
Peterson 2008). The first major divergence in the direct pathway and its parallel counterpart, the 
indirect pathway, occurs in the striatum where direct pathway projecting neurons express the 
dopamine D1 receptor and indirect pathway neurons express the dopamine D2 receptor. Our data 
for the first time describe how direct pathway D1-SPNs are engaged during a compulsive behavior 
that persists in the fact of significant negative consequences, including the development of raw 
skin lesions (Welch et al. 2007a). 
Consistent with our findings, early work demonstrated that agonism of the D1 receptor was 
sufficient to produce repetitive grooming behavior (Page and Terry 1997; Starr and Starr 1986a, 
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1986b) and that genetically stimulating D1 neurons was sufficient to produce other repetitive 
behaviors (Campbell et al. 1999). Similarly, here we demonstrate that D1-SPN activity is increased 
during the production of compulsive behavior. Interestingly, we observed that D1-SPN activity 
was increased throughout the compulsive grooming sequence, not transiently at the onset of a 
grooming bout. These data are supported by findings that suggest D1-SPN activity is critical for 
the ongoing performance of a learned behavioral sequence (Tecuapetla et al. 2016), and that as a 
sequence progressess, there is a shift between D1-SPN activity occurring at the onset of the 
behavioral sequence to occurring during the sequence (Jin, Tecuapetla, and Costa 2014). In this 
framework, we can think of compulsive grooming behavior as a well-learned, habitual behavioral 
sequence. If this is true, we would expect strengthening at specific cortico-striatal synapses onto 
D1-SPNs. Recent work demonstrates the central striatum receives strong cortical input from 
supplementary motor region M2 (M2), and that this projection is strengthened in Sapap3-KO mice 
relative to WT mice (Corbit et al. 2019). These data are supported by findings that sustained 
activity of D1-SPNs during sequence learning is mediated through excitatory synaptic input from 
M2 (Rothwell et al. 2015).  
 Despite the fact that we were unable to directly study indirect pathway projecting D2-
SPNs in vivo in WTs and Sapap3-KOs due to technical challenges, we can use this same 
framework to infer how D2-SPNs may be involved in encoding compulsive grooming. Although 
the classic model of the direct and indirect pathway predict antagonistic control of motor behaviors 
(DeLong 1990; Wichmann and DeLong 1996; Graybiel 2000; Kravitz et al. 2010), more recent 
data suggests concurrent activity of direct and indirect pathway neurons during behavioral 
sequences (Cui et al. 2013; Jin and Costa 2010; Jin, Tecuapetla, and Costa 2014; Tecuapetla et al. 
2016). Specifically, D2-SPNs are active during initiation of (possibly even earlier than D1-SPNs) 
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a sequenced behavior and their activity decreases during behavioral execution (Jin, Tecuapetla, 
and Costa 2014), and this reduction in activity is necessary for accurate sequence completion 
(Rothwell et al. 2015). A prediction could be generated based on these findings that, in Sapap3-
KO mice, increased D2-SPN activity at the onset of grooming is observed relative to WT mice, 
resulting in the interruption of previously ongoing behaviors and the switch to a compulsive 
behavior. It is likely that both the proposed increase in KO D2-SPN activity during compulsive 
behavior, as well as the empirically noted sustained increase D1-SPN activity after the onset of 
compulsive behavior may be generated through changes in the function of striatal FSIs. Indeed, 
dysfunction of striatal FSIs have been previously noted in Sapap3-KO mice (Burguiere et al. 2015; 
Corbit et al. 2019). Given that striatal FSIs preferentially inhibit D1- over D2-SPNs (Gittis et al. 
2010), we might predict that FSI activation at grooming onset is reduced in KO mice relative to 
WTs. However, in the present set of experiments (Fig.4-5) we did not observe this to be the case, 






5.0 General discussion 
5.1 Summary of findings 
Glutamatergic dysfunction in cortico-striatal circuits has been hypothesized as a potential 
contributor to OCD pathophysiology for the better part of a decade (Bloch and Pittenger 2010; 
Pauls 2010; Pittenger, Bloch, and Williams 2011). To date, no direct assessment of this hypothesis 
has been conducted, and the functional consequences of potential dysfunction are mostly 
unknown. Gaining traction into this question is particularly critical, as relative to other major 
neuropsychiatric illnesses such as major depressive disorder (MDD) and schizophrenia for which 
substantial progress has been made identifying mechanistically distinct pharmacological treatment 
strategies, OCD pharmacotherapy still relies on treatments affecting monoaminergic systems 
whose link to pathogenesis has been all but disproven (Pittenger and Bloch 2014).  
Chapter 2 describes the first post-mortem examination of transcriptional dysregulation in 
the OFC and striatum of OCD subjects and focuses on excitatory and inhibitory transcripts, the 
two main neurotransmitters used in cortico-striatal circuits (Haber 2016). Recent work from 
various groups has implicated synaptic glutamatergic dysfunction at the genetic level in OCD 
((OCGAS) 2018; Pauls et al. 2014; Stewart et al. 2013) as well as in rodent models of compulsive 
behavior (Shmelkov et al. 2010; Welch et al. 2007a). Using tissue obtained from two regions of 
OFC (BA11 and BA47) and two striatal brain regions (caudate nucleus and nucleus accumbens) 
in OCD subjects and matched healthy comparison subjects, we assessed the expression of many 
of these candidate transcripts. We find that, contrary to our predictions, the majority of excitatory 
synaptic transcripts are reduced selectively in the OFC of OCD subjects relative to healthy 
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comparison subjects. Several transcripts, including DLGAP3 (also known as SAPAP3) were 
reduced across cortical and striatal brain regions, suggesting their involvement in multiple 
segments of the cortico-striatal loop. This finding is of particular interest, as Sapap3-knockout 
mice display a compulsive behavioral phenotype (Welch et al. 2007a) as well as cortico-striatal 
circuit deficits (Chen et al. 2011; Wan et al. 2014; Wan, Feng, and Calakos 2011) that involve 
specific projections from the lateral OFC (lOFC) to the central striatum (Burguiere et al. 2013). 
These mice present a unique opportunity to investigate the functional consequences of a reduction 
in Sapap3, which is enriched at cortico-striatal synapses (Welch et al. 2007a), similar to what we 
observed in OCD subjects.  
In Chapter 3, we utilize Sapap3-KO mice to investigate how reduced Sapap3 contributes 
to altered in vivo activity in the OFC and central striatum, the regions directly implicated in the 
compulsive grooming phenotype (Burguiere et al. 2013; Welch et al. 2007a). Using in vivo 
miniature microscopy, we find that, in the OFC, Sapap3-KO mice have reduced lOFC activity at 
the onset of compulsive behavior and that this is due to an increase in the percentage of cells that 
are inhibited during grooming onset. Further, we demonstrate that Sapap3-KO mice display central 
striatal hyperactivity transiently at the onset of compulsive behavior. This hyperactivity was not 
driven by an increase in the amplitude of individual central striatal SPNs activated during 
grooming onset, but rather by an increase in the recruitment of a greater percentage of SPNs 
relative to WT mice. Both the increase in the percentage of cells inhibited during grooming onset 
in the lOFC as well as the increase in the percentage of activated SPNs in Sapap3-KO mice were 
reversed by treatment with the first line pharmacotherapy, fluoxetine. In addition, we demonstrate 
that direct activation of central striatal SPNs was sufficient to cause grooming-related movements, 
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suggestive of a causal role for increased activated SPN number in compulsive behavior, and that 
selective activation of lOFC terminals in the central striatum may reduce compulsive grooming.  
Chapter 4 focuses on preliminary experiments assessing the activity of specific genetically 
distinct cell types in the central striatum during Sapap3-KO compulsive grooming. For 20 years 
OCD has been hypothesized to be the result of an imbalance in the direct and indirect pathway 
through the basal ganglia (Saxena and Rauch 2000; Maia, Cooney, and Peterson 2008; Pauls et al. 
2014; Ahmari 2016). In these experiments, we attempt to record activity from the cell type where 
the direct and indirect pathways first diverge, dopamine D1-receptor expressing and dopamine D2-
receptor expressing SPNs (Kravitz et al. 2010), respectively. We also present preliminary data 
recording from parvalbumin positive fast spiking interneurons (FSIs), which critically modulate 
the activity of SPNs (Berke 2011). We find that, consistent with models positing a bias toward 
direct pathway activation promoting compulsive behavior and with ex vivo findings (Ade et al. 
2016), that Sapap3-KO mice display increased activity in D1-SPNs that persists through the 
compulsive grooming sequence relative to WT mice. Fluoxetine administration again normalized 
this increase in activity. Finally, we provide preliminary evidence suggesting that central striatal 
FSI activity is normal in Sapap3-KO mice and speculate as to the role of D2-SPNs in compulsive 
behavior.  
Rather than simply rehash discussion points and conclusions from previous chapters, in the 
following sections I will attempt to synthesize our findings across species and discuss their 
implications for our understanding of OCD and OCD-related disorder pathophysiology as well as 
treatment strategies. I will also discuss limitations of the present experiments as well as future 
directions. 
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5.2 Linking reduced excitatory synaptic transcript expression to cortico-striatal activity 
changes 
The constellation of changes that we observed in excitatory synaptic transcripts and 
excitatory synaptic receptors in the OFC and striatum are difficult to map directly on to changes 
in activity levels in vivo, primarily due to the fact that our findings are likely only an isolated 
snapshot of the molecular disruption that is occurring at a very specific window in time (at time of 
death) (see 5.8 Future directions). It is perhaps more informative to consider changes in specific 
transcripts for which the basic science literature has causally investigated the function of their 
protein product on neural activity in cortical and striatal brain regions.  
One such transcript, SLC1A1, which encodes the neuronal glutamate transporter EAAT3, 
was reduced in the OFC but not the striatum of OCD subjects relative to unaffected comparison 
subjects. EAAT3 is expressed both peri- and post-synaptically (Nieoullon et al. 2006; Underhill et 
al. 2014) where it serves several roles, primarily taking up glutamate from the synapse (Otis et al. 
2004). Genetic association of SLC1A1 and OCD is one of the strongest and most well-replicated 
links in all of psychiatry (Pauls et al. 2014), though no single SNP has reached genome-wide 
significance ((OCGAS) 2018; Stewart et al. 2013). Expression of SLC1A1 and its isoforms has 
been found across the frontal cortex as well as the striatum in humans (Porton et al. 2013). 
Interestingly, reduced expression of SLC1A1 in lymphocytes obtained from OCD subjects 
compared to controls was detected (a finding that was sensitive to fluoxetine treatment), and the 
most commonly associated SNP within SLC1A1 predicts reduced expression in brain tissue 
(Porton et al. 2013; Wendland et al. 2009). Together, these data might suggest insufficient 
glutamate buffering at the synapse, which could contribute to cortico-striatal hyperactivity. 
However, it is worth considering that the majority of preclinical evidence suggests SLC1A1s role 
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in mediating repetitive behavior is through its actions in either the striatum, where we detect no 
change in SLC1A1 expression, or subcortically within dopaminergic neurons (Delgado-Acevedo 
et al. 2018; Zike et al. 2017), which have not yet been evaluated in post-mortem tissue. SLC1A1 
may still contribute to cortical and striatal hyperactivity even if its expression is unchanged within 
striatal neurons perhaps through alterations within the thalamus, as SNPs in SLC1A1 have been 
associated with changes in thalamic volume in OCD subjects (Wu et al. 2013). Reductions in 
thalamocortical SLC1A1 expression in OFC could lead to hyperactivity that is then translated 
downstream to the striatum and perpetuated throughout the cortico-striato-thalamo-cortical 
(CSTC) loop. Finally, it is worth considering that several isoforms of SLC1A1 have been found to 
be negative regulators of EAAT3 transporter function (Porton et al. 2013). As our primers were 
designed to amplify pan-SLC1A1, it is possible that these transcripts are included in this measure 
and would result in opposing effects on excitatory transmission in the OFC and the striatum.  
We also examined the expression of several SLITRK transcripts that encode transmembrane 
proteins known as SLITRKs which aid in neurite outgrowth and both glutamatergic and 
GABAergic synapse development (Takahashi and Craig 2013; Takahashi et al. 2012). Several 
SLITRK family members have been linked to OCD and related disorders, with rare variants in 
SLITRK1 being linked to Tourette’s syndrome (Abelson, Kwan, et al. 2005). Interestingly, in our 
study we did not detect any differences in SLITRK1 expression in any brain region studied. These 
data suggest that SLITRK1 may not be involved in OCD pathophysiology, a finding supported by 
data suggesting that SLITRK1-null mice lack behavioral phenotypes associated with compulsive 
behavior and do not appear to have any cortico-striatal abnormalities (Katayama et al. 2010). By 
contrast, we did observe an OFC specific reduction in another SLITRK family member, SLITRK3. 
SLITRK3 expression was recently implicated in OCD as it interacts with the PTPRD (protein 
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tyrosine phosphatase, receptor type D) protein at excitatory synapses ((OCGAS) 2018). Although 
levels of a third SLITRK family member, SLITRK5, were too low to detect in our experiments, we 
can consider data from Slitrk5 global knockout mice for how cortico-striatal activity may be 
altered. In addition to displaying compulsive grooming behavior, Slitrk5-KO mice display cortico-
striatal alterations, including reductions in the expression of striatal glutamate receptors, 
reminiscent of what we observe in our experiments (reductions of GRIA1 and GRIN2B in both 
OFC and striatum) (Shmelkov et al. 2010). Although these changes in receptor expression were 
striatal specific in Slitrk5-KOs, an increase in neuronal activity as measured by immediate early 
gene activation (FosB) were observed within the OFC and not striatum. One possible explanation 
for this discrepancy is that there may be differential activation of direct and indirect pathway-
projecting neurons in the striatum in Slitrk5-KO mice, and that simply looking at FosB across all 
striatal neuron subtypes may obscure pathway specific changes. Further, Shmelkov and colleagues 
(2010) only examined FosB expression in a restricted area of the dorsolateral striatum which gets 
limited input directly from OFC (Corbit et al. 2019; Oh et al. 2014). Although the exact molecular 
mechanism is not clear, data strongly suggest that reductions in SLITRK expressions in cortical 
and striatal brain regions could contribute to cortico-striatal activity changes in OCD.  
Finally, prior to our experiments, direct links between DLGAP3 and OCD were weak. 
While multiple genomic regions of DLGAP family member encoding DLGAP1 have emerged as 
potentially linked to OCD via two GWAS studies (though no single locus has reached genome-
wide significance) ((OCGAS) 2018; Stewart et al. 2013), DLGAP3 has only been tangentially 
related, with associations made in a subset of OCD patients with grooming disorders (Bienvenu et 
al. 2009a). More recent evidence has linked rare variants of DLGAP3 to OCD in a sample of 
subjects with a comorbid grooming disorder (Trichotillomania) (Zuchner et al. 2009). This 
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association with grooming disorders in humans perhaps should not be a surprise, given that 
Sapap3-knockout mice display a compulsive grooming behavior that leads to the development of 
skin lesions (Welch et al. 2007a). Given that DLGAP protein family members are critical for 
trafficking glutamate receptors (specifically AMPA and NMDA receptors) to excitatory synapses 
(Rasmussen, Rasmussen, and Silahtaroglu 2017), alterations in excitatory neurotransmission in 
cortico-striatal circuits are expected.  
Indeed, multiple studies have demonstrated dysfunctional cortico-striatal signaling in ex 
vivo preparations from Sapap3-KOs; however, most of these studies suggest a reduction in striatal 
activity mediated through changes in AMPA and NMDA composition at cortico-striatal (but not 
thalamo-striatal) synapses in the dorsolateral striatum (Chen et al. 2011; Wan et al. 2014; Wan, 
Feng, and Calakos 2011; Welch et al. 2007a). This is in stark contrast to our findings of increased 
striatal activity, mediated by an increased recruitment of striatal SPNs at the onset of grooming in 
Sapap3-KO mice. Several possible explanations for this discrepancy exist. First, findings from ex 
vivo preparations may not readily translate in vivo within the same circuits, due to a litany of 
factors, including changes in physiological conditions and alterations in connectivity even when 
care is taken to preserve the precise circuit being studied. In an ex vivo preparation it is not possible 
to maintain all relevant CSTC connections, rendering accurate assessment of activity within these 
loops impossible. A substantial and related difference between most ex vivo reports and our in vivo 
findings is also the age of Sapap3-KO when the experiments were conducted. Studies 
demonstrating reduced excitatory synaptic transmission at cortico-striatal synapses as well as 
increased silent synapses were all conducted in 17-25 day old Sapap3-KO mice, well before when 
the compulsive phenotype emerges (post-natal day (PND) 56-60; (Corbit et al. 2019)) and prior to 
occurrence of many plastic synaptic developmental changes. An inverse disconnect was recently 
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demonstrated in mutant mice lacking the post-synaptic density protein Shank3, with reductions in 
cortico-striatal activity identified in Shank3-KOs at adulthood (Peca et al. 2011) but markedly 
increased activity found early (< PND 30) in development (Peixoto et al. 2016). 
Indeed, when similar ex vivo electrophysiological recordings were conducted in adult 
Sapap3-KO mice of phenotypic age, circuit selective changes suggesting striatal hyperactivity 
emerged (Corbit et al. 2019). These data are complemented nicely by in vivo electrophysiological 
observations of baseline hyperactivity in the central striatum of 3-9 month old WT and Sapap3-
KO mice, which coincide nicely with our findings of grooming onset-specific increases in striatal 
hyperactivity (Burguiere et al. 2013). Together, these data suggest that Sapap3-KO mice 
recapitulate a critical and well-replicated observation from OCD patients: cortico-striatal 
dysfunction. With this in mind, it is useful to develop a neuropsychological model for how this 
dysfunction may relate to the canonical OCD symptoms of obsessions and compulsions.  
5.3 Action chunking: A parsimonious explanation for striatal dysfunction in Sapap3-KO 
mice 
One of the more intriguing findings in this thesis is our observation that D1-SPNs are 
hyperactive during grooming behavior in Sapap3-KO mice relative to WT mice (Fig.5-1a), 
although this activity was not time-locked precisely to the start of a grooming bout. Rather it 
persisted during the execution of the compulsive behavior. This sort of increase in direct pathway 
activation during compulsive behavior has long been hypothesized to underlie OCD symptoms 
(Saxena and Rauch 2000; Maia, Cooney, and Peterson 2008). Interestingly, this activation during 
execution of compulsive behavior is in contrast to our finding of a transient increase at grooming 
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onset in overall striatal activity at grooming onset (Fig.5-1c), suggesting that the other predominant 
cell type within the striatum, D2-SPNs, might be mediating this phenomenon (Fig.5-1b). Given 
that classic models of the direct and indirect pathway through the basal ganglia would not predict 
that such an increase in indirect pathway projecting D2-SPNs could lead to compulsive behavior 
(Kravitz et al. 2010), we need to find a conceptual framework that fits our findings. 
Figure 5-1. Hypothesized contribution of D1- and D2-SPNs to striatal hyperactivity 
(a) Activity of D1-SPNs during grooming onset display a pattern of increased calcium fluorescence during compulsive
grooming rather than at grooming onset. (b) Hypothesized transient increase in calcium fluorescence at and just before
grooming onset followed by a reduction in activity in D2-SPNs. (c) Calcium fluorescence from combined putative
D1- and D2-SPNs in the central striatum, characterized by a transient increase in fluorescence at grooming onset and
a slow decay during the execution of the compulsive behavior.
An attractive conceptual model that could explain our findings is that compulsive grooming 
behavior in Sapap3-KOs represent concatenated action sequences, as has been reported to occur 
when a behavior becomes habitual in both rodents and in humans (Graybiel 1998b; Jin, Tecuapetla, 
and Costa 2014; Wymbs et al. 2012). Critically, this concatenation of learned action sequences, or 
“chunking”, requires cortico-striatal circuitry (Graybiel 1995). This conceptual framework has 
previously been proposed to underlie OCD symptoms by numerous groups, and nicely bridges the 
cognitive component of OCD (obsessions) with the repetitive actions (compulsions) through 
dysfunction in parallel motor and cognitive cortico-basal ganglia loops (Graybiel and Rauch 2000). 
Our data of an overall increase in striatal activity at the onset of compulsive grooming sequence 
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(as well as offset; Fig.A-8), combined with data that per individual grooming sequence mice make 
more transitions between different types of grooming behavior per bout suggest that Sapap3-KO 
mice are engaging in chunking multiple segments of the compulsive sequence. Critically, wildtype 
mice do not display the same level of grooming onset activity, and engage in single grooming 
bouts with significantly fewer transitions. These data are consistent with findings that under 
normal conditions in wildtype mice central striatal activity is not associated with the onset of 
individual grooming movements (e.g. face grooming or body grooming in isolation), but is rather 
only found at the onset of syntactic grooming chains (Aldridge and Berridge 1998; Aldridge, 
Berridge, and Rosen 2004), which are sequences of concatenated grooming events conducted 
infrequently in normal mice (Kalueff et al. 2016). Perhaps the aberrant activity in the Sapap3-KO 
striatum signals the improper onset of a syntactic grooming chain, which qualitatively might be 
similar to an individual with OCD engaging in compulsive handwashing, a normative sequence of 
behavior that has become hijacked. An important consideration with this working hypothesis is 
that typically action chunking and habitual behavior is associated with activity in the dorsolateral 
striatum (Graybiel 1998b; Smith and Graybiel 2013a; Smith and Graybiel 2013c; Smith and 
Graybiel 2016), not the central striatum which appears dysfunctional in Sapap3-KO mice both in 
our studies and in those conducted by others (Burguiere et al. 2013). However, it is worth noting 
that onset and offset-related activity has also been detected in other striatal subregions upon 
acquisition of a habit (Howe et al. 2011) and are characteristically found in downstream basal 
ganglia structures that receive input from across the dorsal and ventral striatum, not just the 
dorsolateral portion (Jin and Costa 2010). Further, dorsolateral striatum dysfunction is well 
documented ex vivo in Sapap3-KO mice, and a similar bias toward D1-SPN signaling has been 
identified (Ade et al. 2016; Chen et al. 2011; Wan et al. 2014; Wan, Feng, and Calakos 2011; 
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Welch et al. 2007a). These data suggest the intriguing possibility that the Sapap3-KO striatum 
may be predisposed to developing habitual-like processing strategies, including chunking of 
normative behavioral patterns such as grooming. However, more work must be done to assess 
whether Sapap3-KO mice are more prone to developing canonical habitual behavior (Balleine and 
O'Doherty 2010), and whether it is in any way related to the compulsive grooming phenotype.  
5.4 The role of D1- and D2-SPNs in action chunking 
Our data showing ongoing hyperactivity in direct (D1-SPN) pathway projecting SPNs and 
the hypothesized role of indirect pathway (D2-SPN) projecting neurons during compulsive 
grooming are also broadly consistent with the existing literature on the distinct role of these 
pathways in the concatenation of behavioral sequences. Recent work from Dr. Rui Costa’s lab 
demonstrates that when mice perform a well-learned series of sequential actions, not all that 
dissimilar from the typical grooming sequence, populations of both D1- and D2-SPNs in the dorsal 
striatum are active at the start of the sequence (Jin, Tecuapetla, and Costa 2014). This is in line 
with our data that in both genotypes a percentage of D1-SPNs are active at the onset of a grooming 
bout. Interestingly, Jin and colleagues (2014) demonstrated that  mice performed a well-learned 
sequence, a significantly greater proportion of D1-SPNs displayed increased activity that persisted 
through the execution of the sequence compared to D2-SPNs. These data are consistent with our 
observation that during execution of the compulsive behavior there is a significant increase in the 
percentage of active D1-SPNs in Sapap3-KO mice relative to WTs. By contrast, in (Jin, 
Tecuapetla, and Costa 2014) D2-SPN activity was elevated only at the start of the learned 
behavioral sequence and inhibited during the execution of the behavior, with D2-SPN activity 
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preceding D1-SPN activity. These data suggest that, during well learned action sequences, such as 
a syntactic grooming chain, D2-SPNs will be preferentially active at the onset of the sequence in 
Sapap3-KO mice relative to WT mice. In a different sequence learning task, it was recently 
demonstrated that a similar phenomenon occurs, with sustained activity of D1-SPNs and quiescent 
activity of D2-SPNs necessary for accurate sequence completion (Rothwell et al. 2015). 
Interestingly, in this task it was found that behavioral training was associated with strengthening 
of the synapse from supplementary motor area M2 (M2) to D1-SPNs. This same cortico-striatal 
projection (though not specific to D1- or D2-SPNs) was recently identified as strengthened in 
Sapap3-KO mice relative to WT mice (Corbit et al. 2019), providing a potential substrate for 
central striatal hyperactivity and chunking of action sequences.  
Of course, the activity of D1- and D2-SPNs are not occurring in isolation, and changes 
across the frontocortical-striatal-thalamo-cortical loops have been consistently observed in OCD 
(Pauls et al. 2014; Maia, Cooney, and Peterson 2008; Menzies et al. 2008b). An outstanding 
question is, how are cortical regions that project to the central striatum behaving during sequences 
of compulsive grooming? Interestingly, in the lOFC, a major source of input to the central striatum 
(Corbit et al. 2019; Oh et al. 2014), we observe hypoactivity at the onset of compulsive behavior 
in Sapap3-KO mice relative to WT mice. These data coincide with observations in OCD patients 
that avoidance habit formation was associated with hypoactivation of the OFC and hyperactivation 
of the caudate nucleus (Gillan et al. 2015; Gillan et al. 2014a). One possible mechanism by which 
hypoactivation of OFC could be occurring is through feedback through the cortico-basal ganglia 
loop. It was recently demonstrated that activation of striatal D2-SPNs, while overall reducing 
cortical activity, transiently excited a subpopulation of superficial cortical neurons (Oldenburg and 
Sabatini 2015). As the majority of layer 1 cortical neurons are inhibitory interneurons (Larkum 
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2013), it is possible that in vivo activation of D2-SPNs may result in a reduction in cortical activity 
as the compulsive behavioral sequence unfolds. Importantly, Oldenburg and colleagues (2015) 
found no such population of neurons were found following stimulation of D1-SPNs, suggesting 
that while negative feedback might affect D2-SPNs, D1-SPN activity would remain elevated 
throughout the behavioral sequence, similar to what we observe during compulsive behavior, and 
what has been reported by others during well-learned action sequences (Jin, Tecuapetla, and Costa 
2014; Rothwell et al. 2015; Cui et al. 2013).  
Taken together, these data suggest a complex interplay between direct and indirect pathway 
projecting striatal neurons in regulating compulsive behavior. Overall, they support a role for a 
bias toward direct pathway activation in individuals with OCD, though they suggest a substantial 
role for the indirect pathway as well. Obtaining in vivo data from D2-SPNs as well as other striatal 
neuron subtypes during compulsive behavior will be necessary for a comprehensive interpretation.  
5.5 Fast spiking interneurons: A critical and vulnerable cell type 
While only comprising between 1-3% of all striatal cells, striatal fast-spiking neurons 
(FSIs) are hypothesized to exert feed-forward inhibition onto networks of nearby SPNs (Berke 
2011). Though this property of FSIs has been difficult to observe in vivo, a recent study did 
demonstrate that optogenetically reducing FSI activity was capable of disinhibiting nearby SPNs 
(Owen, Berke, and Kreitzer 2018). Although our extremely preliminary data obtained from only a 
single Sapap3-KO and WT mouse suggest no difference in activity of central striatal FSIs during 
compulsive behavior, previous reports suggest functional changes that implicate them in both the 
compulsive behavioral phenotype as well as the treatment response to fluoxetine. In one report, 
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Burguiere and colleagues (2013) demonstrated that optogenetic stimulation of lOFC terminals in 
the central striatum of Sapap3-KO mice was capable of entraining striatal FSIs and resulted in a 
subsequent reduction in SPN activity. These data suggest that there is a deficit in feed-forward 
inhibition in Sapap3-KO mice, which may serve to produce and maintain the hyperactive state of 
central striatal SPNs discussed previously. While changes in markers of FSIs, such as the calcium 
binding protein parvalbumin (PV), have not been identified in OCD (including in our studies, see 
Chapter 2), it is worth noting that in an OCD-related disorder characterized by repetitive behavior, 
Tourette’s syndrome, expression of PV in the striatum is reduced relative to healthy comparison 
subjects (Kalanithi et al. 2005; Kataoka et al. 2010). A causal link between PV expression and 
repetitive behavior was recently made, with ablation of striatal FSIs (resulting in a 40% reduction) 
causing elevated grooming and anxiety-like behavior, though only following stress paradigms (Xu, 
Li, and Pittenger 2016). A recent report out of our laboratory suggests the picture is also more 
complicated than these previous heavy-hammer approaches suggest, with input to central striatal 
FSIs in Sapap3-KO and WT mice differing as a function of specific cortical inputs (lOFC and M2) 
(Corbit et al. 2019). Regardless, ample data suggest that striatal FSI dysfunction may be relevant 
to repetitive and compulsive behavior.  
We have also raised the intriguing possibility that striatal FSIs may serve as a novel target 
for treatment of OCD and compulsive behaviors, which the field desperately needs (Pittenger and 
Bloch 2014). Consistent with previous studies suggesting that serotonin as well as SSRIs can 
increase the excitability of FSIs (Zhong and Yan 2011; Athilingam et al. 2017; Blomeley and 
Bracci 2009), we observe that fluoxetine can reduce the grooming-associated activity of all 
putative central striatal SPNs, as well as of D1-SPNs specifically, on the same time scale as the 
reduction in compulsive behavior. While glutamatergic agents such as ketamine and memantine 
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are beginning to show promise for the treatment of OCD and related disorders (Hirschtritt, Bloch, 
and Mathews 2017; Rodriguez et al. 2015; Rodriguez et al. 2016), these compounds have 
significant drawbacks often in the form of adverse side effects (Kirby 2015) that necessitate the 
development of more specific compounds with similar therapeutic efficacy (Zanos et al. 2015). 
One possibility raised from our studies would be that rather than decreasing glutamatergic tone via 
glutamate receptor antagonists, potentially directly targeting FSIs would serve as a more specific 
therapy. This could potentially be achieved through activation of the 5-HT2 class of receptors, 
which are expressed on FSIs and mediate the depolarizing effects of fluoxetine (Zhong and Yan 
2011; Athilingam et al. 2017). Preclinically, specific 5-HT2C receptor agonists have been used to 
reduce compulsive eating in a rodent model, and in our hands the same compound reduces 
grooming in Sapap3-KO mice (Fig.A-9). Future experiments will evaluate whether these 
compounds selectively modulate striatal FSIs in vivo.  
5.6 Limitations & Future directions 
Throughout we have discussed some logical immediate follow-up experiments that would 
paint a more complete picture of the role of excitatory synaptic dysfunction in cortical and striatal 
brain regions in OCD. Rather than re-iterate those same experiments here, we will instead focus 
on future experiments born out of the questions and models discussed above.  
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5.6.1  Human post-mortem experiments 
Our post-mortem experiments provide a glimpse of potential excitatory synaptic 
dysfunction in cortical and striatal regions in OCD, but also raise a considerable amount of 
questions that must be addressed in future experiments. First, what is the scope of the dysfunction? 
An unbiased RNA-sequencing experiment of these same subjects and regions is already 
completed, and data analysis is beginning. With a complete picture of the transcriptome, it will be 
much easier to infer how activity in both the cortex and the striatum might be changed in OCD 
subjects relative to healthy comparison subjects. These experiments will also shed light on novel 
molecular pathways that may be involved separate from synaptic dysfunction. We are extremely 
interested into moving closer to function, as transcript changes do not always correlate with 
alterations in functional protein. We already have preliminary large scale proteomic data focusing 
on a curated list of synaptic proteins from a single cortical and single striatal brain region from our 
OCD subjects and matched comparisons. Given the magnitude of change we observe at the 
transcript level, we expect to see similar proteomic changes in both the OFC and striatum.  
Another interesting question is to evaluate the extent of the decreased expression we 
observed in excitatory synaptic transcripts. The similarity in expression levels within the OFC 
regions examined suggests that perhaps these reductions in expression would be found in other 
regions that participate in other cortico-basal ganglia loops. Further, it would be useful to examine 
a cortical region not typically associated with cortico-striatal signaling, such as a primary sensory 
area (e.g. V1) (Haber 2016). In this case I would not expect to see the same changes in excitatory 
synaptic gene expression that we observed in the OFC. Overall, our post-mortem experiment 
serves as excellent hypothesis generating data, both for future studies in post-mortem tissue as well 
as studies in rodents.  
 138 
5.6.2  Translational rodent experiments 
Future experiments in Sapap3-KO mice will seek to further investigate the circuit and 
specific cellular mechanisms underlying compulsive behavior. A major limitation of the present 
experiments pertains to investigating the effects of fluoxetine on circuit function. It will be critical 
to include vehicle treated control groups for future experiments, as interpretation of neural activity 
after fluoxetine treatment may simply represent activity changes that might occur over time or 
following repeated injections. Current datasets all include two-week washout days (data not yet 
analyzed), where imaging was conducted two weeks after the final fluoxetine administration, 
which should help clarify whether our effects are due to drug or the aforementioned confounding 
factors. Our current data strongly suggest that cells in the central striatum control grooming or 
grooming related movements, but it is still unclear the causal role they play in the compulsive 
grooming phenotype shown by Sapap3-KO mice. In order to directly test their role, 
complementary inhibitory experiments in Sapap3-KO mice using an inhibitory opsin such as 
halorhodopsin expressed in striatal neurons must be conducted. However, these experiments are 
quite challenging without a closed-loop stimulation paradigm that would allow for stimulation 
immediately at the onset (or even prior to onset) of compulsive behavior. Current experiments are 
evaluating whether data from an accelerometer attached to the miniature microscope can be 
accurately decoded on-line to provide rapid and precise information about whether an animal is 
grooming. While our data suggest that lOFC input to the central striatum of Sapap3-KO mice is 
reduced at the onset of grooming, recently published data from our lab suggests that there is 
increased input from M2. Additionally, ChR2 stimulation of M2 terminals in the central striatum 
of WT mice causes an increase in grooming probability relative to control virus (Fig.A-10). Future 
experiments will use a variety of strategies, including using transsynaptic viruses that will allow 
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for cre-mediated transgene expression in cells that project to central striatum from isolated cortical 
regions in order to explore the precise role of lOFC versus M2 in compulsive grooming in Sapap3-
KO mice.  
We have also suggested that, based on activity patterns observed during compulsive 
behavior in the lOFC and striatum, Sapap3-KO mice may be prone to developing habitual 
behavior. This hypothesis should be directly tested using conventional operant devaluation or 
contingency degradation experiments. Our hypothesis for these experiments would be that 
Sapap3-KO mice might shift from using a goal-directed response strategy to a habitual one earlier 
in training, and that this dysfunction may be associated with elevated central striatal activity (as 
opposed to dorsolateral striatal activity).  Another active area of investigation is how Sapap3-KOs 
perform on sequence learning tasks where the roles of D1- and D2-SPNs have recently been 
elucidated (Cui et al. 2013; Jin, Tecuapetla, and Costa 2014; Rothwell et al. 2015). Based on the 
data presented here, we might predict that Sapap3-KOs would have a bias toward more sequence 
starts but less completions, similar to their fragmented and uncompleted grooming chains.  
Finally, given the goals set out in the introduction of this dissertation, a future experiment 
that would be broadly interesting would be to attempt to investigate the causal effects of modifying 
multiple transcripts in a single mouse model. While monogenic knockouts are excellent for 
isolating the effects of a single gene or protein on a circuit of interest (Picciotto and Wickman 
1998), the reality is that most neuropsychiatric diseases are likely caused by multiple genetic 
insults, each of small effect size ((OCGAS) 2018; Bloch and Pittenger 2010). Just as optogenetics 
has revolutionized our ability to associate specific circuits and cells, as we utilized in this 
dissertation, with particular behavioral phenotypes, the CRISPR-cas9 system may dramatically 
improve our ability to precisely target specific molecular pathways (Sadhu et al. 2018). Disrupting 
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multiple genes (e.g. multiple genes encoding for excitatory synaptic proteins) at once would allow 
for a more accurate model of specific pathological phenotypes, though it has the potential to make 
interpretation of these changes more challenging.  
5.7 Conclusions 
In summary, this dissertation provides the first evidence that OCD subjects have altered 
expression of glutamatergic synaptic transcripts in regions consistently linked to OCD via 
structural and functional neuroimaging studies (the OFC and the striatum).  Taking a translational 
approach, we also investigated how compulsive behavior was encoded in homologous brain 
regions (lateral OFC and the central striatum) of a mouse globally lacking one of these critical 
excitatory synaptic transcripts (Sapap3). These data lend support to hypotheses positing that 
compulsive behavior may be the result of imbalance in the direct and indirect pathway through the 
basal ganglia and demonstrate how a first-line pharmacological treatment for OCD may be 
normalizing this balance. Altogether, these data lay the groundwork for future investigations of 






Appendix A Chapter 2, 3 & 4 Supplemental details 
Figure A-1. Stable expression of two housekeeping genes, ACTB and PPIA, in OCD and unaffected comparison 
subjects. 
No significant differences were observed across all 4 brain regions in the geometric mean of the cycle threshold values 














Figure A-2. No effect of antidepressant medications at time of death on expression of significantly altered 
transcripts in OCD subjects. 
No significant differences in expression of 8 transcripts that were differentially affected by OCD diagnosis were 
observed between OCD subjects on (n = 5) and off (n = 3) antidepressants at time of death within BA11 (A), BA47 










Figure A-3. No effect of benzodiazepines at time of death on expression of significantly altered transcripts in 
OCD subjects. 
No significant differences in expression of 8 transcripts that were differentially affected by OCD diagnosis were 
observed between OCD subjects on (n = 4) and off (n = 4) benzodiazepines at time of death within BA11 (A), BA47 
(B), caudate (C), or NAc (D). All t6 < 2.7 and all p > 0.23. 
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Figure A-4. No effect of comorbid major depressive disorder (MDD) diagnosis on expression of significantly 
altered transcripts in OCD subjects. 
No significant differences in expression of 8 transcripts that were differentially affected by OCD diagnosis were 
observed between OCD subjects with an MDD diagnosis (n = 4) and those without an MDD diagnosis (n = 4) within 
BA11 (A), BA47 (B), caudate (C), or NAc (D). All t6 < 2.2 and all p > 0.44. 
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Figure A-5. Histological verification of lens placement in lOFC 
Each line indicates the estimated location of bottom of the 200 µm focal distance below the 0.5 mm diameter lens 
(inset image).  
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Figure A-6. Histological verification of lens implants into central striatum 
Each line indicates the estimated location of bottom of the 200 µm focal distance below the 0.5 mm diameter lens 









Figure A-7. Effect of fluoxetine on central striatal FSI activity in Sapap3-KO mice 
(top) Image depicting mCherry reporter expression from PV-cre / Sapap3-KO mouse injected with a cre-mediated 
reporter virus. (bottom) Ex vivo voltage clamp recording of central striatal FSI firing rates at baseline at a variety of 









Figure A-8. Central striatal activity aligned to grooming-stop in WT and Sapap3-KO mice 
(a) Heatplots for all cells in WT (top) and Sapap3-KO mice (bottom). Each row represents an individual SPNs 
response to all grooming bout stops, sorted by average fluorescence in the peri-grooming window (-0.5s to 3s). (b) 
Grooming-stop aligned calcium fluorescence across all SPNs in each genotype (all significant t(2577) ≥ 4.28, p ≤ 
0.000019, unpaired t-test). (c) Percentage of groom-stop activated (t(17) = 4.748, p = 0.0002, unpaired t-test) and 








Figure A-9. Effect of 5-HT2C receptor agonist on compulsive grooming in WT and Sapap3-KO mice. 
Effect of subchronic (5 day) treatment with the 5-HT2C receptor agonist (1R,3S)-(−)-trans-1-phenyl-3-dimethylamino-
1,2,3,4-tetrahydronaphthalene (PAT) on grooming in WT and Sapap3-KO mice (t(13) = 2.511, p = 0.0514, Sidak’s 













Figure A-10. Effect of M2 terminal stimulation in central striatum of wildtype mice.  
(top) Average response of M2 terminal activation (blue bar; 20Hz 473nm wavelength stimulation for 20s) in ChR2-
positive and eYFP-positive WT mice. (bottom) Individual ChR2-positive mice demonstrates heterogeneity in response 










Table A-1. Oligonucleotide sequences of forward and reverse primers used for each transcript in this study. 
Oligonucleotide sequence length was between 18 and 23 bases for each primer. Primers were designed using NCBI 
Primer-Blast and synthesized by Integrated DNA technologies (IDT; Coralville, Iowa, USA). Transcript variants 
(indicated by the letter V) were considered detectable if the primer sequence and target sequence template was a 100% 
match1. Genes with no characterized transcript variants are indicated by2.  
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Table A-2. Detailed information on data analyzed for each transcript across subject pairs and regions. 
For most transcripts and subject pairs, all 8 subjects were analyzed (empty squares). Two transcripts (SLITRK3 and 
PVALB) did not have detectable levels of transcript expression in the NAc of all subjects, and SLC17A7 expression 
was too low to be detected in both the caudate and NAc of all subjects; these values could therefore not be included 
in the analysis (indicated by grey crosshatch). In addition, a single subject pair (pair 8) had low RNA yield for 6 
transcripts (indicated by orange shading).  
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Table A-3. Expanded demographic information for all subjects 
Demographic characteristics for all subjects (n = 8 per diagnostic group), including comorbidities. a: PMI (post-
mortem interval) in hours. b: RIN (RNA integrity) measured by Agilent Genomics Bioanalyzer 2100. c: MOD 
(manner of death). d: COD (cause of death), ASVCD (arrhythmogenic right ventricular dysplasia). e: Comorbidities: 
OCPD (obsessive-compulsive personality disorder), MDD (major depressive disorder), BPD (bipolar disorder), GAD 
(generalized anxiety disorder), PD (panic disorder), PTSD (post-traumatic stress disorder).  
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Table A-4. Detailed uncorrected and corrected p-values using the Benjamini-Hochberg adjustment for false 
discovery rate. 

















DLGAP1 F1,10  =  2.8 0.1300 0.1600 F3,30   =  1.8 0.1700 0.1943 F3,30  = 3.5 0.0300 0.0800 0.1460 0.0468 0.8624 0.1122 0.2294 0.1287 0.8624 0.1899
DLGAP2 F1,10  = 34.4 0.0001 0.0016 F3,30  = 3.5 0.0300 0.0914 F3,30  = 5.4 0.0040 0.0320 0.0004 0.0026 0.4717 0.1010 0.0044 0.0191 0.5765 0.1852
SLITRK3 F1,8 = 21.7 0.0020 0.0160 F2,16 = 2.9 0.0800 0.1600 F2,16 = 4.2 0.0300 0.0800 0.0004 0.0230 0.1680 0.0044 0.1012 0.2464
DLGAP3 F1,10 = 7.0 0.0300 0.0600 F3,30 = 1.9 0.1600 0.1943 F3,30 = 0.2 0.9000 0.9000
DLGAP4 F1,10 = 7.4 0.0200 0.0600 F3,30 = 3.3 0.0400 0.0914 F3,30 = 1.3 0.3000 0.4000
SLITRK1 F1,8 = 3.0 0.1200 0.1600 F3,24 = 2.4 0.0900 0.1600 F3,24 = 1.0 0.4000 0.4571
GRIA1 F1,8 = 9.0 0.0200 0.0600 F3,24 = 1.0 0.3900 0.4160 F3,24 = 1.6 0.2100 0.3733
GRIN2B F1,8 = 6.9 0.0300 0.0600 F3,24 = 1.8 0.1700 0.1943 F3,24 = 1.1 0.3600 0.4431
SLC1A1 F1,10 = 5.0 0.0500 0.0889 F3,30 = 3.2 0.0400 0.0914 F3,30 = 3.7 0.0200 0.0800 0.0757 0.0337 0.7060 0.3133 0.1514 0.1236 0.8121 0.4308
SLC17A7 F1,10 = 12.4 0.0050 0.0267 F1,10 = 0.02 0.8900 0.8900 F1,10 = 0.02 0.8900 0.9000
GAD1 F1,10 = 6.9 0.0300 0.0600 F3,30 = 4.3 0.0100 0.0533 F3,30 = 7.2 0.0010 0.0160 0.0115 0.0693 0.8489 0.0532 0.0633 0.1514 0.8624 0.1300
GAD2 F1,10 = 2.6 0.1400 0.1600 F3,30 = 3.9 0.0200 0.0800 F3,30 = 2.9 0.0520 0.1189
PVALB F1,10 = 2.8 0.1300 0.1600 F2,20 = 5.6 0.0100 0.0533 F2,20 = 4.9 0.0200 0.0800 0.1134 0.7383 0.4256 0.1287 0.8121 0.5508
CALB1 F1,10 = .84 0.3800 0.4053 F3,30 = 24.7 0.0001 0.0016 F3,30 = 1.3 0.2700 0.4000
GABARAP F1,8 = .2.8 0.1300 0.1600 F3,24 = 2.3 0.1000 0.1600 F3,24 = 1.3 0.3000 0.4000
SLC32A1 F1,8 = .004 0.9500 0.9500 F3,24 = 2.0 0.1400 0.1943 F3,24 = 2.2 0.1000 0.2000

















Synaptic F1,10 = 21.2 0.0010 0.0027 F3,30 = 2.9 0.0520 0.0780 F3,30 = 5.2 0.0050 0.0075 0.0062 0.0003 0.7894 0.1034 0.0213 0.0024 0.7894 0.2122
Receptor F1,8 = 21.2 0.0018 0.0027 F3,24 = 2.5 0.0814 0.0814 F3,24 = 4.7 0.0103 0.0103 0.0004 0.0097 0.2607 0.1878 0.0024 0.0233 0.3476 0.2817
GABA F1,10 = 6.1 0.0335 0.0335 F3,30 = 4.9 0.0071 0.0213 F3,30 = 8.7 0.0003 0.0009 0.0071 0.3597 0.3437 0.1635 0.0213 0.3924 0.3924 0.2803
Main effect of diagnosis Main effect of brain region Diagnosis by brain region interaction Uncorrected B-H correction
Uncorrected B-H correctionMain effect of diagnosis Main effect of brain region Diagnosis by brain region interaction
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Appendix B Using Optogenetics to Dissect the Neural Circuits Underlying OCD and 
Related Disorders 
Using Optogenetics to Dissect the Neural Circuits Underlying  
OCD and Related Disorders 
Current Treatment Options in Psychiatry (2015) 2:297-311 
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Clinical and preclinical studies have uncovered substantial evidence that dysfunction in 
cortico-striatal-thalamo-cortical (CSTC) loops central to the selection of action strategies may 
underlie OCD symptoms. In human OCD, data suggest that the balance between selection of 
habitual versus goal-directed action strategies is disrupted, with concomitant hyperactivation of 
CSTC regions associated with these strategies. Preclinical lesion and inactivation studies of 
homologous CSTC regions in rodents have shed light on how sub-regions of the frontal cortex and 
striatum can have dissociable effects on the exhibition of goal-directed or habitual behavior. 
However, these traditional methods lack the precision necessary to dissect the exact projections 
and cell types underlying these behaviors. It is essential to uncover this information to begin to 
determine how disruption in these circuits may lead to disease pathology. Here we summarize 
several recent studies that utilize optogenetics, a technique that allows stimulation or inhibition of 
specific neural projections and cell types using light, to further understand the contribution of 
CSTC activity to both action selection and the OCD-relevant behavior of perseverative grooming. 
Based on these experiments and findings in human OCD patients, we argue that OCD symptoms 
may not only be associated with an enhancement of habitual behavior, but also with aberrant 
recruitment of goal-directed neural circuits. We also discuss the current status of translating 
optogenetic technology to primates, as well as how findings in rodents may help inform treatment 
of patients suffering from OCD and related disorders.  
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B.2 Introduction 
Maladaptive repetitive actions and thoughts are key features of many neuropsychiatric 
illnesses, including autism (McDougle et al. 1995), substance abuse disorders (Everitt and Robbins 
2005), Tourette's syndrome (Diagnostic and statistical manual of mental disorders, (DSM-5®)  
2013), and eating disorders (Smith and Robbins 2013). The burden of these symptoms is perhaps 
most clearly highlighted in obsessive compulsive disorder (OCD), a chronic and severe mental 
illness affecting 2-3% of people worldwide and identified as a leading cause of illness-related 
disability by the World Health Organization (Kessler et al. 2005). Recently separated from anxiety 
disorders in the DSM-5 based on proposed differences in neural substrates, subtypes of OCD are 
unified by the commonality of repetitive behaviors and/or thoughts that severely impair 
functioning. Several theories exist that may explain the pathophysiologic processes leading to 
compulsive behavior. Importantly, these proposed models posit dysfunction in distinct brain 
regions that comprise cortico-striato-thalamo-cortical (CSTC) loops, which are thought to be 
responsible for controlling action selection and behavioral inhibition (Valentin, Dickinson, and 
O'Doherty 2007). Specific cortical and striatal regions within each loop have been linked to the 
development of either goal-directed or habitual behavior. In rodent studies, compulsive behavior 
has been linked to a progressive shift from recruitment of goal-directed systems to habit-related 
systems (Everitt and Robbins 2005, 2013), which has led to the proposal of the habit hypothesis 
of OCD (Graybiel and Rauch 2000). However, the habit theory may not account for a key facet of 
compulsions in OCD - the intense urge to act (Denys 2014), which is indicative of a behavior that 
is still goal-directed. Similar to models within the framework of addiction (Sjoerds et al. 2014), 
we propose that compulsive behaviors observed in OCD contain a substantial motivational and 
goal-directed component.  
 158 
 
Here we will summarize evidence from both human and preclinical animal studies linking 
dysfunctional CSTC activity to repetitive behaviors, and discuss potential implications of these 
findings for treatment. We will also highlight recent studies that investigate whether directly 
altering activity in discrete CSTC loops can change action strategies and affect compulsive 
behaviors. Based on convergent findings from animal and human OCD studies, we propose that 
compulsive behaviors may be induced either through increased habit system activity or enhanced 
recruitment of goal-directed systems.  
B.2.1 Neuroimaging studies highlight abnormalities in CSTC loops in OCD 
While the pathogenesis of OCD is still unknown, structural and functional neuroimaging 
studies have identified alterations in CSTC regions that are major players in the development of 
both goal-directed behaviors and habits in OCD patients compared to unaffected controls. Three 
general CSTC loops are believed to be important for controlling different neurocognitive functions 
and are comprised of different interconnected brain regions (Milad and Rauch 2012b). These 
include the sensorimotor loop, which controls motor and response inhibition via lateral OFC 
(lOFC) projections to the putamen, the cognitive loop, which regulates working memory via 
connections between dorsolateral PFC (dlPFC) and the caudate nucleus, and the affective loop, 
which directs reward processing through interactions between the anterior cingulate cortex (ACC), 
the medial OFC (mOFC), and the ventral striatum (Di Martino et al. 2008; Posner et al. 2014). For 
each loop, information from the striatum is passed through the basal ganglia and ultimately 
conveyed back to the cortex via thalamic relays (Milad and Rauch 2012b; Di Martino et al. 2008). 
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Multiple lines of evidence suggest dysfunction in many of these regions– most of which contribute 
to producing goal-directed and habitual behavior– in OCD.    
Functional magnetic resonance imaging (fMRI) studies highlight a role for both 
frontocortical structures (such as the OFC and ACC) and the striatum in OCD. Resting state studies 
suggest that, compared to healthy controls, OCD subjects have increased activity within both OFC 
and ACC (Baxter et al. 1987; Swedo et al. 1989), as well as the caudate (dorsal striatum) (Nordahl 
et al. 1989). OFC and caudate hyperactivity and ACC activity are further accentuated during 
symptom provocation, suggesting a potential casual role for these nuclei in the generation or 
expression of OCD symptoms (Rauch et al. 1994b; Adler et al. 2000b). Successful treatment of 
symptoms correlates with reduced activity in both caudate and OFC, regions associated with goal-
directed action strategies (Valentin, Dickinson, and O'Doherty 2007), as measured by positron 
emission tomography and magnetic resonance spectroscopy (Abelson, Curtis, et al. 2005; Rauch 
et al. 2002; Rosenberg et al. 2000). In addition to elevated resting state activity, abnormal 
functional connectivity between these regions has also been observed. In particular, some (but not 
all, see (Posner et al. 2014)) data suggest increased functional connectivity between the ventral 
striatum/nucleus accumbens and medial OFC (mOFC) (Harrison, Soriano-Mas, Pujol, Ortiz, 
López-Solà, et al. 2009; Fitzgerald et al. 2011b; Hou et al. 2012), a finding that is predictive of 
illness severity (Harrison, Pujol, Cardoner, Deus, Alonso, López-Solà, et al. 2013). These 
functional imaging studies provide evidence that activity in regions involved in the development 
of both goal-directed and habitual behaviors is abnormal in OCD. 
Though structural imaging studies have also suggested alterations in the caudate in both 
adults (Robinson et al. 1995; Scarone et al. 1992) and children (Rosenberg et al. 1997) with OCD, 
the directionality of change has not been consistent. In addition, increases in ventral striatal gray 
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matter are observed in OCD subjects compared to controls and subjects with other anxiety 
disorders, implicating the ventral striatum in the formation of repetitive behavior rather than 
generalized anxiety (Menzies et al. 2008b). Structural differences have also been detected in 
fronto-cortical regions. Decreased ACC volume has been reported in OCD patients (Menzies et al. 
2008b; Radua et al. 2010), and alterations in OFC grey matter volume in adult OCD have been 
observed (Radua et al. 2010; Rotge et al. 2009b; Atmaca et al. 2007b) (though it is unclear if these 
changes are compensatory (Radua and Mataix-Cols 2009)). In addition to changes in gray matter 
density, abnormalities in white matter integrity have been identified using diffusion tensor imaging 
in corpus callosum, anterior limb of the internal capsule, and cingulum bundle. As with the 
aforementioned neurochemical and fMRI findings, decreases in white matter integrity within the 
left striatum of OCD patients could be reversed with chronic pharmacotherapy (Fan et al. 2012), 
suggesting that these changes may be central to the pathophysiology of the disorder. Although less 
consistent than functional imaging studies, structural MRI studies therefore identify alterations in 
OCD subjects within many of same brain regions which are responsible for the development of 
goal-directed and habitual behavior. 
Further evidence of CSTC dysfunction in OCD comes from invasive neurosurgical 
techniques used in treatment refractory OCD patients. It is estimated that 10-20% of patients with 
OCD do not respond to traditional pharmacological and psychological therapy (Husted and 
Shapira 2004; Rodman et al. 2012; Greenberg et al. 2010; Denys et al. 2010). Some of these 
individuals may benefit from treatments that directly target dysfunctional circuitry, including deep 
brain stimulation (DBS). DBS uses constant high-frequency electrical stimulation in targeted brain 
regions, and although the mechanism of action is unknown, some theories suggest that it is 
efficacious due to normalization of hyperactivity (Abelson, Curtis, et al. 2005). Currently, one of 
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the most frequently studied DBS targets with substantial efficacy for OCD treatment is the ventral 
capsule/ventral striatum (VC/VS), with 25% of patients achieving remission after a year of 
stimulation (Greenberg et al. 2010; Greenberg, Rauch, and Haber 2010; Denys et al. 2010). VC/VS 
DBS normalized intraregion hyperactivity and reduced the increased functional activity observed 
between striatum and frontal cortex (Figee, Luigjes, et al. 2013; Figee, Wielaard, et al. 2013). 
Again, this highlights the possible role of dysfunctional goal-directed behavior in OCD, since the 
VS is implicated in the prediction and evaluation of reward value, a necessary component of 
successful goal-directed action (Everitt and Robbins 2005). Together, these data highlight the 
involvement of regions that regulate habitual and goal directed behavior in the pathophysiology of 
OCD, and provide hypotheses that can be tested utilizing new circuit-based interventions in animal 
models. 
B.2.2 Disruptions in habitual and goal directed behavior in OCD 
Several recent studies in OCD patients have supported the hypothesis that compulsions 
stem from abnormal goal directed versus habitual striatal-mediated action strategies. First, in an 
instrumental conditioning paradigm, both OCD patients and controls learned to correctly 
discriminate between two visual stimuli at the same rate (Gillan et al. 2011). However, following 
devaluation of one of the two stimuli, OCD patients continued to respond to the devalued reward, 
reminiscent of rodents with DMS lesions (Yin, Knowlton, and Balleine 2005) (see animal model 
section below). Similarly, in an aversive conditioning paradigm, where correct discrimination of 
two visual stimuli leads to avoidance of a shock, no learning differences were detected (Gillan et 
al. 2014b). However, following overtraining and devaluation, OCD patients continued to avoid the 
devalued stimulus, despite the fact that they were consciously aware that it no longer predicted the 
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shock. Using a modified version of the same task, researchers recently linked this increased habit 
formation back to CSTC circuits, finding increased activation of the caudate (DMS) in patients 
whose behavior had become habitual, and increased activation of the mOFC in all OCD subjects 
(Gillan et al. 2015).  Together these data suggest a shift in balance from goal directed to habitual 
action selection strategy in OCD. However, it is worth noting that the degree of shock avoidance 
did not correlate with compulsion symptom severity (as measured by YBOCS compulsion 
subscale), suggesting the bias toward habitual strategy may not be relevant to OCD 
symptomatology. Further, OCD patients reported an increased urge to respond despite devaluation, 
suggesting that enhanced responding may still be goal-directed (Gillan et al. 2015; Gillan et al. 
2014b). These findings are broadly consistent with one current theory of drug addiction proposed 
by Sjoerds and colleagues (Sjoerds et al. 2014), in which compulsive drug seeking can be 
conceptualized as a maladaptive motivational habit with a substantial goal directed component. 
Taken together with the identification of hyperactivity in regions linked to goal-directed behavior 
(the mOFC and caudate) by Gillan et al. (Gillan et al. 2015), it is possible that compulsivity in 
OCD may arise, at least for avoidance habits, from aberrant goal-directed recruitment.  
Several other lines of evidence support a potential enhancement of the goal-directed action 
system in OCD. In experiments in which implicit (habitual) learning is examined, enhanced 
utilization of regions of the goal directed system, including the OFC, is observed in OCD patients 
compared to controls (Rauch, Savage, Alpert, Dougherty, et al. 1997; Rauch et al. 2007b). When 
explicit learning or processing is introduced during the implicit task (thereby activating goal-
directed circuitry), the performance of OCD patients compared to controls is impaired 
(Deckersbach et al. 2002; Joel et al. 2005). A parsimonious explanation for these seemingly 
contradictory behavioral results, in which some data suggest an over-reliance on habit systems at 
 163 
the expense of goal-directed systems (Gillan et al. 2011), while others indicate a strengthening of 
goal-directed actions in OCD (Deckersbach et al. 2002; Joel et al. 2005), has recently been 
summarized by Gruner and colleagues (Gruner et al. 2015). However, the exact circuit level 
mechanisms regulating the inappropriate recruitment of either behavioral strategy are still not 
clear. Until recently, correlations between systems level disruptions in cortico-striatal-thalamic-
cortical (CSTC) circuits and relevant behavioral abnormalities in OCD have provided the best 
available insight into the underlying neurobiology of OCD, since manipulation of specific neural 
circuits is still not possible in humans. Researchers have therefore now turned to animal models to 
address questions of causality. 
B.2.3 Circuits mediating goal directed and habitual behavior 
To dissect the circuit mechanisms underlying the recruitment of goal-directed versus 
habitual behaviors, elegant studies have been performed in rodent models. This work has been 
essential to our understanding of drug addiction, which has been conceptualized as a disorder in 
which there is a gradual shift from recruitment of goal-directed systems to habit systems (Everitt 
and Robbins 2005). According to classic theory, the formation of habits arises when action-
outcome driven (A-O) behaviors lead to learned stimulus-response (S-R) associations (Adams 
2007; Balleine and Dickinson 1992). Habitual behavior in normal animals (S-R driven) is typically 
induced by overtraining an animal during an operant task (e.g. pressing a lever for a reward). When 
the reward is then subsequently devalued through aversive conditioning, overtrained animals 
continue to respond despite the change in outcome, while normally trained animals respond less 
for the devalued outcome, indicative that the behavior remains goal-directed and flexible (Yin, 
Knowlton, and Balleine 2006). The neural basis for this change in strategy appears to lie in a shift 
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from associative CSTC circuits to sensorimotor circuits, in analogous structures to those that are 
dysfunctional in OCD.  Specifically, habitual responding can be induced via lesion of dorsomedial 
striatum (DMS: caudate in primates) (Yin, Knowlton, and Balleine 2005, 2004). In contrast, 
disruption of the dorsolateral striatum (DLS: putamen in primates) promotes goal-directed 
behavior, even after overtraining and outcome devaluation (Yin and Knowlton 2006; Yin, 
Knowlton, and Balleine 2004). Furthermore, substantial plasticity in these regions has been 
observed via in vivo recordings during habit formation. For example, during learning of a maze 
task, DLS activity rapidly shifts to a task-bracketing pattern during training, in which activity is 
high during both the beginning and end of a maze run (Thorn et al. 2010). This "chunking" pattern 
is believed to allow for more rapid and efficient neural processing during habitual behavior 
(Graybiel 2008). By contrast, activity in DMS is initially high at decision points during training 
and gradually decreases throughout overtraining, consistent with its role in action-outcome 
learning (Thorn et al. 2010).  
Less is known about upstream mediators that may regulate the shift between goal directed 
and habitual action strategies. Lesion and inactivation studies suggest that two adjacent frontal 
cortical regions, the prelimbic (PL) and infralimbic (IL) cortices, may be important for regulating 
the switch between behavioral strategies. When activity of IL (akin to primate BA25) is inhibited, 
an animal's behavior becomes goal directed ((Coutureau and Killcross 2003): inactivation, 
(Killcross and Coutureau 2003): lesion). In contrast, when activity of PL (akin to primate BA32, 
part of anterior cingulate cortex) is disrupted, an animal's behavior becomes less goal-directed 
(Killcross and Coutureau 2003; Balleine and Dickinson 1998). In addition to these regions, lesions 
of the lateral OFC in the monkey disrupt the ability to form action-outcome associations 
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(Rudebeck and Murray 2011), indicating that OFC is also crucial for goal-directed decision 
making.  
B.2.4 Development of optogenetics for investigation of complex behavior 
Although animal models have provided great insight into the brain regions mediating goal-
directed vs habitual behavior, until recently they were limited by the inability to manipulate 
specific cell-types in particular neural circuits. This limitation has recently been surmounted by 
the development of optogenetics, a technique that leverages light-sensitive ion channels, known as 
opsins, for the precise activation and inhibition of neural circuits of interest. Although opsins were 
first isolated from microbial organisms approximately 40 years ago (Oesterhelt and Stoeckenius 
1971; Matsuno-Yagi and Mukohata 1977), their utility for manipulating cellular activity has only 
recently been harnessed (Boyden et al. 2005). In the first wave of studies, two major opsins were 
used to bidirectionally alter cellular activity: 1) channelrhodopsin (ChR2), a cation channel that 
depolarizes cells in response to blue light (Boyden et al. 2005; Nagel et al. 2002); and 
halorhodopsin (NpHR), a chloride pump that hyperpolarizes cells in response to yellow light 
(Zhang, Aravanis, et al. 2007; Zhang, Wang, et al. 2007). As first reported in the seminal paper 
from Boyden and colleagues in 2005 (Boyden et al. 2005), the expression of these light sensitive 
ion channels in mammalian neurons combined with local light delivery (Aravanis et al. 2007; 
Arenkiel et al. 2007) allows for control of membrane excitability with millisecond temporal 
precision; this is significantly faster and more precise than traditional pharmacological methods. 
Significant efforts have since focused on expansion of the opsin family to improve kinetics, 
enhance photocurrents, limit toxicity, and broaden the range of usable light wavelengths. This has 
led to the creation of many valuable reagents, such as C1V1 (Erbguth et al. 2012) and ReaChR 
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(Lin et al. 2013), which are red-shifted excitatory opsins; archaerhodopsin (ArchT), an outward 
driven proton pump that more efficiently hyperpolarizes cell membranes and therefore yields 
larger photocurrents compared to NpHR (Han et al. 2011); and more potent forms of ChR2, such 
as ChETA with improved kinetics (Gunaydin et al. 2010), ChR2-TC that allows for lower intensity 
light stimulation (Berndt et al. 2011), and step function opsins (SFO) with which single light pulses 
can stably alter membrane potential (Berndt et al. 2009).  
In addition to unrivaled temporal resolution, optogenetics provides unique advantages over 
traditional pharmacological and electrical stimulation, including spatial resolution and targeting to 
genetically distinct cell populations via stereotactic injection of viral vectors under the control of 
cell-type specific promoters (Mattis et al. 2012). Additional specificity can be gained using 
combinatorial genetic approaches that include virally expressing opsins only in cells with 
genetically encoded cre-recombinase, a strategy which has now been successfully used many times 
to manipulate small populations of cells during behavioral tasks (Tsai et al. 2009; Witten et al. 
2010; Fenno, Yizhar, and Deisseroth 2011). Furthermore, optogenetic methods allow for the 
dissection of microcircuits on a scale not previously possible. Following injection of an opsin-
encoding virus (either promoter or cre-dependent) into a region of interest, infected cells will 
express the channel or pump throughout the cell membrane, including at the axon terminals. 
Implanting a light source into the terminal region allows for precise manipulation of very specific 
projections within a microcircuit rather than pan-activation of cell bodies that project to multiple 
target sites (see Fig.B-1 and (Tye and Deisseroth 2012) for detailed description). As we will 
highlight later in this review, this technique can be used to tease apart the contribution of 
subregion-specific projections to complex behaviors.  
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B.2.5 Optogenetic manipulation of habit and goal directed circuits 
Over the past 5 years, optogenetics has been utilized to more precisely define the circuits 
that control goal directed versus habitual behavior according to traditional lesion and inactivation 
studies, as well as to determine how activity of these circuits may contribute to OCD-relevant 
behavior. In 2013, Gremel & Costa established a behavioral paradigm to better understand the 
mechanisms underlying the shift from goal directed to habitual actions. To test whether separate 
neural ensembles within CSTC circuits control goal directed versus habitual behavior, or whether 
two types of action strategies are encoded by identical ensembles, they constructed a novel 
behavioral task in which animals performed an identical action (a lever press) using either a goal 
directed (random ratio) or habitual (random interval) strategy. As predicted based on prior studies, 
lesions to DMS resulted in habitual behavior in both conditions, while lesions to DLS led to goal 
directed behavior. Lesioning lOFC had the same effect as a DMS lesion–i.e. producing habitual 
responding. These data suggest that the lOFC and DMS are critical for encoding changes in 
outcome value. In order to test the necessity and sufficiency of lOFC activation in encoding 
outcome value, the authors next conducted chemogenetic loss of function (Alexander et al. 2009; 
Pei, Dong, and Roth 2010) and optogenetic gain of function studies. After injection of a virus 
encoding the inhibitory designer receptor exclusively activated by designer drug (DREADD) 
(hM4Di) into the lOFC and subsequent inhibition via administration of its ligand clozapine-N-
oxide (CNO), mice behaved in a habitual manner, similarly to performance following an OFC 
lesion. Based on these findings, the authors hypothesized that activation of OFC projection neurons 
would enhance goal directed behavior. Bilateral activation of lOFC cell bodies via optical 
stimulation had no effect when the reward was still valued in the random ratio condition. Instead, 
it drastically increased lever pressing when the reward was devalued, resulting in levels of pressing 
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similar to non-devalued rats, which the authors interpreted as an enhancement of goal directed 
behavior. These data support previous studies suggesting that goal directed behavior is controlled 
by the DMS, while habitual behavior is subserved by the DLS (Yin, Knowlton, and Balleine 2005; 
Dezfouli and Balleine 2012). Furthermore, they confirm the role of the OFC in encoding value and 
goal directed behavior (Valentin, Dickinson, and O'Doherty 2007; Damasio, Tranel, and Damasio 
1990).  
Optogenetics has also been used to investigate the contribution of affective/prefrontal 
circuits to the shift from goal directed to habitual behavior. These experiments focused on 
manipulating the infralimbic PFC (IL), which directly projects to the DMS (Killcross and 
Coutureau 2003; Balleine and Dickinson 1998) and may indirectly project to the DLS via the 
ventral striatum or the amygdala (Hurley et al. 1991). A dual pattern of connections to the 
sensorimotor network (DLS; promoting habitual behavior) and to regions that promote goal 
directed behavior (DMS) suggests that the IL may exert executive control over habit formation. 
To assess the real-time impact of IL activity on habit formation, Smith and colleagues (2012) 
selectively expressed halorhodopsin (NpHR3) bilaterally in IL pyramidal cells. Based on tones, 
rats then learned to predict which arm of a T-maze contained one of two food rewards. After 
overtraining, rats received home-cage devaluation of one of the rewards through conditioned taste 
aversion. After devaluation, control rats continued to run to the devalued arm, suggesting this 
behavior had become habitual. In contrast, rats that received optical inhibition of the IL 
immediately after devaluation generally ran to the non-devalued arm, suggesting that IL inhibition 
blocked habit expression. Consistent with literature suggesting that once a habit is broken it is 
often replaced with another habit, all rats that received devaluation began to run consistently to the 
non-devalued reward in response to the devalued tone. These responses increased over time in 
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both groups, suggestive of new habit formation. Strikingly, when IL optical inhibition was 
performed 2 weeks post-devaluation, the rats immediately ran back to the devalued arm. This 
suggests that, as with initial habit formation, the IL was responsible for the establishment of the 
new habit. These data support the idea that inhibition of the IL restores previously learned action 
strategies once a new habit is ingrained (Killcross and Coutureau 2003). Consistent with this 
interpretation, while in vivo activity in the DLS exhibited characteristic task bracketing during the 
middle of acquisition of this T-maze task (Thorn et al. 2010; Graybiel 1998a), activity in the IL 
only became task bracketed very late in overtraining, when habits become crystallized (Smith and 
Graybiel 2013b). To test the significance of IL task bracketing during overtraining, rats received 
bilateral injection of NpHR3 in the IL and underwent T-maze training in an independent study 
(Smith et al. 2012). Optical inhibition of IL pyramidal neurons was conducted selectively during 
overtraining, when task-bracketing activity appeared during recording. As predicted, habit 
formation was blocked in rats with IL perturbation during overtraining (Smith and Graybiel 
2013b). Together, these data suggest that IL activity has a role in both the formation and the 
expression of habits. Recent computational work in humans corroborates these findings, 
implicating the inferior lateral PFC (ilPFC) and frontopolar cortex (FPC) as potential arbitrators 
of the switch from goal-directed to habitual behavior through connections with the putamen (Lee, 
Shimojo, and O'Doherty 2014). 
B.2.6 Optogenetic manipulation of circuits underlying compulsive behavior 
Two recent optogenetic studies have begun to explore the relationship of the hyperactivity 
of CSTC pathways observed in human OCD to the development and resolution of perseverative 
behavior. An experiment conducted by Burguiere and colleagues (2013) used a transgenic mouse 
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model of OCD-like behavior based on deletion of Sapap3 (SAP90/PSD95-associated protein 3), 
which is found in the post-synaptic density of glutamatergic synapses and interacts with PSD95 
and other scaffolding proteins (Takeuchi et al. 1997). Genetic variants of SAPAP3 have been 
linked to OCD and grooming disorders, such as trichotillomania and skin-picking ((Bienvenu et 
al. 2009a; Züchner et al. 2009) correspondingly), and Sapap3 knockout (KO) mice exhibit OCD-
related behaviors including compulsive over-grooming and increased anxiety (Welch et al. 2007b). 
In this study, an aversive conditioning paradigm was used to train mice to associate a tone with 
delivery of a drop of water on their head. As training progressed, both wild-type and SAPAP3 KOs 
successfully learned that the tone predicted the water drop, and groomed in response to the tone. 
However, wild-type mice began to inhibit this response late in training, only grooming after the 
water drop was presented. In contrast, Sapap3 KOs were unable to inhibit the response to the tone, 
and instead continued to groom after tone presentation throughout training (Burguiere et al. 2013); 
this was reminiscent of the findings from the conditioning experiments in OCD patients described 
above. The authors then characterized the neural underpinnings of this impaired behavioral 
inhibition, finding that the deficit was correlated with elevated striatal activity in Sapap3 KOs. 
Supporting the hypothesis that this increased activity of striatal medium spiny neurons (MSNs) 
resulted from a loss of striatal inhibitory interneurons, they observed that Sapap3 KOs had fewer 
parvalbumin-positive (PV+) interneurons in the centromedial striatum (CMS). In an attempt to 
correct for this deficit, they then performed selective ChR2-mediated optogenetic stimulation of 
projections from lOFC to CMS. This intervention both reversed the deficit in behavioral inhibition 
and the increased striatal activity, presumably via enhancing the responsiveness of the remaining 
PV-positive interneurons and restoring normal feed-forward inhibition. These experiments 
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provided support for the idea that lOFC regulates the inhibition of conditioned responses, and 
linked hyperactivity in striatum to compulsive behavior.  
In a complementary set of studies, our lab used optogenetics to test whether inducing 
hyperactivity in CSTC circuits in wild-type mice directly leads to abnormal repetitive behaviors. 
Focusing on the subregions that have been implicated in goal-directed behavior and anxiety, we 
selectively expressed ChR2 in excitatory projections from mOFC to ventromedial striatum (VMS). 
Although acute optogenetic stimulation did not lead to OCD-related behavioral changes, brief but 
repeated stimulation of mOFC-VMS projections led to a significant increase in perseverative 
grooming over the course of 5-6 days (Ahmari et al. 2013). Strikingly, this increase in grooming 
was persistent for up to 2 weeks after cessation of the optogenetic stimulation. Together, these 
findings suggested the development of pathologic plasticity at mOFC-VMS. In support of this 
concept, we demonstrated a progressive increase in evoked firing rate of VMS neurons over 5 days 
of stimulation using in vivo recording. Lending support to the idea that these plastic changes may 
have relevance to pathologic processes involved in OCD, both the increased grooming behavior 
and the increase in evoked firing were normalized by chronic SSRI administration. Our data 
suggest that brief but repeated hyperstimulation of regions implicated in both goal-directed 
behavior (mOFC and medial striatum) and limbic/anxiety circuits (VMS) can lead to perseverative 
behavior that may be relevant to OCD. These data therefore support the hypothesis that 
hyperactivity in goal-directed circuits can lead to the development of abnormal repetitive 
behaviors. Future studies will seek to synthesize these two sets of findings, which together suggest 
there may be two paths to producing perseverative behavior– i.e. through dysfunction of either 
habit systems or goal-directed/limbic systems.    
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Figure B-1. Projection-specific expression and activation of excitatory opsin (ChR2) to dissect OCD-related 
circuitry. 
Presynaptic neurons within the OFC of EMX-cre mice are transduced with ChR2-EYFP. An optical fiber is implanted 
into the target region (VMS) and blue light (473 nm wavelength) is delivered to excite infected projection neurons. 
(Inset)Blue light stimulation selectively activates OFC projection neurons infected with ChR2, resulting in 
depolarization of post-synaptic medium spiny neurons (MSNs) selectively connected to OFC. Uninfected projection 
neurons from the OFC or from other regions are unaffected by optical stimulation. 
B.3 Summary and conclusions
Over the past 5 years, optogenetic experiments have led to rapid progress in dissecting the 
functional relationship between CSTC circuits and the development of OCD-relevant behaviors in 
animal models. Chief among these findings are the importance of different prefrontal and striatal 
subregions in the control of goal-directed versus habitual behavior, and the direct test of the 
hypothesis that hyperactivity in OFC and striatal circuitry is involved in OCD-relevant behavioral 
phenotypes in normal and pathological animals (Gremel and Costa 2013; Ahmari et al. 2013; 
Burguiere et al. 2013). These findings provide a causal link to some of the most well replicated 
findings in human OCD imaging studies, demonstrating OFC hyperactivity and altered functional 
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connectivity between OFC and the medial striatum (Harrison, Pujol, Cardoner, Deus, Alonso, 
López-Solà, et al. 2013; Menzies et al. 2008b). Interestingly, involvement of the mOFC suggests 
that an over-reliance on the goal directed system (including the mOFC and medial striatum) may 
play a role in the development of compulsive behavior (Gruner et al. 2015). These data are 
particularly interesting in light of recent neuroimaging findings in which increased avoidance habit 
formation in OCD patients was associated with hyperactivation of mOFC and medial striatum, 
classically thought of as regions promoting goal directed behavior (Yin, Knowlton, and Balleine 
2005; Gillan et al. 2015; Balleine and Dickinson 1998). Future work will determine how other 
regions outside of the CSTC involved in anxiety and reward, such as the amygdala, ventral 
hippocampus, and VTA, may be involved in mediating compulsive behavior.  
B.4 Future directions and prospective implications for treatment of OCD and related 
disorders 
Optogenetics has allowed for unparalleled precise control in animal model systems over 
circuits implicated in OCD and known to be involved in goal directed and habitual behavior. Future 
research will focus on elucidating the molecular mechanisms underlying not only the onset of 
compulsive and perseverative behaviors, but also their persistence. The striking findings of 
Burguiere and colleagues (2013) and our group that optogenetic stimulation of disease-relevant 
neural circuits can alter perseverative behavior raises the attractive possibility of optogenetics as a 
potential therapeutic tool for OCD and related disorders. However, substantial hurdles exist before 
this technology can be translated to humans, including synthesizing viruses that are both safe for 
humans and can effectively target specific cell types. In addition, experiments using optogenetics 
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in primates to date have had substantial difficulty in generating the striking behavioral effects that 
are commonly observed in rodent studies (Han et al. 2011; Diester et al. 2011); the reasons for this 
are unclear, but must be determined before progress can be made towards using the technology in 
people. Finally, further progress still needs to be made towards development of wireless systems 
for effective stimulation, though this goal is clearly within reach (Diester et al. 2011). More 
practically, optogenetics will continue to be utilized as a valuable tool for dissection of circuits 
known to be dysfunctional in human disease. Indeed, the potential combination of optogenetics 
and fMRI (Desai et al. 2011) or in vivo calcium imaging (Shipley et al. 2014) provide important 
avenues for enhancing our understanding of how hyperactivity of a single pathway (e.g. OFC to 
VMS) can impact brain-wide networks. Critically, the information gained from these targeted 
approaches will inform therapeutics either through the refinement of current technologies, such as 
DBS and transcranial magnetic stimulation (TMS), or through the development of new 
technologies, such as closed loop systems that would allow for real-time adjustment of stimulation 
parameters based on abnormal neural activity patterns (Kent and Grill 2011). 
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